A M EDICAL D ICTIONARY , B IBLIOGRAPHY , AND A NNOTATED R ESEARCH G UIDE TO I NTERNET R EFERENCES
J AMES N. P ARKER , M.D. AND P HILIP M. P ARKER , P H .D., E DITORS
ii
ICON Health Publications ICON Group International, Inc. 4370 La Jolla Village Drive, 4th Floor San Diego, CA 92122 USA Copyright Ó2003 by ICON Group International, Inc. Copyright Ó2003 by ICON Group International, Inc. All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without written permission from the publisher. Printed in the United States of America. Last digit indicates print number: 10 9 8 7 6 4 5 3 2 1
Publisher, Health Care: Philip Parker, Ph.D. Editor(s): James Parker, M.D., Philip Parker, Ph.D. Publisher's note: The ideas, procedures, and suggestions contained in this book are not intended for the diagnosis or treatment of a health problem. As new medical or scientific information becomes available from academic and clinical research, recommended treatments and drug therapies may undergo changes. The authors, editors, and publisher have attempted to make the information in this book up to date and accurate in accord with accepted standards at the time of publication. The authors, editors, and publisher are not responsible for errors or omissions or for consequences from application of the book, and make no warranty, expressed or implied, in regard to the contents of this book. Any practice described in this book should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation. The reader is advised to always check product information (package inserts) for changes and new information regarding dosage and contraindications before prescribing any drug or pharmacological product. Caution is especially urged when using new or infrequently ordered drugs, herbal remedies, vitamins and supplements, alternative therapies, complementary therapies and medicines, and integrative medical treatments. Cataloging-in-Publication Data Parker, James N., 1961Parker, Philip M., 1960High Blood Pressure: A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References / James N. Parker and Philip M. Parker, editors p. cm. Includes bibliographical references, glossary, and index. ISBN: 0-597-83709-0 1. High Blood Pressure-Popular works. I. Title.
iii
Disclaimer This publication is not intended to be used for the diagnosis or treatment of a health problem. It is sold with the understanding that the publisher, editors, and authors are not engaging in the rendering of medical, psychological, financial, legal, or other professional services. References to any entity, product, service, or source of information that may be contained in this publication should not be considered an endorsement, either direct or implied, by the publisher, editors, or authors. ICON Group International, Inc., the editors, and the authors are not responsible for the content of any Web pages or publications referenced in this publication.
Copyright Notice If a physician wishes to copy limited passages from this book for patient use, this right is automatically granted without written permission from ICON Group International, Inc. (ICON Group). However, all of ICON Group publications have copyrights. With exception to the above, copying our publications in whole or in part, for whatever reason, is a violation of copyright laws and can lead to penalties and fines. Should you want to copy tables, graphs, or other materials, please contact us to request permission (E-mail:
[email protected]). ICON Group often grants permission for very limited reproduction of our publications for internal use, press releases, and academic research. Such reproduction requires confirmed permission from ICON Group International Inc. The disclaimer above must accompany all reproductions, in whole or in part, of this book.
iv
Acknowledgements The collective knowledge generated from academic and applied research summarized in various references has been critical in the creation of this book which is best viewed as a comprehensive compilation and collection of information prepared by various official agencies which produce publications on high blood pressure. Books in this series draw from various agencies and institutions associated with the United States Department of Health and Human Services, and in particular, the Office of the Secretary of Health and Human Services (OS), the Administration for Children and Families (ACF), the Administration on Aging (AOA), the Agency for Healthcare Research and Quality (AHRQ), the Agency for Toxic Substances and Disease Registry (ATSDR), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the Healthcare Financing Administration (HCFA), the Health Resources and Services Administration (HRSA), the Indian Health Service (IHS), the institutions of the National Institutes of Health (NIH), the Program Support Center (PSC), and the Substance Abuse and Mental Health Services Administration (SAMHSA). In addition to these sources, information gathered from the National Library of Medicine, the United States Patent Office, the European Union, and their related organizations has been invaluable in the creation of this book. Some of the work represented was financially supported by the Research and Development Committee at INSEAD. This support is gratefully acknowledged. Finally, special thanks are owed to Tiffany Freeman for her excellent editorial support.
v
About the Editors James N. Parker, M.D. Dr. James N. Parker received his Bachelor of Science degree in Psychobiology from the University of California, Riverside and his M.D. from the University of California, San Diego. In addition to authoring numerous research publications, he has lectured at various academic institutions. Dr. Parker is the medical editor for health books by ICON Health Publications.
Philip M. Parker, Ph.D. Philip M. Parker is the Eli Lilly Chair Professor of Innovation, Business and Society at INSEAD (Fontainebleau, France and Singapore). Dr. Parker has also been Professor at the University of California, San Diego and has taught courses at Harvard University, the Hong Kong University of Science and Technology, the Massachusetts Institute of Technology, Stanford University, and UCLA. Dr. Parker is the associate editor for ICON Health Publications.
vi
About ICON Health Publications To discover more about ICON Health Publications, simply check with your preferred online booksellers, including Barnes & Noble.com and Amazon.com which currently carry all of our titles. Or, feel free to contact us directly for bulk purchases or institutional discounts: ICON Group International, Inc. 4370 La Jolla Village Drive, Fourth Floor San Diego, CA 92122 USA Fax: 858-546-4341 Web site: www.icongrouponline.com/health
vii
Table of Contents FORWARD .......................................................................................................................................... 1 CHAPTER 1. STUDIES ON HIGH BLOOD PRESSURE ........................................................................... 3 Overview........................................................................................................................................ 3 The Combined Health Information Database................................................................................. 3 Federally Funded Research on High Blood Pressure ..................................................................... 5 E-Journals: PubMed Central ....................................................................................................... 31 The National Library of Medicine: PubMed ................................................................................ 32 CHAPTER 2. NUTRITION AND HIGH BLOOD PRESSURE................................................................ 121 Overview.................................................................................................................................... 121 Finding Nutrition Studies on High Blood Pressure .................................................................. 121 Federal Resources on Nutrition ................................................................................................. 122 Additional Web Resources ......................................................................................................... 123 CHAPTER 3. ALTERNATIVE MEDICINE AND HIGH BLOOD PRESSURE ......................................... 127 Overview.................................................................................................................................... 127 National Center for Complementary and Alternative Medicine................................................ 127 Additional Web Resources ......................................................................................................... 128 General References ..................................................................................................................... 149 CHAPTER 4. DISSERTATIONS ON HIGH BLOOD PRESSURE ........................................................... 151 Overview.................................................................................................................................... 151 Dissertations on High Blood Pressure ....................................................................................... 151 Keeping Current ........................................................................................................................ 152 CHAPTER 5. CLINICAL TRIALS AND HIGH BLOOD PRESSURE ...................................................... 153 Overview.................................................................................................................................... 153 Recent Trials on High Blood Pressure ....................................................................................... 153 Keeping Current on Clinical Trials ........................................................................................... 155 CHAPTER 6. PATENTS ON HIGH BLOOD PRESSURE ...................................................................... 157 Overview.................................................................................................................................... 157 Patents on High Blood Pressure ................................................................................................ 157 Patent Applications on High Blood Pressure............................................................................. 170 Keeping Current ........................................................................................................................ 183 CHAPTER 7. BOOKS ON HIGH BLOOD PRESSURE.......................................................................... 185 Overview.................................................................................................................................... 185 Book Summaries: Federal Agencies............................................................................................ 185 Book Summaries: Online Booksellers......................................................................................... 186 Chapters on High Blood Pressure .............................................................................................. 195 Directories.................................................................................................................................. 196 CHAPTER 8. MULTIMEDIA ON HIGH BLOOD PRESSURE ............................................................... 199 Overview.................................................................................................................................... 199 Video Recordings ....................................................................................................................... 199 Bibliography: Multimedia on High Blood Pressure ................................................................... 204 CHAPTER 9. PERIODICALS AND NEWS ON HIGH BLOOD PRESSURE ............................................ 205 Overview.................................................................................................................................... 205 News Services and Press Releases.............................................................................................. 205 Newsletters on High Blood Pressure ......................................................................................... 207 Newsletter Articles .................................................................................................................... 208 Academic Periodicals covering High Blood Pressure................................................................. 208 CHAPTER 10. RESEARCHING MEDICATIONS................................................................................. 211 Overview.................................................................................................................................... 211 U.S. Pharmacopeia..................................................................................................................... 211 Commercial Databases ............................................................................................................... 217 APPENDIX A. PHYSICIAN RESOURCES .......................................................................................... 221
viii Contents
Overview.................................................................................................................................... 221 NIH Guidelines.......................................................................................................................... 221 NIH Databases........................................................................................................................... 223 Other Commercial Databases..................................................................................................... 226 APPENDIX B. PATIENT RESOURCES ............................................................................................... 227 Overview.................................................................................................................................... 227 Patient Guideline Sources.......................................................................................................... 227 Finding Associations.................................................................................................................. 243 APPENDIX C. FINDING MEDICAL LIBRARIES ................................................................................ 245 Overview.................................................................................................................................... 245 Preparation................................................................................................................................. 245 Finding a Local Medical Library................................................................................................ 245 Medical Libraries in the U.S. and Canada ................................................................................. 245 ONLINE GLOSSARIES ................................................................................................................ 251 Online Dictionary Directories ................................................................................................... 251 HIGH BLOOD PRESSURE DICTIONARY .............................................................................. 253 INDEX .............................................................................................................................................. 317
1
FORWARD In March 2001, the National Institutes of Health issued the following warning: "The number of Web sites offering health-related resources grows every day. Many sites provide valuable information, while others may have information that is unreliable or misleading."1 Furthermore, because of the rapid increase in Internet-based information, many hours can be wasted searching, selecting, and printing. Since only the smallest fraction of information dealing with high blood pressure is indexed in search engines, such as www.google.com or others, a non-systematic approach to Internet research can be not only time consuming, but also incomplete. This book was created for medical professionals, students, and members of the general public who want to know as much as possible about high blood pressure, using the most advanced research tools available and spending the least amount of time doing so. In addition to offering a structured and comprehensive bibliography, the pages that follow will tell you where and how to find reliable information covering virtually all topics related to high blood pressure, from the essentials to the most advanced areas of research. Public, academic, government, and peer-reviewed research studies are emphasized. Various abstracts are reproduced to give you some of the latest official information available to date on high blood pressure. Abundant guidance is given on how to obtain free-of-charge primary research results via the Internet. While this book focuses on the field of medicine, when some sources provide access to non-medical information relating to high blood pressure, these are noted in the text. E-book and electronic versions of this book are fully interactive with each of the Internet sites mentioned (clicking on a hyperlink automatically opens your browser to the site indicated). If you are using the hard copy version of this book, you can access a cited Web site by typing the provided Web address directly into your Internet browser. You may find it useful to refer to synonyms or related terms when accessing these Internet databases. NOTE: At the time of publication, the Web addresses were functional. However, some links may fail due to URL address changes, which is a common occurrence on the Internet. For readers unfamiliar with the Internet, detailed instructions are offered on how to access electronic resources. For readers unfamiliar with medical terminology, a comprehensive glossary is provided. For readers without access to Internet resources, a directory of medical libraries, that have or can locate references cited here, is given. We hope these resources will prove useful to the widest possible audience seeking information on high blood pressure. The Editors
1
From the NIH, National Cancer Institute (NCI): http://www.cancer.gov/cancerinfo/ten-things-to-know.
3
CHAPTER 1. STUDIES ON HIGH BLOOD PRESSURE Overview In this chapter, we will show you how to locate peer-reviewed references and studies on high blood pressure.
The Combined Health Information Database The Combined Health Information Database summarizes studies across numerous federal agencies. To limit your investigation to research studies and high blood pressure, you will need to use the advanced search options. First, go to http://chid.nih.gov/index.html. From there, select the “Detailed Search” option (or go directly to that page with the following hyperlink: http://chid.nih.gov/detail/detail.html). The trick in extracting studies is found in the drop boxes at the bottom of the search page where “You may refine your search by.” Select the dates and language you prefer, and the format option “Journal Article.” At the top of the search form, select the number of records you would like to see (we recommend 100) and check the box to display “whole records.” We recommend that you type “high blood pressure” (or synonyms) into the “For these words:” box. Consider using the option “anywhere in record” to make your search as broad as possible. If you want to limit the search to only a particular field, such as the title of the journal, then select this option in the “Search in these fields” drop box. The following is what you can expect from this type of search: ·
High Blood Pressure and Diabetes Mellitus: Are All Antihypertensive Drugs Created Equal? Source: Archives of Internal Medicine. 160(16): 2447-2452. September 11, 2000. Contact: Available from American Medical Association. Subscriber Services Center, P.O. Box 10946, Chicago, IL 60610-0946. (800) 262-2350. Fax (312) 464-5831. E-mail:
[email protected]. Summary: This article describes a study that analyzed available data to evaluate the efficacy of various antihypertensive agents in hypertensive patients with diabetes. A MEDLINE search of English language articles published until June 1999 was undertaken with the use of the terms diabetes mellitus,' hypertension,' blood pressure,' and therapy.'
4
High Blood Pressure
Pertinent articles cited in the identified reports were also reviewed. Included were only prospective randomized studies of more than 12 months' duration that evaluated the effect of drug treatment on morbidity and mortality in hypertensive patients with diabetes. The study also estimated the risk associated with the combination of diabetes and hypertension and the effect of treatment on morbidity and mortality. The study found that the coexistence of diabetes doubled the risk of cardiovascular events, cardiovascular mortality, and total mortality in hypertensive patients. Intensive blood pressure control to levels lower than 130/85 mm Hg was beneficial in hypertensive patients with diabetes. Diuretics, beta blockers, angiotensin converting enzyme inhibitors, and calcium antagonists were effective in reducing cardiovascular events in hypertensive patients with diabetes. In elderly patients with isolated systolic hypertension and diabetes, calcium antagonists reduced the rate of cardiac end points by 63 percent, stroke by 73 percent, and total mortality by 55 percent. In more than 60 percent of hypertensive patients with diabetes, combination therapy was required to control blood pressure. The article concludes that, in hypertensive patients with diabetes, intensive control of blood pressure to levels lower than 130/85 mm Hg reduces the risk of cardiovascular events. 6 tables. 47 references. (AA-M). ·
Reining In High Blood Pressure Source: Diabetes Self-Management. 16(6): 8, 10-12, 14. November-December 1999. Contact: Available from R.A. Rapaport Publishing, Inc. 150 West 22nd Street, New York, NY 10011. (800) 234-0923. Summary: This article discusses the management of high blood pressure. People who have diabetes are more likely to develop hypertension and two to four times more likely to have a stroke or acute heart problems. Hypertension and diabetes are strong risk factors for the development of congestive heart failure. The blood pressure goal established by the American Diabetes Association for most people who have diabetes is blood pressure less than 130/85 millimeters of mercury. The top number represents the pressure in an artery during a contraction of the heart, and the bottom number represents the pressure in an artery between heartbeats. The higher the blood pressure, the greater the risk of stroke and heart, kidney, and eye disease. Many lifestyle habits can be modified to help lower blood pressure, including quitting smoking, losing weight, making dietary changes, restricting sodium, exercising, using relaxation techniques, consuming alcohol in moderation, and setting goals that are specific and attainable. In addition to making lifestyle changes, people who have diabetes and hypertension will also have to take one or more drugs daily to control their blood pressure. Many people who have diabetes and hypertension are treated with angiotensin converting enzyme inhibitors. The most important action that people who have diabetes and hypertension can take is to get involved in their care and treatment. One way to take an active role in managing hypertension is to take blood pressure measurements between doctor visits. The article includes information on the Dietary Approach to Stop Hypertension diet and drugs for treating high blood pressure.
·
Low Down on High Blood Pressure Source: Living Well With Diabetes. 7(1): 25-26. Winter 1992. Summary: This article focuses on preventing and controlling high blood pressure, with the end goal of preventing and controlling serious complications of diabetes, including stroke and heart, eye, and kidney problems. Topics include a definition of high blood
Studies
5
pressure, how to prevent hypertension, how to control high blood pressure, and the role of lifestyle changes or medication. 2 tables. 2 references. ·
Lowdown On High Blood Pressure Source: Diabetes Self-Management. 8(3): 44-47. May-June 1991. Contact: Available from R.A. Rapaport Publishing Company. 150 West 22nd Street, New York, NY 10011. (800) 234-0923. Summary: This article reviews the problems of high blood pressure, or hypertension. Topics include the link between hypertension and diabetes; what a blood pressure measurement means; the probable causes of hypertension; what can be done to control blood pressure and blood glucose in people with diabetes; the role of diet, exercise and stress reduction; and drug therapy used to treat hypertension. Pharmaceutical agents discussed include diuretics, centrally acting agents, alpha-blocking agents, beta-blocking agents, vasodilators, calcium channel blockers, and angiotensin converting enzyme (ACE) inhibitors. One chart lists the generic and brand names of agents commonly used in the treatment of hypertension.
·
How Much Do You Know About High Blood Pressure? Source: Diabetes Self-Management. 9(3): 46-47. May-June 1992. Contact: Available from R.A. Rapaport Publishing Company. 150 West 22nd Street, New York, NY 10011. (800) 234-0923. Summary: This brief article consists of a quiz of ten questions about high blood pressure and a discussion of the answers to each question. Subjects touched upon include how blood pressure levels are influenced, the complications arising from high blood pressure, normal blood pressure readings, systolic and diastolic blood pressure readings, what can be done to reduce blood pressure, the influence of beverages containing alcohol or caffeine, blood pressure medications that are safe and effective for people with diabetes, and beta blockers.
·
Weight Loss Diet, Regular Exercise Needed to Control High Blood Pressure Source: Diabetes in the News. 10(2): 12-13. March-April 1991. Summary: This brief article stresses the importance of a healthy weight loss diet and regular exercise in controlling high blood pressure in people with diabetes. The author notes that high blood pressure seems to go along with high blood glucose, citing that up to half of all people with diabetes also have high blood pressure. The article briefly overviews the diagnosis and complications of high blood pressure and medications that may be needed for hypertension control. One figure lists eight recommendations to combat high blood pressure, including controlling blood glucose and blood pressure; following a recommended diet; exercising; stopping smoking; minimizing alcohol consumption; reducing stress; taking your own blood pressure; and maintaining goals for systolic and diastolic readings.
Federally Funded Research on High Blood Pressure The U.S. Government supports a variety of research studies relating to high blood pressure. These studies are tracked by the Office of Extramural Research at the National Institutes of
6
High Blood Pressure
Health.2 CRISP (Computerized Retrieval of Information on Scientific Projects) is a searchable database of federally funded biomedical research projects conducted at universities, hospitals, and other institutions. Search the CRISP Web site at http://crisp.cit.nih.gov/crisp/crisp_query.generate_screen. You will have the option to perform targeted searches by various criteria, including geography, date, and topics related to high blood pressure. For most of the studies, the agencies reporting into CRISP provide summaries or abstracts. As opposed to clinical trial research using patients, many federally funded studies use animals or simulated models to explore high blood pressure. The following is typical of the type of information found when searching the CRISP database for high blood pressure: ·
Project Title: A PHARMACOGENETICS APPROACH TO DRUG INDUCED WEIGHT GAIN Principal Investigator & Institution: Coe, Natalie R.; Jackson Laboratory 600 Main St Bar Harbor, Me 04609 Timing: Fiscal Year 2001; Project Start 26-MAY-2001 Summary: (Scanned from the applicant?s description) Obesity, often the result of a person?s genetic predisposition, can lead to serious medical conditions, including noninsulin dependent diabetes, heart disease, stroke, high blood pressure, kidney failure, and depression. Clozapine is a highly prescribed anti-psychotic drug, but unfortunately, many patients become obese within several months after initiation of this drug therapy. Identification of the clozapine weight responsive genetic locus and subsequent gene identification will 1) further enhance our understanding of obesity, including genetic suscepibility and onset as well as the its underlying molecular basis, 2) allow psychiatric patients to be screened prior to clozapine treatment to avoid potential health risks brought on by obesity, 3) identify potential cross talk of neuronal and obesity-related metabolic pathways, and 4) help aid in the design of new anti-psychotic drugs that do not interfere with metabolic weight homeostasis. The potential correlation (positive or negative) between formation of the principal active metabolite of clozapine(Ndesmethyl-clozapine) and the onset of obesity will be explored as a viable tool to screen psychiatric patients genetically predisposed to clozapine induced weight gain. The involvement of histamine (H1) receptors and the neuroleptic induced obesity phenotype has abeen eluded to but not formally addressed in the literature. The potential role of the H1 receptor will be examined directly by the proposed work. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: AGING WORKERS WITH HYPERTENSION: MANAGING OR MAKING DO? Principal Investigator & Institution: Davenport, Beverly A.; Anthropolgy, History & Soc Med; University of California San Francisco 500 Parnassus Ave San Francisco, Ca 94122 Timing: Fiscal Year 2001; Project Start 01-AUG-2001; Project End 31-JUL-2003 Summary: (provided by applicant): This ethnographic study will explore the way a multi racial/ethnic sample of aging urban transit operators and their doctors
2
Healthcare projects are funded by the National Institutes of Health (NIH), Substance Abuse and Mental Health Services (SAMHSA), Health Resources and Services Administration (HRSA), Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDCP), Agency for Healthcare Research and Quality (AHRQ), and Office of Assistant Secretary of Health (OASH).
Studies
7
communicate with each other about the transit operators chronic health condition, hypertension. It will also look at the way transit operators interpret medical advice they receive in the routine practices of their daily lives. The study seeks to illuminate the choices that transit operators make in the way they manage their health. In addition, it seeks to describe the impact that various treatment regimens, including the use of prescription drugs, have on these workers quality of life, both on and off the job. The study will also seek to reveal the meaning that hypertension has for transit operators, considering such possibilities as the effect that labeling as "ill" may have on the transit operators view of themselves, and the impact of personal and cultural beliefs on the transit operators understanding and management of their condition. The research will attempt to distinguish effective and ineffective communication patterns and successful and unsuccessful self-management strategies with regard to an outcome of great importance as America s population ages -"controlled" high blood pressure. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: APOLIPOPROTEIN-MEDIATED CHOLESTEROL EFFLUX Principal Investigator & Institution: Davidson, William S.; Associate Professor; Pathology and Lab Medicine; University of Cincinnati 2624 Clifton Ave Cincinnati, Oh 45221 Timing: Fiscal Year 2001; Project Start 01-APR-1999; Project End 31-MAR-2004 Summary: It is well known that plasma levels of apolipoprotein (apo)AI and high density lipoprotein (HDL) are inversely correlated with the risk of cardiovascular disease (CVD). CVDs, which include heart attacks, stroke and high blood pressure, are estimated to shorten the average American life expectancy by about 10 years. Unfortunately, the mechanisms that protect the body from the pathological accumulation of lipid and cholesterol that cause CVD are not well understood. However, recent studies have shown that lipid-poor forms of apoAI may be particularly effective at promoting cholesterol removal from the periphery by a mechanism that is distinct from that used by the bulk of plasma HDL. The long-term goal of this research is to determine how the structure of lipid-poor modulates its ability to remove cholesterol from peripheral cells such as those that comprise the vessel wall. A secondary goal is to develop variant forms of apoAI that vary in their ability to interact with cell surfaces and to promote cholesterol efflux. These mutants will not only provide valuable information on the mechanism of cholesterol removal by lipid-poor apoAI, but will also be useful for future transgenic mouse and gene therapy studies designed to improve the effectiveness of HDL in the prevention of CVD. The approaches will include the use of sophisticated fluorescence studies combined with mutants of apoAI that contain single tryptophan residues to study the structure of apoAI in the lipid- free form and in various states of HDL particle maturation. This will provide information on apoAI dynamics that is not yet been possible by X-ray crystallography or NMR. Mutagenesis techniques will also be used to modulate the ability of apoAI to interact with lipids and to cell surface proteins. These mutants will be examined using detailed lipid binding and cell surface association assays. Finally, the effect of those modifications on the ability of apoAI to promote cholesterol removal from cells will be determined in cell culture-based studies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: BEHAVIORAL TREATMENT OF HIGH BLOOD PRESSURE Principal Investigator & Institution: Blumenthal, James A.; Professor; Psychiatry; Duke University Durham, Nc 27706
8
High Blood Pressure
Timing: Fiscal Year 2003; Project Start 01-SEP-2003; Project End 31-AUG-2007 Summary: (provided by applicant): High Blood Pressure (HBP) is a major health problem in the United States, with most adults >35 years of age exhibiting BP above optimal levels. Persons with HBP exhibit subclinical vascular disease, which is associated with increased risk for cardiovascular and cerebrovascular morbidity and mortality. Although pharmacologic treatments have proven to be successful in reducing HBP in many patients, drug therapy is not always successful and may be associated with iatrogenic effects that compromise compliance and impair quality of life. Furthermore, abnormalities associated with HBP, including insulin resistance and dyslipidemia, may persist or may even be exacerbated by anti-hypertensive medications. Thus, there continues to be a need to develop behavioral treatments for reducing HBP. There is now good reason to believe that diet and exercise may be one such approach. The study proposed in this application will build upon our previous work in which we demonstrated that exercise, especially when combined with a behavioral weight loss program, resulted in clinically significant BP reductions. In addition, feeding studies have demonstrated that a diet high in low fat dairy products as well as fruits and vegetables (i.e., the DASH diet) may significantly reduce BP without weight loss. The present application seeks to extend these findings by (a) evaluating the efficacy of the DASH diet in a free-living situation; (b) considering the DASH diet alone and in combination with a cognitive-behavioral weight loss program including aerobic exercise; (c) examining the impact of diet and exercise on cardiac, metabolic, and vascular function, and (d) following patients for one year to determine the longer term impact of the interventions on BP, body weight, and cardiovascular function. One hundred twenty men and women with HBP will be randomly assigned to the DASH diet alone, the DASH diet combined with a behavioral weight loss program, or to a usual care control condition. Before and after 4 months of treatment, patients will undergo assessments of BP and measures of arterial stiffness, endothelial function, baroreflex control, body composition, insulin resistance, systemic hemodynamics, and left ventricular structure and function. Twelve month follow-up will assess maintenance of benefit. The data generated from this study will have important clinical significance by determining the extent to which the DASH diet, alone and combined with caloric restriction and exercise, may lower BP and improve associated risk factors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: BLOOD PRESSURE REDUCTION AND INSULIN SENSITIVITY IN HYPERTENSION Principal Investigator & Institution: Raskin, Phillip; University of Texas Sw Med Ctr/Dallas Dallas, Tx 753909105 Timing: Fiscal Year 2001 Summary: Excess insulin production might be a factor leading to high blood pressure since it has been shown that insulin produces salt retention in the kidneys and increases the blood levels of adrenalin. It has also been suggested that decreased insulin sensitivity could be a consequence not a cause of hypertension. In order to evaluate if decreased insulin sensitivity is a consequence or a cause of high blood pressure investigators will study the effects of different hypotensive medications on insulin sensitivity. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
9
Project Title: BPDIETS DIETARY INTERVENTION TOOL-HYPERTENSION Principal Investigator & Institution: Knebel, Ellen J.; Targeted Dietetics, Inc. Box 2893 Merrifield, Va 22116 Timing: Fiscal Year 2003; Project Start 15-JAN-2003; Project End 16-JUL-2003 Summary: (provided by investigator): Dietary modifications are recognized as an integral part of adjuvant medical management for the treatment of high blood pressurea disease that affects over 50 million US adults, and which middle-age Americans face an estimated 90% lifetime risk. The current challenge is how to facilitate meaningful long-term lifestyle and nutritional changes in hypertensive patients that overcomes patient, physician, and lifestyle barriers. Targeted Dietetics' Web-Based Dietary Intervention Tool for High Blood Pressure (BPDiets TM) may provide an excellent resource for physicians, health professionals, and case managers, to facilitate long-term dietary changes in adults with hypertension. The tool locates "meals" that fit with antihypertensive diets and individual tastes (from restaurant, make-at-home, a la carte, ethnic, and frozen selections). Currently listing >150 meals the BPDiets TM tool enables users to: auto-generate their own menus; interact with registered dieticians specializing in hypertension online, self-monitor, and more. Phase 1 Feasibility Trials will aim to further understand the unique needs of the target user group, and improve the BPDiets TM tool to ensure the greatest utilization by target users. Phase 2 Efficacy Trials will test the hypothesis that a program of dietary modification using the BPDiets TM tool, can improve blood pressure control in adults who have Hypertension. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: COMPREHENSIVE HIGH BLOOD PRESSURE CARE IN YOUNG URBAN BL Principal Investigator & Institution: Hill, Martha N.; Associate Professor, School Of; None; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2001; Project Start 10-JUN-1996; Project End 29-FEB-2004 Summary: The main long term goal of this study is to improve the health care and health outcomes of young, hypertensive black men, the age-sex-race group which suffers disproportionately from premature high blood pressure (HBP) related morbidity and mortality. In an ongoing 24 month clinical trial, we have enrolled 309 black inner city hypertensive men, 21-54 years of age. They have been randomized to two parallel arms to test the effectiveness of an educational, behavioral and pharmacological HBP control program, provided by a nurse practitioner (NP)community health worker (CHW)- physician (MD) team (special intervention-SI), compared to usual medical care (UC). We have examined cardiovascular and renal abnormalities associated with HBP and identified barriers to HBP care and control. Preliminary results indicated that we have high rates of tracking and follow up (86% unadjusted; 97% adjusted) and have lowered both systolic and diastolic BP (DBP) in the SI group and DBP in the UC group. Over the first 12 months in the men (n=248) seen to date, BP changed from 146 to 136/99 to 90 mm Hg in the SI group and 145 to 144/98 to 94 mm Hg in the UC group. The primary objective of this continuation proposal is to extend the trial for 36 additional months to maintain and further lower BP, and to reduce cardiovascular complications associated with HBP, such as left ventricular hypertrophy, diastolic and systolic dysfunction, central vascular stiffness, and renal impairment. We will also integrate ancillary studies of newly discovered genetic polymorphisms and their relationships to cardiac, arterial and renal structure and function as well as response to HBP treatment. We plan to build upon our innovative
10 High Blood Pressure
model, which integrates, basic, clinical and behavioral sciences with sound research principles and methodology. Our ongoing intervention includes educational counseling and treatment sessions with an NP-MD team (using an angiotensin receptor +/diuretic), and telephone follow-up and 3 home visits by a CHW with the man and family members/friends who provide social support. In addition, we will document the cost of delivering the SI, an important step toward planning for cost-effectiveness and cost-utility analysis of the intervention. This study is significant because it: 1) is the only randomized longitudinal study we are aware of that specifically targets the understudied, vulnerable, population of black men who are at disproportionately high risk of the adverse consequences of uncontrolled HBP, 2) extends the care and evaluation of a well characterized cohort of young hypertensive black me, 3) builds upon innovative multidisciplinary tem intervention strategies and biologic science techniques over a total of five years, 4) it integrates ancillary studies of genetic risk factors and cost, and 5) it has the potential for impact through future generalizability and sustainability of effective strategies. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: DECOUPLING OF PRINCIPAL RENAL AUTOREGULATORY MECHANISMS Principal Investigator & Institution: Chon, Ki H.; Electrical Engineering; City College of New York 138Th St and Convent Ave New York, Ny 10031 Timing: Fiscal Year 2001; Project Start 21-AUG-2001; Project End 31-MAY-2002 Summary: (provided by applicant): Renal autoregulation is the, process that minimizes the effect of blood pressure variations on renal blood flow fluctuations. Two separate but interacting control mechanisms autoregulate renal blood flow: the myogenic mechanism and tubuloglomerular feedback (TGF). TGF is an intrarenal control system found in each nepbron, and the myogenic response is a mechanism intrinsic to the vascular wall of the blood vessel. Highly regular blood pressure fluctuations in the kidney tubules in normotensive rats are replaced by highly irregular pressure fluctuations in hypertensive rats. The pressure fluctuation differences between the two strains of rats may be an indication of different autoregulatory dynamics. The primary goal of the proposed work is to unravel the underlying reasons for the changes in autoregulatory mechanics. The chief complication we must overcome, however, is the coupling between the autoregulatory mechanisms themselves. Specific Aim (1) of the project is to test the hypothesis that the dynamic characteristics of interactions between TGF and the myogenic mechanism are modulated by blood pressure and that chronic high blood pressure further affects the interaction. IN addition to these intra-nephron interactions between TOP and the myogenic mechanism, nephrons derived from the same radial cortical artery interact through the arteriolar wall. Oscillations in vascularlyconnected nepbrons are entrained in normotensive rats, but the entrainment is less complete in hypertensive rats. The static connection strength is stronger in hypertension, and the reduced entrainment is probably due to loss of signal coherence caused by the bifurcation to chaos. These observations suggest that these nephron-nephron interactions are affected by hypertension. Thus, in Specific Aim (2) we propose to measure the pressure dependence of the intra- and inter-nephron interactions, and use mathematical simulation to test the importance of these interactions to the dynamics of renal blood flow regulation. In Specific Aim (3) we propose to evaluate possible timevarying characteristics of autoregulation of single and whole kidney blood flow. With valuable information gathered from the first three specific aims, in Specific Aim (4) we propose to develop and test a block-structured mathematical model that will be able to
Studies
11
emulate the observed functional behavior of the renal autoregulatory mechanisms under both normotensive and hypertensive conditions. By exercising this model, as described under Specific Aim (5), we plan to begin understanding the underlying reasons for the changes observed in autoregulation under pathological conditions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: ECONOMIC TRANSITION--THE EFFECTS ON HEALTH CARE IN CHINA Principal Investigator & Institution: Akin, John S.; Professor; Economics; University of North Carolina Chapel Hill Office of Sponsored Research Chapel Hill, Nc 27599 Timing: Fiscal Year 2001; Project Start 20-MAR-2001; Project End 28-FEB-2005 Summary: The purpose of this project is to define and statistically test the determinants of health outcome differences over regions and changes over time in 8 provinces of China through a model that incorporates individual, household, and community variable The model will be designed to take advantage of panel data estimation techniques to estimate both a fixed effect for individual (an estimate of unobserved, innate healthiness) and the impact of random shocks to health that cannot be explained by t variables in the model. No one-health outcome will be defined as the objective; the determinants of several specific ill health outcomes (such as diarrhea for children and high blood pressure for adults) will be modeled and the relationships estimated. The project addresses 2 basic failings of the literature on the determinants of health outcomes. A statistical model based on the micro-economic theory of household behavior is developed. Second, household and community data collected as part (the China Health and Nutrition Survey, over the 1989 to 1997 time period, is used so that the impact of the full set (determinants on changes in health can be analyzed. The hypothesis is that interventions such as education and higher incomes raise the demand for health care and also increase the efficiency of the use of inputs that enhance the ability of the household to deal with health shocks and to slow the depreciation of the stock of health. Government investments in public health goods reduce the probability of health shocks from specific sources (e.g., malaria) and reduce costs of curative interventions (b increasing the availability of inexpensive sources of curative care). The project outputs will include: (1) behavioral and statistical models of determinants of health; (2) a comparative analyst of the periods 1989, 1991, 1993 and 1997; (3) a longitudinal comparative analysis across the 4 panels of the China data; (4) a macrolevel policy paper relating changes in macro-model variables to societal outcomes; and (5) a final report an Presentation of the findings. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: GENETIC ANALYSIS OF RENAL DISEASE IN SHR AND DAHL S RATS Principal Investigator & Institution: Rapp, John P.; Professor and Chairman; Physiology/Molecular Medicine; Medical College of Ohio at Toledo Research & Grants Admin. Toledo, Oh 436145804 Timing: Fiscal Year 2001; Project Start 08-MAR-2001; Project End 28-FEB-2004 Summary: (Verbatim from the application): End stage renal disease (ESRD) in humans is an important medical problem requiring the expensive treatments of dialysis and renal transplantation. Studies in humans suggest that ESRO has a complex genetic component. In order to understand the genetic causes of ESRD we propose to define the genetic components responsible for the development of the rapidly progressing renal
12 High Blood Pressure
pathology in the Dahi salt sensitive (S) rat. To do this, segregating populations derived from crossing S rats with spontaneously hypertensive rats (SHR) will be studied. The two strains are markedly different with regard to proteinuria and progression of renal disease. Young S rats have very high proteinuria and rapidly develop renal lesions; young SHR show essentially minimal proteinuria and very slow progression of renal disease in spite of their high blood pressure. Linkage analysis for the quantitative trait loci (QTL) controlling the marked difference in proteinuria between S and SHR will be performed starting at a young age and also at successive time points in an F2(SHR X S) population fed a low salt diet to minimize the development of hypertension. The QTL for blood pressure that differentiate S and SHR rats have already been defined on high salt diet as residing on rat chromosomes 3, 6, 8 and 9. The relationship of these blood pressure QTL to the QTL for progressive proteinuria/renal disease will be sought by determining the positions of the QTL for both traits in an F2(SHR X S) population fed high salt diet. One of the blood pressure QTL differentiating S and SHR is likely to be related to the marked difference in the vascular smooth muscle response between S and SHR to ionic cobalt. This is a Mendelian trait and it will be placed on the rat genetic map to determine its relationship to blood pressure and proteinuria QTL. Lastly, the development of congenic strains will be initiated for any unique QTL, especially those for proteinuria/renal disease, defined by the above genetic analysis. These congenic strains are required for later fine genetic mapping and ultimate gene identification. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: GENETIC DETERMINANTS OF HIGH BLOOD PRESSURE (GENOA) Principal Investigator & Institution: Brown, C A.; Medicine; University of Mississippi Medical Center 2500 N State St Jackson, Ms 39216 Timing: Fiscal Year 2001; Project Start 05-SEP-1995; Project End 30-JUN-2005 Summary: The NHLBI Family Blood Pressure Program is made up of four cooperating networks whose overall objective is to localize and characterize genes contributing to variation in blood pressure levels and hypertension status. The four networks were originally separately funded and competitive, but two critical realizations have led to full cooperation and collaboration. First, the oligogenic nature of blood pressure control dictates that large samples are necessary to achieve adequate statistical power for genomic linkage and association analyses. Second, linkage intervals are broad and contain large numbers of genes, so that success in identifying genes and mutations requires the effort of multiple laboratories freely sharing information. This coordination extends far beyond phenotyping and genotyping and is best exemplified by the Program's creation of a pooled data set and agreements about coordinated publications. During the initial funding period, the Program surpassed its original recruitment goals, carried out multiple genome-wide linkage and association analyses and created an interim pooled data set consisting of phenotype and genotype data from more than 10,000 individuals. In this renewal application, the Program proposes five specific aims to be carried out by all four networks. These aims can be grouped according to two complementary themes: First, these applicants will create and analyze a database of blood pressure- related phenotype and genotype data from all FBPP participants (Aim 1). Within linked regions, they will identify allelic variation within positional candidate genes and evaluate the relationship of these polymorphisms with blood pressure levels and hypertension status (Aims 2 and 3). Second, they will use quantitative measures of target organ damage to identify genes that influence susceptibility to develop hypertensive heart and kidney diseases (Aims 4 and 5). In addition to the Program specific aims, each network proposes specific aims to be carried out by that network
Studies
13
alone, based on unique aspects of their population and interests and expertise of the investigators. The Family Blood Pressure Program represents the most determined multidisciplinary approach to the genetics of hypertension ever assembled. The resulting synthesis of ideas and amassed data permits rigorous hypothesis testing not otherwise possible and will hasten understanding of the previously elusive genetic variation responsible for disease risk. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: HEALTH EFFECTS OF JOB DISPLACEMENT AMONG OLDER WORKERS Principal Investigator & Institution: Bradley, Elizabeth A.; Assistant Professor; Epidemiology and Public Health; Yale University 47 College Street, Suite 203 New Haven, Ct 065208047 Timing: Fiscal Year 2001; Project Start 15-JUL-2001; Project End 30-JUN-2002 Summary: In the last two decades, older workers have represented an increasing proportion of the displaced workers in the U.S. Displaced workers are workers who experience involuntary loss of a permanent job, due to either business closing or layoff. Although the impact of job displacement on earnings is well established, the health effects of displacement among older workers in the U.S remain largely unknown. The broad objective of the proposed research is to examine the health consequences of job displacement among older workers in the U.S. The specific aims are to: 1) assess the effect of job displacement on subsequent physical disability and mental health, and investigate the persistence of observed effects; 2) assess the impact of re-employment and jobless duration on physical disability and mental health; and 3) examine the effect of job displacement on reports of disease onset. Using data from the first three waves of the Health and Retirement Survey (HRS), a nationally representative sample of older workers in the U.S., multivariate, longitudinal techniques will be used to investigate each aim. Physical disability will be measured using a composite score derived from self reports of difficulties with activities of daily living and mobility tasks. Mental health will be assessed using available items from the Center for Epidemiological StudiesDepression scale. Onset of disease will be measured by self-reported myocardial infarction, high blood pressure, and cancer. The proposed analyses build on the Investigators' previous examinations of the health effects of job displacement among older workers using data from the first two waves of the HRS. In addition, these proposed analyses are an important component of the Investigators' longer term goal of examining and explaining variations in the health effects of job displacement among older workers in comparable data sets in other countries. The larger goal of exploring cross-national comparisons will be the aim of a future application for national funding and is planned as the next step in the Investigators' research. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: HIGH BLOOD PRESSURE CARE FOR KOREAN AMERICANS Principal Investigator & Institution: Kim, Miyong T.; None; Johns Hopkins University 3400 N Charles St Baltimore, Md 21218 Timing: Fiscal Year 2003; Project Start 10-SEP-2003; Project End 31-AUG-2006 Summary: (Provided by the Applicant) The primary objective of this study is to develop and test an innovative self-help program for Korean Americans (KA) that is culturally sensitive, built on valid behavioral theories and principles, and aimed at improving the control of high blood pressure (HBP) and enhancing health related quality of life.
14 High Blood Pressure
Specifically, we will focus on the self-help aspects of HBP control by empowering patients with greater knowledge about HBP, greater self-efficacy, and enhancing selfcare skills including general and HBP related problem-solving skills. We therefore propose to undertake a project to test the effectiveness of a self-help HBP control intervention program specifically designed for KA with HBP. This Self-Help Intervention Program (SHIP) will have three concurrently administered components: (1) a structured behavioral education intervention that focuses on fostering self-help skills in controlling HBP; (2) home BP monitoring with a telephone transmission system (HBPMT); and (3) telephone interaction with a bilingual nurse who will facilitate effective communication between KA with HBP and their care providers. Our specific aims are to: (1) further develop and test a self-help intervention program (SHIP) protocol that specifies the process and content of the intervention for KA with HBP; (2) enroll 260 KA, ages 40-65, with HBP in the SHIP intervention program; (3) deliver the SHIP intervention to the study participants; (4) measure the effect of the SHIP intervention on both primary outcome, BP reduction, and on secondary cognitive behavioral outcomes, including self-efficacy, problem-solving skills, and adherence to treatment recommendations; and (5) explore relevant methodological issues, which include evaluating the dose-response association with respect to the self-help education treatment strength, level of adherence necessary to induce the desirable changes in BP levels and psychological well-being. The outcome variables will be measured before the intervention and at 12 and 24 months after the start of the intervention. This investigation will allow us to examine theoretical, logistical, and methodological issues prior to implementing the proposed community-based intervention designed to improve health care outcomes in this vulnerable minority ethnic group. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: HIGH BLOOD PRESSURE RESEARCH Principal Investigator & Institution: Ayers, Carlos R.; Professor; Internal Medicine; University of Virginia Charlottesville Box 400195 Charlottesville, Va 22904 Timing: Fiscal Year 2001; Project Start 01-JUL-1994; Project End 30-JUN-2004 Summary: This is an interdisciplinary post-doctoral training grant application for 6 positions per year. The area of training is in hypertension, arteriosclerosis and vascular biology. The research training period is for two more years. The trainees are trained for positions in academic medicine. Additional clinical training for board qualification is supported by hospital sources. The departments include Internal Medicine Cardiology, Endocrinology and Nephrology), Pediatrics (Nephrology Cardiology), Anesthesiology, Biochemistry, Physiology Pharmacology and Biomedical Engineering. This is the only NIH institutional training grant supporting M.D. cardiovascular research training in the clinical departments of this institution. Almost all of the trainees have a basic scientist as a mentor; some have more than one mentor. The main research training projects have been in molecular or cell biology, however, and projects in whole animals and human subjects are done. There are three strong research areas that support the major part of research training: vascular smooth muscle program project group, the group working on the renin-angiotensin-aldosterone system and the vascular biology/arteriosclerosis program group. The greatest strength of this training program is the recruitment of highly qualified MD trainees to this program. We are now averaging 6 MD trainees/year. These trainees elect basic training that my include both a basic and clinical science mentors. Basic statistics, data management and research ethics are the only required courses but those training in vascular biology are required to take Vascular Cell Biology and Cellular and Molecular Biology are strongly recommended.
Studies
15
The trainees are expected to attend lab meetings, selected seminars in Physiology, Vascular Smooth Muscle, Vascular Biology, Pharmacology, Biochemistry and Internal Medicine. Monthly journal clubs and research seminars in Cardiology are attended. MD trainees may earn the PhD degree. The research environment is superior and research grant support of the faculty is excellent. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: IMPROVING CARE FOR HIGH RISK MINORITY PATIENTS WITH CHRONIC ILLNESS Principal Investigator & Institution: Carson, Deborah Stier.; Medical University of South Carolina 171 Ashley Ave Charleston, Sc 29425 Timing: Fiscal Year 2001 Summary: Title: A Randomized Trial of Pharmacist-intervention to increase prescription refills. Abstract This study will use the capabilities of a commercially available pharmacy computer system to identify chronically ill black patients who are at risk for not refilling their prescriptions for medications that have proven value in controlling exacerbation of their illnesses. This intervention will be evaluated using data from the pharmacy computer system. The purpose of this project is to demonstrate that commercial pharmacy computer systems can be used to identify black patients at risk for poor adherence to life and cost saving medications. The patients identified through this method will receive a call from a pharmacist to remind them that it is time for their medication to be refilled, and to discuss any problems. This approach of selecting high risk patients should prove more cost effective than approaches where all patients receive counseling. We will compare responses to mailed reminders and to no reminders. The study design is a before-after time series with two interventions and a control group. Using an electronic data collection system at study design is a before-after time series with two interventions and a control group. Using an electronic data collection system at two pharmacies, non-adherent patients will be identified. Patients who have missed at least one prescription refill by one week during the last six months will be selected. They will be assigned randomly to two treatment groups and a control group. The control group will receive no special treatment; one experimental group will get a telephone reminder/counseling; the other will receive a reminder in the mail. After six months compliance will be re-evaluated using the electronic data collection system. Various types of medications for certain chronic diseases will be targeted (see attached medication list). The conditions include high blood pressure, elevated cholesterol, heart failure, diabetes, and depression. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: INSULIN, INSULIN CARDIOVASCULAR DISEASE
RESISTANCE,
HYPERGLYCEMIA
&
Principal Investigator & Institution: Haffner, Steven M.; University of Texas Hlth Sci Ctr San Ant 7703 Floyd Curl Dr San Antonio, Tx 78229 Timing: Fiscal Year 2001 Summary: Non-insulin dependent diabetes (NIDDM) is associated with increased risk for coronary artery, peripheral vascular, and cerebrovascular diseases. It has been hypothesized that cardiovascular disease (CVD) is not a consequence of NIDDM but that both conditions share common antecedents. Risk factors such as obesity, high fasting plasma glucose and total and low-density lipoprotein cholesterol concentrations with low levels of high-density lipoprotein cholesterol, high blood pressure -- all cluster
16 High Blood Pressure
in normoglycemic subjects who subsequently develop impaired glucose tolerance. This study proposes to determine if insulin resistance is associated with increased prevalence of CVD independent of obesity, glycemia, and insulinemia, to determine the impact of insulin resistance on CVD risk factors, to determine if there are ethnic differences in the relationship between insulin resistance and the prevalence of CVD, and to establish the basis for a prospective study to determine if insulin resistance predicts the development of CVD and its risk factors. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: JACKSON HEART STUDY--COORDINATING CENTER Principal Investigator & Institution: Garrison, Robert J.; None; Jackson State University 1400 John R. Lynch St Jackson, Ms 39217 Timing: Fiscal Year 2001; Project Start 01-JUN-1999; Project End 31-MAY-2005 Summary: Despite encouraging declines over the past three decades, cardiovascular disease (CVD) remains the number one cause of death in the U.S. A number of risk factors for coronary heart disease (CHD) and stroke have been identified; however, relatively few population-based studies have examined CVD in a large group of African-Americans. Existing evidence indicated that death rates in Mississippi are the highest in the nation and particularly high among African-Americans. Between 1980 and 1995, the decline in CVD death rates has been the slowest among African-American men and women in Mississippi relative to other groups in the state and nation. The Jackson Heart Study (JHS) is a single-site prospective epidemiologic investigation of CVD among approximately 6,500 African-Americans ages 35 to 84, from Jackson, Mississippi metropolitan area. The primary objective of the JHS is to investigate the causes of CVD in African- Americans to learn how to best prevent this group of diseases in the future. More specific objectives include: (1) Identifying factors which influence the development and worsening of CVD in African-Americans, with an emphasis on Manifestations related to high blood pressure (such as enlargement of the left ventricle of the heart, coronary artery disease, heart failure, stroke and disorders affecting the blood vessels of the kidney). (2) Building research capabilities in minority institutions at the undergraduate and graduate level by developing partnerships between minority and majority institutions and enhancing participation of minority investigators in largescale epidemiologic studies. (3) Attaching minority students to and preparing them for careers in public health and epidemiology. This project serves as the Coordinating Center where all data collected during the study will be managed, analysis of the data will be performed, and community involvement will be coordinated. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: JACKSON HEART STUDY--EXAM CENTER Principal Investigator & Institution: Jones, Daniel W.; Professor; Medicine; University of Mississippi Medical Center 2500 N State St Jackson, Ms 39216 Timing: Fiscal Year 2001; Project Start 01-JUN-1999; Project End 31-MAY-2005 Summary: Despite encouraging declines over the past three decades, cardiovascular disease (CVD) remains the number one cause of death in the U.S. A number of risk factors for coronary heart disease (CHD) and stroke have been identified; however, relatively few population-based studies have examined CVD in a large group of African-Americans. Existing evidence indicated that death rates in Mississippi are the highest in the nation and particularly high among African-Americans. Between 1980 and 1995, the decline in CVD death rates has been the slowest among African-American
Studies
17
men and women in Mississippi relative to other groups in the state and nation. The Jackson Heart Study (JHS) is a single-site prospective epidemiologic investigation of CVD among approximately 6,500 African-Americans ages 35 to 84, from Jackson, Mississippi metropolitan area. The primary objective of the JHS is to investigate the causes of CVD in African- Americans to learn how to best prevent this group of diseases in the future. More specific objectives include: (1) Identifying factors which influence the development and worsening of CVD in African-Americans, with an emphasis on Manifestations related to high blood pressure (such as enlargement of the left ventricle of the heart, coronary artery disease, heart failure, stroke and disorders affecting the blood vessels of the kidney). (2) Building research capabilities in minority institutions at the undergraduate and graduate level by developing partnerships between minority and majority institutions and enhancing participation of minority investigators in largescale epidemiologic studies. (3) Attaching minority students to and preparing them for careers in public health and epidemiology. This project serves as the Coordinating Center where all data collected during the study will be managed, analysis of the data will be performed, and community involvement will be coordinated. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: JACKSON HEART STUDY--TRAINING CENTER Principal Investigator & Institution: Srinivasan, Asoka; None; Tougaloo College Tougaloo, Ms 39174 Timing: Fiscal Year 2001; Project Start 01-JUN-1999; Project End 31-MAY-2005 Summary: Despite encouraging declines over the past three decades, cardiovascular disease (CVD) remains the number one cause of death in the U.S. A number of risk factors for coronary heart disease (CHD) and stroke have been identified; however, relatively few population-based studies have examined CVD in a large group of African-Americans. Existing evidence indicated that death rates in Mississippi are the highest in the nation and particularly high among African-Americans. Between 1980 and 1995, the decline in CVD death rates has been the slowest among African-American men and women in Mississippi relative to other groups in the state and nation. The Jackson Heart Study (JHS) is a single-site prospective epidemiologic investigation of CVD among approximately 6,500 African-Americans ages 35 to 84, from Jackson, Mississippi metropolitan area. The primary objective of the JHS is to investigate the causes of CVD in African- Americans to learn how to best prevent this group of diseases in the future. More specific objectives include: (1) Identifying factors which influence the development and worsening of CVD in African-Americans, with an emphasis on Manifestations related to high blood pressure (such as enlargement of the left ventricle of the heart, coronary artery disease, heart failure, stroke and disorders affecting the blood vessels of the kidney). (2) Building research capabilities in minority institutions at the undergraduate and graduate level by developing partnerships between minority and majority institutions and enhancing participation of minority investigators in largescale epidemiologic studies. (3) Attaching minority students to and preparing them for careers in public health and epidemiology. This project serves as the Coordinating Center where all data collected during the study will be managed, analysis of the data will be performed, and community involvement will be coordinated. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: MEDITATION FOR HIGH BLOOD PRESSURE Principal Investigator & Institution: Lane, James D.; Psychiatry; Duke University Durham, Nc 27706
18 High Blood Pressure
Timing: Fiscal Year 2001; Project Start 01-SEP-2001; Project End 31-AUG-2004 Summary: (provided by applicant): High blood pressure is a major public health problem that affects nearly 25 percent of adults in the United States and contributes to increased risks of morbidity and mortality via cardiovascular and renal diseases. Although anti-hypertensive medications are often effective in the treatment of hypertension, non-pharmacological therapies are recognized as important first-line or adjunctive treatments for blood pressure management. A variety of relaxation and stress management techniques have been tested for their potential contributions to blood pressure control through stress reduction. Among these interventions, meditation training has shown the greatest promise as an adjunctive behavioral treatment for lowering blood pressure. This project investigates the effectiveness of a meditationtraining program for the reduction of blood pressure. The 3-year study is a randomized, controlled clinical trial involving 120 adult men and women with hypertension or highnormal blood pressure recruited from the community. After extended screening and baseline testing, participants will be assigned at random to receive the experimental meditation training program (N= 60), to receive a progressive muscle relaxation training program that serves as a placebo control (N = 30), or to continue with usual care (N= 30). Post-treatment testing will be conducted 1, 2, and 3 months after training begins. Treatment outcome will be assessed by changes in laboratory-based and 24-hour ambulatory measures of blood pressure from baseline to follow-up. In addition, the study will test whether stress-reduction is a plausible mechanism that can account for clinical outcomes, using measurements of treatment-related changes in neuroendocrine and subjective measures of stress. Finally, the study will investigate the characteristics of those who respond best to this treatment and determine whether those individuals who begin training with higher levels of stress and anxiety show greater improvements in blood pressure and measures of stress than those who begin with lower levels. Meditation training may be a cost-effective non-pharmacological treatment for the management of high blood pressure. The results of this trial will advance our understanding of the potential benefits of this behavioral intervention, the mechanisms through which it works, and the kind of person who will benefit most from it. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: MOTIVATIONAL INTERVIEWING IN HYPERTENSIVE AFRICAN AMERI* Principal Investigator & Institution: Ogedegbe, Godwin O.; Assistant Professor; Medicine; Weill Medical College of Cornell Univ New York, Ny 10021 Timing: Fiscal Year 2001; Project Start 26-SEP-2001; Project End 31-AUG-2005 Summary: (provided by investigator): In the United States, prevalence of high blood pressure in African-Americans is among the highest in the world. Prevalence of hypertension for non-Hispanic blacks age 20 and older is 50 percent higher than among non-Hispanic whites. African-Americans develop high blood pressure at an earlier age and are more likely to have poorly controlled blood pressure. Blacks have a 1.8 times greater rate of fatal stroke, a 1.5 times greater rate of heart disease death and a 4.2 times greater rate of end-stage hypertension-related kidney disease than whites. Adherence with anti-hypertensive medications can help reduce risk of negative outcomes. Motivational interviewing is a promising patient-centered approach for improving treatment compliance. This technique consists of brief, patient-driven counseling sessions to facilitate initiation and maintenance of behavior change. This study will assess whether adherence can be enhanced through motivational interviewing, an integrated, multiple-component, and culturally-sensitive intervention. The proposed
Studies
19
study is a longitudinal, randomized controlled trial of 190 poorly controlled hypertensive patients. Subjects will be recruited from a community-based primary care practice and randomly assigned to one of two conditions: non-supportive counseling or motivational interviewing. Patients in both arms will have 4 sessions of either nonsupportive counseling or motivational interviewing at 3-month intervals after randomization. The primary outcome is medication adherence and the secondary outcomes are changes in systolic and diastolic blood pressure between baseline and oneyear follow-up assessment. Changes in medication-adherence self-efficacy will also be measured. The long-term objective is to determine whether better adherence to prescribed medications can be achieved through motivational interviewing, leading to reduction in hypertension-related outcomes like end-stage renal disease, cardiovascular mortality and stroke among African-American patients with poorly controlled hypertension. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEURAL CONTROL OF FLUID HOMEOSTASIS IN HYPERTENSION Principal Investigator & Institution: Fink, Gregory D.; Associate Professor; Pharmacology and Toxicology; Michigan State University 301 Administration Bldg East Lansing, Mi 48824 Timing: Fiscal Year 2001; Project Start 01-JUL-1987; Project End 31-JUL-2003 Summary: High blood pressure (hypertension) continues to have a major impact on mortality and morbidity in most human populations. This is particularly the case where dietary sodium chloride (salt) intake is high. Thus, the long-term goal of this project is to provide an understanding of the mechanisms by which abnormal regulation of body sodium and water balance promote hypertension development. It is very likely that intrinsic kidney dysfunction plays a key role in this process. The central hypothesis motivating this work, however, is that humoral factors also involved in regulating body fluid volume and electrolyte concentration cause an increase in blood pressure by affecting neural cardiovascular control mechanisms (i.e. brain and autonomic nervous system). The proposed studies will focus on two such factors--angiotensin II and endothelin. Experiments utilizing chronic infusion of these peptides indicate that they influence blood pressure by at least two mechanisms: 1) "fast" pressor effects, primarily due to direct vasoconstriction; and 2) "slow" pressor effects, probably mediated via multiple indirect actions, including activation of neurogenic (sympathetic) pressor responses. High salt intake alone strongly enhances the slow pressor effects of angiotensin II and endothelin. Recent work, moreover, showed that both stenosis of a renal artery and experimental chronic renal failure (reduction in renal mass) also produced such enhancement (to the slow pressor effect of angiotensin II). The experiments proposed in this application will examine the mechanism and implications of these recent findings. All studies will be conducted in conscious Sprague-Dawley rats instrumented for direct, daily measurements of blood pressure and sodium/water balance; and for chronic administration of peptides. Several protocols will seek to establish if renal artery stenosis or reduced renal mass augment slow pressor mechanisms by: 1) affecting plasma peptide concentrations, 2) altering body fluid volume/electrolyte status, or 3) affecting neural input via renal sensory afferents. Others will address the question of how high salt intake is "sensed" by neurogenic pressor mechanisms responsive to angiotensin II and endothelin. The overall role of endothelin in the chronic maintenance of hypertension in rats with reduced renal mass will be assessed using newly developed pharmacological antagonists of endothelin receptors. Finally, a possible contribution of endothelin to angiotensin II induced hypertension will
20 High Blood Pressure
be explored. These investigations should provide new insights into the link between abnormalities in renal function and/or body fluid regulation and the pathogenesis of hypertension. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NEUROPLASTICITY IN ACQUIRED AND INHERITED FORMS OF HYPERTENSION Principal Investigator & Institution: Aileru, Azeez A.; Associate Professor of Neurophysiology; Winston-Salem State University 601 Martin Luther King Jr Dr Winston-Salem, Nc 27110 Timing: Fiscal Year 2002; Project Start 30-SEP-2002; Project End 29-SEP-2007 Summary: Many studies suggest that hypertensive humans and animal models of hypertension exhibit increased peripheral sympathetic nervous system activity (SNA). Knowledge of the events that lead to elevated SNA and its significance in the genesis and maintenance of elevated blood pressure is rudimentary. Our longrange goal is to understand how blood pressure alters the efficiency of autonomic transmission and how neuroplastic behavior can be modulated for preventive and therapeutic purposes. The objective of this application is to understand the mechanisms by which high blood pressure produces profound changes in the physiology of autonomic synaptic transmission. The general approach is to 1) monitor the activity-dependent and activityindependent changes in neuroplasticity of the sympathetic ganglia isolated from hypertensive rat; 2) monitor the excitability of postganglionic neuron of acutely isolated ganglion cells and their responsiveness during sustained high blood pressure. In animal models of hypertension, our preliminary data show dramatic changes in the electrophysiological behavior of sympathetic ganglion neurons ranging from alterations in the pattern of action potential activity recorded in postganglionic neurons to an enhanced efficacy of synaptic transmission. The central hypotheses are that i) hypertension induces modulation of synaptic efficacy in sympathetic ganglia, and it) Angiotensin II (AnglI), either by long term actions at the ganglion or by increased activation of sympathetic nervous system outflow from the central nervous system, contributes to the alterations in ganglionic function. The rationale for the proposed research is that, once knowledge of the mechanisms that are responsible for alteration of synaptic plasticity in hypertension has been obtained, it will lead to new strategies that can be used to prevent and/or treat hypertension, thereby reducing the morbidity and mortality associated with high blood pressure. The central hypotheses will be tested and the objective of the application will be accomplished by three specific aims. The proposed work is innovative because it capitalizes on the autonomic control of hypertension. It is our expectation that the resultant approach will lead to a better perception of how autonomic ganglia function to regulate blood pressure or vice versa. This proposal uses electrophysiological techniques, receptor autoradiography techniques and neurotransmitter pharmacology in concert with genetic strains of hypertensive animals to learn how genesis and maintenance of high blood pressure alter the function of peripheral neural elements in autonomic ganglia. Such outcomes will be significant because it is expected that the new knowledge will suggest novel targets for preventive and therapeutic interventions. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
Project Title: NEW FUNCTIONING
CVD
RISK
FACTORS
FOR
LOWERED
21
CONGITIVE
Principal Investigator & Institution: Elias, Merrill F.; Research Professor of Epidemiology; Psychology; University of Maine Orono Orono, Me 04469 Timing: Fiscal Year 2001; Project Start 01-APR-2001; Project End 31-MAR-2006 Summary: Arterial hypertension and high blood pressure (BP) are major risk factors for cardiovascular disease (CVD) and stroke; they are also risk factors for lowered cognitive functioning. Except for diabetes, there have been comparatively few studies of other common risk factors, particularly with regard to interrelationships among risk factors which may adversely affect cognitive ability. This study is concerned with associations between cognitive functioning and three major CVD risk factors: (1) BP, (2) high total plasma homocysteine (tHcy), and (3) ApoE e4 genotype. Although high BP is a wellestablished risk factor for lowered cognitive functioning, tHcy and ApoE e4 are relatively unexplored variables with respect to cognitive functioning. A major objective is to investigate the individual, cumulative, and synergistic effects of BP, tHcy levels, and ApoE e4 genotype on cognitive functioning over a broad range of cognitive abilities. Three secondary, but important, objectives are to determine: (1) the extent to which the adverse influence of these three CYD risk factors on cognitive functioning is affected by the presence of coexisting CVD risk factors (e.g., cigarette smoking); (2) the cumulative impact of multiple risk factors on cognitive functioning; (3) the extent to which age effects on cognitive functioning are attenuated by adjustment for BP, tHey, ApoE genotype, and other CVD risk factors. The study makes use of existing data from a large longitudinal study of hypertension and cognitive functioning. Additionally, important new information about relations among tHey, ApoE, and BP will be obtained by calling back the longitudinal subjects for additional studies of cognitive functioning and making use of concurrent, prospective, and retrospective analyses. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: NURSE-MANAGED BP TELEMONITORING WITH AFRICAN AMERICANS Principal Investigator & Institution: Artinian, Nancy T.; None; Wayne State University 656 W. Kirby Detroit, Mi 48202 Timing: Fiscal Year 2001; Project Start 01-SEP-2001; Project End 31-MAY-2005 Summary: There is an urgent need to find better ways to control and treat high blood pressure in African Americans. Although there is some evidence to suggest there may be advantages to home blood pressure (BP) telemonitoring, there is a need for more research since: a) we do not know about the effects of this strategy on long-term control of BP; and b) we do not know the mechanisms by which telemonitoring works to lower BP and achieve BP control. Accordingly, the specific aims of this "new investigator"-led randomized controlled trial are to: a) compare usual care only with home telemonitoring plus usual care to determine which has the greatest effect on change in blood pressure from baseline; and b) determine the extent to which the effects of the intervention are mediated by changes in dietary habits, physical activity level, weight loss, alcohol intake, compliance with an antihypertensive medication regimen, or contact with a primary care provider. Our study is one of the first of its kind using a community-based rather than clinic-based recruitment strategy, thereby expanding access to care. Otherwise healthy African American English speaking men and women (n=400) who are > 18 years with a SBP > 140 mmHG and a DBP > 90 mmHG (unless the individual self-identifies as a diabetic or with a history of a heart attack, then SBP> 130 mmHG,
22 High Blood Pressure
DBP > 85 mmHG) will be conveniently selected from specified community sites. Participants will be randomly assigned to one of two groups that are stratified by use or non-use of antihypertension medication: Group A--home telemonitoring plus usual care; or Group B--usual care only. Participants in Group A will receive usual care plus weekly telemonitoring for 12 months and 15 sessions of telecounseling which provide information about lifestyle modifications in accordance with JNC-VI guidelines. The proposed intervention is intended to increase the saliency of the hypertension for participants, provide a cue to take action and assist them to learn about what actions to take. Data (change in blood pressure from baseline, dietary habits, physical activity level, weight loss, alcohol intake, compliance with an antihypertensive medication regimen, and contact with a primary care provider) will be collected at baseline and at 3, 6 and 12 months. Analysis will include a general mixed linear model approach to repeated measures MANOVA and structural equation growth curve modeling. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: OVERCOMING HEALTH RACIAL HEALTH DISPARITIES Principal Investigator & Institution: Carey, Timothy S.; Professor of Medicine; Sheps Center for Hlth Serv Res; University of North Carolina Chapel Hill Office of Sponsored Research Chapel Hill, Nc 27599 Timing: Fiscal Year 2001; Project Start 15-SEP-2000; Project End 31-AUG-2005 Summary: The Cecil G Sheps Center and the Program on Health Outcomes of the University of North Carolina propose to establish a Center of Excellence on Overcoming Racial Disparities (CEORHD). The CEORHD will focus the expertise of a diverse and unique research community on causes and contributing factors leading to inequalities in access to and outcomes of care. We will work with two historically black North Carolina universities, NC Central and Shaw University, in both the research projects and through research training linkages. We will establish two core groups: the Administrative and Methods Core and the Data Management Core. We will be assisted by an external advisory board as well an internal group to aid in training issues. Over the 5 years of the proposed program project, we will complete seven research projects. These projects will share research infrastructure and contribute to research seminars at UNC, NCCU, and Shaw. Our clinical area of interest is the understanding and elimination of health disparities for adult cancer and other chronic illnesses among black adults, with a special focus on rural black populations: (1) racial disparities in rectal cancer (community-based case-control study); (2) racial differences in prostate cancer treatment outcomes (community- based case-case study assessing differences between prostate cancer in whites and blacks); (3) interventions to reduce disparities between black and white women in physicians' recommendations for mammography (community-based RCT); (4) community-based disease management for (5) service coordination for patients with HIV and STD infections (study of administrative coordination among agencies in rural areas and its relationship to health disparities); (6) racial concordance and outcomes of care for black patients with high blood pressure (secondary data analysis); and (7) measurement of functioning and well-being in minority populations (secondary data analysis). Taken together, these projects will substantially advance our understanding of both the etiology of and redress for current racial disparities in health. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
23
Project Title: PILOT--FAMILIES IMPLEMENTING GOOD HEALTH TRADITIONS FOR LIFE Principal Investigator & Institution: Collins, Rakale; Morehouse School of Medicine Atlanta, Ga 30310 Timing: Fiscal Year 2003; Project Start 01-JUL-2003; Project End 30-JUN-2009 Summary: African Americans engage in the least amount of regular physical activity, exhibit an increased prevalence of obesity and have diets that are low in fruit and vegetable intake compared to other Americans. It is postulated that this unhealthy lifestyle contributes to the extremely high rates of cardiovascular disease and stroke in this population. It is for that reason that the Families Implementing Good Health Traditions for Life (FIGHT for Life) program will be developed. FIGHT for Life will be a community-based intervention pilot study to reduce blood pressure and improve other stroke risk factors by improving physical activity and dietary habits among African American families. This study will use a three-group, cluster-randomized design, with families rather than individuals, assigned to treatment conditions. Prior to randomization the families will be matched by socioeconomic status and family size. Group 1 (control=C) will receive standard physical activity and nutrition education materials. Group 2 (MI) will receive standard physical activity and nutrition education materials and in addition participate in the motivational interviewing (MI) intervention. Group 3 (TTM) will participate in a class-based transtheoretical model (TTM)-guided intervention. The three-group design will allow us to examine three questions. First, what is the feasibility of a family-tailored self-help diet and physical activity intervention using MI principles versus standard health education materials? Second, what is the feasibility of a TTM diet and physical activity intervention tailored to the stage of readiness of the family versus standard health education materials. Finally, do these interventions aid in reducing stroke risk factors such as high blood pressure and serum cholesterol by modifying physical activity and dietary habits? Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: POST-EXERCISE MECHANISMS
HYPOTENSION:
CENTRAL
SITES
AND
Principal Investigator & Institution: Bonham, Ann C.; Professor & Chair; Internal Medicine; University of California Davis Sponsored Programs, 118 Everson Hall Davis, Ca 95616 Timing: Fiscal Year 2001; Project Start 07-MAR-2001; Project End 28-FEB-2006 Summary: (Applicant's Abstract): Single bouts of exercise in hypertensive subjects can lead to a long-lasting decrease in sympathetic nerve activity that results in a postexercise hypotension (PEH) which can normalize high blood pressure. PEH requires an intact baroreflex system; but, the gain of the system in regulating sympathetic nerve activity is reduced. Although the potential therapeutic benefits are appreciated, the mechanisms whereby exercise in hypertensive subjects leads to a persistent lowering of high blood pressure through a decreased central sympathetic output and at the same time to a reduced gain of baroreflex control of sympathetic output are unknown. The goal of this proposal is to resolve those mechanisms. Our data suggest that PEH and the reduced gain are mediated by exercise-induced changes in the central baroreflex network, specifically, in the nucleus tractus solitarius (NTS) where baroreceptor signals are first processed and at sympathetic cardiovascular neurons in the rostral ventrolateral medulla (RVLM), the sympathetic output pathway. We pose two Specific Hypotheses: 1. The underpinning of PEH is a decrease in the impulse activity of RVLM sympathetic
24 High Blood Pressure
cardiovascular neurons, a decrease mediated by: a) a tonic increase in the impulse activity of baroreceptor NTS neurons (increasing the tonic level of GABA release at GABAA receptors (GABAA-Rs) on RVLM neurons), and b) an upregulation of RVLM GABAA-RS (amplifying the efficacy of the tonic GABA inhibitory input to the RVLM neurons). 2. The reduced baroreflex gain originates in the NTS (such that for a given change in blood pressure and baroreceptor input, the corresponding change in NTS neuronal output (and hence dynamic GABA release in the RVLM) is reduced. The hypotheses will be tested by four aims using extracellular recording of NTS and RVLM neuronal activity in the central baroreflex network in vivo; patch-clamping in medullary slices containing NTS and RVLM neurons in the central network; and real-time RT-PCR from NTS and RVLM micropunches in spontaneously hypertensive rats (SHR). Aims 1-2 will resolve GABA mechanisms in the RVLM (GABA release and GABAA-R gene expression) mediating PEH and Aims 3-4 will address pre- and postsynaptic mechanisms in the NTS in mediating PEH and the reduced gain. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: PRESSURE
PSYCHOSOCIAL
FACTORS
AND
AMBULATORY
BLOOD
Principal Investigator & Institution: Goldstein, Iris B.; None; University of California Los Angeles 10920 Wilshire Blvd., Suite 1200 Los Angeles, Ca 90024 Timing: Fiscal Year 2001; Project Start 11-AUG-1995; Project End 31-AUG-2004 Summary: (investigator's abstract): Family history of hypertension is a primary predictor of high blood pressure in later life. The principal goal of this application is to determine how 24-hour ambulatory blood pressure distinguishes between individuals with different family histories: 2 hypertensive parents, 1 hypertensive parent, normotensive parents. The investigators will also examine effects of family history of blood pressure in combination with other factors linked to elevated blood pressure and hypertension: job strain, social support and personality traits (i.e., hostility, unexpressed anger, anxiety, defensiveness). Effects will be evaluated on a work day and an off work day in 192 men and women, aged 22-50 years, in a broad range of occupations. The investigators hypothesize that ambulatory blood pressure during waking and sleeping hours will be highest in offsprings of 2 hypertensive parents, somewhat elevated in those with 1 hypertensive parent, and lowest in those with normotensive parents. Predicted blood pressure elevations as a function of family history are expected to be greater in individuals with any of the following characteristics: high job strain, anxiety, hostility, defensiveness, or low anger-out. Also, the combination of a personality trait such as high hostility (or high anxiety, high defensiveness, or low anger-out), high job strain, and a family history of hypertension (particularly with 2 hypertensive parents) should lead to greater blood pressure magnifications. All predicted blood pressure effects are expected to be further elevated during work days, whereas the presence of high social support is expected to moderate blood pressure elevations. By sampling serum lipids, insulin, and glucose and daytime and nighttime urinary catecholamines and cortisol, the investigators will evaluate the role of insulin resistance and the sympathetic nervous system in family history. Investigating healthy men and women at risk for hypertension will help identify variables associated with high blood pressure before the disease is fully manifested and enable early intervention through diet and life-style changes. Since hypertension is predictive of future coronary heart disease, stroke, and renal disease, lowering the blood pressure for individuals at risk for hypertension can result in decreased morbidity and mortality rates. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
Studies
·
25
Project Title: PULSATILE ARTERIAL LOAD IN PREECLAMPSIA Principal Investigator & Institution: Shroff, Sanjeev G.; Mcginnis Professor of Bioengineering& Me; Magee-Women's Health Corporation 204 Craft Ave Pittsburgh, Pa 15213 Timing: Fiscal Year 2002; Project Start 14-JUN-2002; Project End 31-JAN-2007 Summary: Changes in pulsatile arterial load (PAL) early in gestation (e.g., increased global arterial compliance, AC) play an important adaptive role in normal pregnancy (e.g., minimize arterial pressure and flow pulsatiles) and preliminary data suggest that aberrant PAL responses may be involved in the pathophysiology of preeclampsia. Working model: AC does not increase early in gestation in subjects destined to develop preeclampsia resulting in increased arterial pressure and flow pulsatiles, and consequently, increased pulsatile (oscillatory) shear stress at vascular endothelium, which is known to cause a sustained activation of endothelial pro-oxidant processes. Over time, this sustained endothelial dysfunction and/or inadequate compensation by anti-oxidant defenses can lead to the hemodynamic milieu commonly seen with the onset of the clinical syndrome of preeclampsia (high blood pressure; high systemic vascular resistance, SVR; and normal-to-low cardiac output). Thus, the focus of the present proposal is to comprehensively examine systemic arterial and left ventricular (LV) properties in primiparous control and prior preeclamptic women, both in the nonpregnant state and throughout the second gestation. Hypotheses: 1) In subjects with a history of preeclampsia, differences in vascular mechanical properties (PAL in particular) and/or endothelial function exist in the non-pregnant state and chronic antioxidant therapy(vitamin C supplementation) can help reduce these differences. 2) In subjects destined to develop preeclampsia, the increase in AC during early gestation, which is seen in normal pregnancy, is significantly attenuated. Two groups of primiparous women will be studied at 6-12 months post- partum (Aim 1a): i) prior preeclamptic subjects (n=70, Group 1) and ii) control subjects (n=70, Group 2). Group 1 subjects will be restudied following an 8-week supplementation with either vitamin C (N=35) or placebo (n=35) (Aim 1b). Finally, a longitudinal study will be conducted in two groups of primiparous women (pre-conception-during second gestation-postpartum) (Aim 2): i) prior preeclamptic subjects (n=70) and ii) control subjects (n=15). Non-invasive measurements will be performed to quantify arterial properties (global: aortic input impedance spectrum, SVR, AC, wave reflection indices; regional: pulse wave velocity, pressure-diameter relationships, indices of vessel wall stiffness), LV properties (size, shape, and mass, indices of myocardial contractility), and endothelial function (forearm blood flow response to mental stress). Blood and urine samples will be analyzed to derive indices of endothelial activation, oxidative stress, and dyslipidemia. Results of these studies are expected to provide insights into the role of pulsatile arterial load in the pathogenesis of preeclampsia. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: RACISM, SOCIAL SUPPORT, AND ALCOHOL USE AND BLOOD PRESSURE IN AFRICAN AMERICANS Principal Investigator & Institution: Robinson, Elwood L.; Professor; North Carolina Central University 160 Alexander-Dunn Bidg. Durham, Nc 27707 Timing: Fiscal Year 2001 Summary: Two of the leading threats to american health are high blood pressure and alcohol-abuse. It is well documented that high blood pressure is linearly related to higher rates of certain forms of coronary heart disease (CHD) and stroke, and the
26 High Blood Pressure
relationship between hypertension and mortality is especially strong for African Americans. Moreover, African Americans alcoholics may run a greater risk than white alcoholics for blood pressure elevations as their drinking careers lengthen. Stressors, or the problems and pressures of life, have long been suspected as culprits linked to both hypertension and alcohol abuse. Racism has been reported to prevail as a primary stressor facing African Americans today. Several studies have described the potentially damaging social, economic, and political consequences of racism and its negative effects on individual well-being (Jaynes & Williams, 1989; Katz & Taylor, 1988; Schuman, Steeth, & Bobo, 1985). Recent studies from epidemiological literature have suggested that exposure to chronic stress of racism, prejudice, and discrimination may contribute to the disproportionately high rates of hypertension among African Americans. Social support has been purported to exert a buffering effect in ameliorating or attenuating the deleterious effects of stress on physical and mental health. Many epidemiological studies suggest that social support is related to reduced morbidity and mortality, particularly for cardiovascular disease. However, most of these studies have focused on white populations in the United States, Western Europe, and Scandinavia. This study proposes to investigate racism/discrimination, social support, alcohol use, and blood pressure in subjects that were drawn from a random sample survey of household residents in Erie county, New York. Overall, three waves of data are available for both cross-sectional and longitudinal data analysis. The specific aims are: (l) To examine the influence of racism on alcohol use and BP in African Americans; (2) To determine if social support buffers these relations and investigate the relation between social network measures and social support; and (3) To assess the effects of age, gender, and socioeconomic status on the above relations. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: RECIPES, MENUS, AND FOOD GUIDELINES FOR TREATMENT & PREVENTION OF HYPERTENSION Principal Investigator & Institution: Mcmurry, Martha; Oregon Health & Science University Portland, or 972393098 Timing: Fiscal Year 2001 Summary: The purpose of this study is to develop recipes which are tasty and which sound like foods which American families might like to prepare and eat. These foods will be based on the DASH (Dietary Approaches to Stop Hypertension) national blood pressure study. The DASH diet has been found to lower blood pressure. We will examine the results of using this diet in persons with high blood pressure or are at risk for high blood pressure (also called "hypertension"). We will provide meals which include foods to sample that are based on the DASH eating plan. These foods and recipes will be evaluated according to taste preferences and eating habits, with feedback requested on how we can improve them. 15 mealtime sessions will occur at the CRC over a 6 month period. Participants will be members of the "DASH Foods Tasting Panel." Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: REDUCING RACIAL DISPARITY IN CV DISEASE THROUGH BP CONTROL Principal Investigator & Institution: Egan, Brent M.; Medical University of South Carolina 171 Ashley Ave Charleston, Sc 29425 Timing: Fiscal Year 2001
Studies
27
Summary: TITLE: Reducing the Racial Disparity in CV Disease Through Better BP control ABSTRACT. Background. Hypertension clearly contributes to the racial disparities in health outcomes. The Charleston Health Study indicated that hypertension contributed to approximately 40% of deaths in African Americans compared to 20% in Caucasians/1. The prevalence and complications are hypertension are greater and control rates lower among hypertensive patients of lower socioeconomic status (SES) which are disproportionately African American/2. For these and other reasons, African Americans in South Carolina continue to die from stroke at double the rate of caucasians/3. The hypertension Detection and Follow- up Program (HDFP) showed that stepped-care treatment of high blood pressure (BP) reduced stroke and total mortality more in African Americans than in caucasians/4. Although access to care is a significant issue for low income individuals, especially the uninsured, control of hypertension to 50% of hypertensive patients who are already in the system but the majority of whom are not consistently at the goal BP/5. Once that is accomplished, then improving access will lead to a more efficient utilization of resources and greater control rates. Reluctance off providers to increase therapy is a major contributor to inadequate BP control/6. An outpatient hypertension management program at Univ. of Pennsylvania, which focused on providers, increased BP control rates from 19-53% within one year/7. Thus, our initial focus and the principal emphasis of this proposal is on the provider and treatment of hypertension and associated risk factors. Hypothesis. Raising provider awareness through a either local Hypertension Expert or feedback on BP control for individual patients will be more effective than traditional continuing medical education (CME) in improving BP control rates. Study design. Using a randomized design, we propose to identify primary care providers in geographically separate areas serving a large proportion of lower income African American patients, Given an aging population, a disproportionate increase of systolic BP with aging, and the fact that systolic BP is less often controlled than diastolic BP and contributes to cardiovascular events and dementia, practices serving a high proportion or elderly African Americans will be selected Practices will be randomly allocated to one of three groups. (1) Hypertension Expert-Selected providers will be trained as the group expert (opinion leader) to (a) develop goals and practice guidelines for implementation in their practice (b) educate their peers and provide consultations on uncontrolled hypertensive patients and (c) participate in evaluating B control at their site. (2) Feedback on BP control. These providers will receive written feedback on treatment goals and control for individual hypertensive patients in their practice. (3) Hypertension CME. Providers at these sites will receive hypertension CME on JNC VI guidelines. BP control rates at one year will be assessed by chart review. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: REGULATION OF CGMP DEPENDENT PROTEIN KINASE Principal Investigator & Institution: Corbin, Jackie D.; Molecular Physiol & Biophysics; Vanderbilt University 3319 West End Ave. Nashville, Tn 372036917 Timing: Fiscal Year 2001; Project Start 01-SEP-1989; Project End 31-AUG-2003 Summary: Interest in cGMP as a second messenger has dramatically escalated in recent years. The list of cGMP actions in mammalian tissues is now quite large, and it is growing. The cGMP-dependent protein kinase (PKG) is a major intracellular receptor for cGMP. Elucidation of the physiological regulation of PKG is the long-term objective of this investigation. In addition to the classical roles ascribed to PKG in mediating effects of natriuretic peptides, nitric oxide or guanylins on airway and vascular smooth muscle relaxation, inhibition of platelet aggregation, and neutrophil degranulation, PKG may
28 High Blood Pressure
also mediate the cGMP-dependent effects of these and other agents on gene expression, chloride transport in intestine and kidney, heart contractility, water transport through the vascular endothelium, bone resorption, melanogenesis in skin, long-term nerve depression and opioid effects. PKG activation is believed to account for many of the pharmacological actions of medications such as "PDE inhibitors" (e.g., caffeine, papaverine) and nitrovasodilators (e.g., nitroglycerin) which are used for relief of chest pain, asthma, male impotence, and high blood pressure. PKG may also mediate the secretory diarrhea caused by certain bacterial enterotoxins. The importance of PKG has recently been enhanced by the realization that some effects of cAMP are mediated by cross-activation of PKG. The mechanism of dimerizaiton of PKG-I-alpha and PKG-I-beta will be studied using mutagenesis and proteolysis. Native and mutant PKG-I- alpha and PKG-I-beta will be utilized to define functional elements of the autoinhibitory domain and to study autophosphorylation. The autophosphorylation site(s) responsible for activation of each isoform will be identified. Conformational changes associated with cGMP binding and autophosphorylation will be measured using small angle X-ray scattering, gel filtration and native gel electrophoresis. PKG will be used as a model for other serine/threonine- and tyrosine-specific protein kinases that are activated by both ligand-binding (e.g., cyclic nucleotides Ca2+/calmodulin, insulin, growth factors) and autophosphorylation by determining whether or not activation by cGMP- binding or autophosphorylation produces the same enzyme conformation. The molecular mechanism of the activation processes will be examined. Native gel electrophoresis, which separates the different autophosphorylated species of the PKGs, and liquid chromatography-mass spectrometry will be used to determine if these species are present in intact tissues. Physiological regulation of PKG protein and mRNA levels will be explored. Results of these investigations will address major aspects of cGMP signaling through PKG. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: REGULATION OF KALLIKREIN MK9 IN HYPERTENSION Principal Investigator & Institution: Uddin, Mukarram; Anatomy and Physiology; Meharry Medical College 1005-D B Todd Blvd Nashville, Tn 37208 Timing: Fiscal Year 2001; Project Start 01-JUN-1999; Project End 31-MAY-2004 Summary: (Adapted from applicant's abstract): This seeks funding to retrain, to acquire additional technical skills, and to gain hand-on experience on the state-of-the-art molecular biology techniques. This retraining, and acquirement of additional state- ofthe-art technical skills will help the candidate not only in gaining cutting-edge technology experience but also making him competitive in seeking R01 type funding. The experience gained by the candidate will be applied to the proposed investigation in the evaluation of altered gene regulation of epidermal growth factor- binding protein (EGF-BP C), (Kallikrein mK9),a prorenin converting enzyme in mice genetically selected for high blood pressure. The funding will also provide opportunity to train minority students in the area related to cardiovascular diseases. Preliminary results of the proposed investigation, utilizing the submandibular gland(whole issue) from mice genetically selected for high blood pressure, indicated increase expression of EGF-BP C(kallikrein mK9), a prorenin converting enzyme. Immuno- histochemical localization of this kallikrein indicated it to be present in the submandibular gland duct cells. It is hypothesized that higher expression of this prorenin converting enzyme is due to altered activity of its gene MKlk-9. The main objective of the proposed investigation is to evaluate the molecular mechanism of the up regulation of EGF-BP C in long-term duct cell cultures. Specific aims to test the hypothesis include development of long- term duct
Studies
29
cell cultures, quantitation and steady state levels of EFG-BP specific mRNA, mutational changes in the promoter region of EGF-BP C gene (mKlk-9), and evaluation of transcription factor binding to the promoter region of this kallikrein. This research will be conducted in the mentor's laboratory, Department of Biochemistry, Vanderbilt University and the candidate's laboratory, Department of Anatomy and Physiology, Meharry Medical College. Both of these laboratories are located in Nashville, TN. During retraining, facility will be developed with techniques, data collected and affiliation developed will further the missions of Meharry Medical College. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: ROLE OF CEREBROVASCULAR K+ CHANNELS IN HYPERTENSION Principal Investigator & Institution: Rusch, Nancy J.; Professor; Physiology; Medical College of Wisconsin Po Box26509 Milwaukee, Wi 532264801 Timing: Fiscal Year 2002; Project Start 01-MAR-1998; Project End 30-NOV-2005 Summary: The goal of this project is to provide a profile of the disease-specific expression of the Shaker (Kv1) gene family of voltage-gated K+ channels in the cerebral microcirculation of hypertensive rats. Our early results suggest that Shaker Kv1 channels upregulate in the cerebral circulation of normal Wistar Kyoto (WKY) rats during the maturation of the animal to emerge as predominant contributors to cerebral arterial membrane potential and diameter. However, this progression is highly suppressed in spontaneously hypertensive rats (SHR), in which maturation results in the exposure of the cerebral microcirculation to progressively higher blood pressure levels in vivo. Indeed, patch-clamped cerebrovascular smooth muscle cells from adult SHR show reduced Shaker Kv1 current compared to cells from normal Wistar Kyoto (WKY) rats, and this alteration is associated with smooth muscle cell depolarization and constriction. Notably, this vasoconstriction is regarded as a fundamental adaptive response of small cerebral arteries to the development of high blood pressure in vivo, which minimizes the damaging transmission of the high systemic pressure to the blood brain barrier. Based on these findings, and our evidence that the remodeling of K+ channels in the cerebral circulation critically protects this vascular bed from the lethal effects of high blood pressure, we will: (a) combine RT-PCR gene expression studies, Western blotting, and patch-clamp techniques to examine the expression and function of Shaker Kv1 channels in rat cerebrovascular smooth muscle cells during the development of genetic and renal forms of hypertension, and after correction of hypertension by vasodilator drugs (b) assess the physiological impact of these changes in Shaker Kv1 channel expression on the membrane potential and diameter of isolated cerebral arteries in vitro and arterioles in vivo, and (c) test the hypothesis that pressure-induced membrane depolarization is a triggering stimulus for the remodeling of Shaker Kv1 channels in the vascular smooth muscle membranes of the cerebral circulation. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: SOFTWARE PROMOTES NCEP/AHA PROVIDER GUIDELINE ADHERENCE Principal Investigator & Institution: Baruch, Lawrence; Coecare.Com, Llc 185 Bridge Plaza N, Ste 306 Fort Lee, Nj 07024 Timing: Fiscal Year 2003; Project Start 01-SEP-2003; Project End 31-MAR-2004 Summary: (provided by applicant): Cardiovascular disease continues to be the leading cause of mortality and morbidity in the United States To assist health care practitioners in their integration of new information into clinical practice, professional organizations
30 High Blood Pressure
such as the National Cholesterol Education Program Expert Treatment Panel (ATP Ill), American Heart Association (AHA), American College of Cardiology (ACC), and Expert Treatment Panel (ATP III), Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI), develop guidelines to promote evidence-based standards of care in the management of cardiovascular disease. Despite the comprehensive nature and widespread dissemination of these guidelines, target parameters are not being achieved, and patients are not managed optimally. These diseases include achievement of lipid and blood pressure goals, usage of antiplatelet or anticoagulant therapy in patients with coronary artery disease and atrial fibrillation, usage of 13-blockers in patients post myocardial infarction, and the usage of t3-blockers and converting enzyme inhibitors in patients with systolic left ventricular dysfunction. The failure of implementation of optimal evidenced based guideline care has been attributed to a number of reasons including lack of knowledge of the guidelines and the failure of the guidelines to instruct the health care provider on strategies to implement the guidelines in individual patients. To facilitate the incorporation of these treatment guidelines in everyday medical practice, the Cardiac Goal Program software has been developed to prompt entry of data essential to the management of cardiovascular disease, based on Class I or Grade A recommendations using established guidelines, into standardized, computerized forms with a reminder system. The aims of the proposal are the incorporation of NCEP cholesterol treatment algorithms into the existing Cardiovascular Goal Program, employ usability methodologies, including in-depth interviews and focus groups with physicians, nurses, and physicians assistants, and refine the existing software based on the feedback from the practitioner's and retest the feasibility. If this automated clinical information and decision support system is successful and widely implemented, the best outcomes from care for chronic cardiovascular disease may be achieved. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen ·
Project Title: VASCULAR DISEASE AND HIGH BLOOD PRESSURE--PA1, INSULIN AND GENES Principal Investigator & Institution: Williams, Gordon H.; Professor of Medicine; Brigham and Women's Hospital 75 Francis Street Boston, Ma 02115 Timing: Fiscal Year 2001 Summary: The purpose of the study is to investigate why patients develop high blood pressure, atherosclerosis, and heart disease. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
·
Project Title: VISUAL ADAPTATION LIMITS AND AGE-RELATED DISEASE Principal Investigator & Institution: Eisner, Alvin; Senior Scientist; None; Oregon Health & Science University Portland, or 972393098 Timing: Fiscal Year 2001; Project Start 01-FEB-1999; Project End 31-JAN-2003 Summary: The proposed research will determine the extent to which diseased visual systems can be pushed selectively beyond the limits of their effective adaptation capabilities so that their sensitivities become categorically different from normal. The emphasis will be on glaucoma-related visual dysfunction that cannot be attributed directly to the loss of optic nerve cells. This dysfunction involves adaptation processes that actively maintain visual response. It occurs for people who have a slight degree of glaucomatous optic neuropathy combined with high blood pressure, and could be due to either condition. The research will help clarify the relation between high blood
Studies
31
pressure and glaucoma-related visual dysfunction. It will focus on how to exceed the limits of the visual system's adaptation capabilities so that subtle physiologic compromise can be amplified into large sensitivity changes. A major emphasis will concern the visual system's ability to maintain a stable effective operating range for resolving temporally modulated stimuli, i.e. for detecting flicker. Psychophysical tests of visual function after adaptation-field onset will be compared with clinical assessments of early glaucomatous damage. The prevalence of visual adaptation abnormalities will be examined for four clinically-defined groups of middle-age subjects: 1) glaucoma subjects with positive medical histories of high blood pressure, 2) glaucoma subjects with negative medical histories of high blood pressure, 3) non-glaucoma subjects with positive medical histories of high blood pressure and negative clinical histories of ocular hypertension, and 4) healthy normal subjects. Young healthy subjects will be tested also. The experiments will identify the types of processes that underlie flicker response abnormalities and will integrate a diverse set of existing results concerning suppression of flicker response under taxing adaptation conditions. The specific aims are 1) to determine whether people with high blood pressure have a higher-thannormal prevalence of visual dysfunction, 2) to determine how often foveal visual adaptation is abnormal for people who have high blood pressure but do not have glaucoma, and vice versa, 3) to determine whether certain subtypes or stages of glaucoma are associated with certain types of foveal adaptation abnormalities, 4) to identify the mechanisms by which glaucoma and/or high-blood-pressure alter foveal flicker response, and 5) to determine if the limits of the visual system's flicker-response operating-range can be specified as precisely at bright ambient light levels as they have been at dim ambient light levels. Website: http://crisp.cit.nih.gov/crisp/Crisp_Query.Generate_Screen
E-Journals: PubMed Central3 PubMed Central (PMC) is a digital archive of life sciences journal literature developed and managed by the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).4 Access to this growing archive of e-journals is free and unrestricted.5 To search, go to http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Pmc, and type “high blood pressure” (or synonyms) into the search box. This search gives you access to full-text articles. The following is a sample of items found for high blood pressure in the PubMed Central database: ·
3 4
Chronic Control of High Blood Pressure in the Spontaneously Hypertensive Rat by Delivery of Angiotensin Type 1 Receptor Antisense. by Iyer SN, Lu D, Katovich MJ, Raizada MK.; 1996 Sep 3; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&rendertype=abstr act&artid=38537
Adapted from the National Library of Medicine: http://www.pubmedcentral.nih.gov/about/intro.html.
With PubMed Central, NCBI is taking the lead in preservation and maintenance of open access to electronic literature, just as NLM has done for decades with printed biomedical literature. PubMed Central aims to become a world-class library of the digital age. 5 The value of PubMed Central, in addition to its role as an archive, lies in the availability of data from diverse sources stored in a common format in a single repository. Many journals already have online publishing operations, and there is a growing tendency to publish material online only, to the exclusion of print.
32 High Blood Pressure
·
Contribution of parental blood pressures to association between low birth weight and adult high blood pressure: cross sectional study. by Walker BR, McConnachie A, Noon JP, Webb DJ, Watt GC.; 1998 Mar 14; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=28489
·
Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. by Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS.; 2003 Jul 1; http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&artid=162290
The National Library of Medicine: PubMed One of the quickest and most comprehensive ways to find academic studies in both English and other languages is to use PubMed, maintained by the National Library of Medicine.6 The advantage of PubMed over previously mentioned sources is that it covers a greater number of domestic and foreign references. It is also free to use. If the publisher has a Web site that offers full text of its journals, PubMed will provide links to that site, as well as to sites offering other related data. User registration, a subscription fee, or some other type of fee may be required to access the full text of articles in some journals. To generate your own bibliography of studies dealing with high blood pressure, simply go to the PubMed Web site at http://www.ncbi.nlm.nih.gov/pubmed. Type “high blood pressure” (or synonyms) into the search box, and click “Go.” The following is the type of output you can expect from PubMed for high blood pressure (hyperlinks lead to article summaries): ·
A “touch” of high blood pressure. Author(s): Moser M. Source: Journal of Clinical Hypertension (Greenwich, Conn.). 2002 January-February; 4(1): 10-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11821632&dopt=Abstract
·
A clinical trial to improve high blood pressure care in young urban black men: recruitment, follow-up, and outcomes. Author(s): Hill MN, Bone LR, Hilton SC, Roary MC, Kelen GD, Levine DM. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1999 June; 12(6): 548-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10371363&dopt=Abstract
6
PubMed was developed by the National Center for Biotechnology Information (NCBI) at the National Library of Medicine (NLM) at the National Institutes of Health (NIH). The PubMed database was developed in conjunction with publishers of biomedical literature as a search tool for accessing literature citations and linking to full-text journal articles at Web sites of participating publishers. Publishers that participate in PubMed supply NLM with their citations electronically prior to or at the time of publication.
Studies
33
·
A comparison of compliance techniques on the control of high blood pressure. Author(s): Binstock ML, Franklin KL. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1988 July; 1(3 Pt 3): 192S-194S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3415798&dopt=Abstract
·
A comparison of the prevalence and risk factors of high blood pressure among Japanese living in Japan, Hawaii, and Los Angeles. Author(s): Imazu M, Sumida K, Yamabe T, Yamamoto H, Ueda H, Hattori Y, Miyauchi A, Hara H, Yamakido M. Source: Public Health Reports (Washington, D.C. : 1974). 1996; 111 Suppl 2: 59-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8898778&dopt=Abstract
·
A history of the Council for High Blood Pressure research. Past imperfect, present indicative, and future perfect. Author(s): Page IH. Source: Hypertension. 1984 March-April; 6(2 Pt 2): I208-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6373597&dopt=Abstract
·
A history of the Council for High Blood Pressure Research: the first 50 years. Author(s): Dustan HP. Source: Hypertension. 1997 December; 30(6): 1307-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9403546&dopt=Abstract
·
A hospital-based screening, referral, and follow-up program for high blood pressure. Author(s): Theisen V, Caldwell JR, Erfurt JC, Foote A. Source: American Journal of Public Health. 1979 June; 69(6): 599-601. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=443501&dopt=Abstract
·
A hypertension survey: respondents' knowledge of high blood pressure. Author(s): Hinds C. Source: International Nursing Review. 1983 January-February; 30(1): 12-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6551358&dopt=Abstract
·
A model for the pharmacist's involvement in high blood pressure control. Author(s): McKenney JM. Source: Family & Community Health. 1981 May; 4(1): 53-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10250954&dopt=Abstract
34 High Blood Pressure
·
A nutrition curriculum for families with high blood pressure. Author(s): Farris RP, Frank GC, Webber LS, Berenson GS. Source: The Journal of School Health. 1985 March; 55(3): 110-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3845257&dopt=Abstract
·
A positive parental history of high blood pressure. Author(s): Samani NJ. Source: Journal of Human Hypertension. 1998 April; 12(4): 209-10. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9607686&dopt=Abstract
·
A prospective study of high blood pressure and cardiovascular disease in women. Author(s): Fiebach NH, Hebert PR, Stampfer MJ, Colditz GA, Willett WC, Rosner B, Speizer FE, Hennekens CH. Source: American Journal of Epidemiology. 1989 October; 130(4): 646-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2773913&dopt=Abstract
·
A review of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report, 1993. Author(s): Alderman MH. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1993 October; 6(10): 896-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8267949&dopt=Abstract
·
A review of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Schwartz GL, Sheps SG. Source: Current Opinion in Cardiology. 1999 March; 14(2): 161-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10191976&dopt=Abstract
·
A simple and effective method to teach patients about high blood pressure and obesity. Author(s): Neyses L, Greminger P, Bartsch A, Luscher T, Keller U, Bachmann L, Siegenthaler W, Vetter W. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1985 April; 3(1): S27-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2439671&dopt=Abstract
·
A social-psychological perspective on successful community control of high blood pressure: a review. Author(s): Kasl SV. Source: Journal of Behavioral Medicine. 1978 December; 1(4): 347-81. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=385886&dopt=Abstract
Studies
35
·
A three-year study of obesity and its relationship to high blood pressure in adolescents. Author(s): Adeyanju M, Creswell WH, Stone DB, Macrina DM. Source: The Journal of School Health. 1987 March; 57(3): 109-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3645176&dopt=Abstract
·
A young woman with high blood pressure on haemodialysis: it is never too late to evaluate hypertension. Author(s): Nickeleit V, Moll S, Cynke E, Brunner FP, Mihatsch MJ. Source: Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 1999 November; 14(11): 2734-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10534523&dopt=Abstract
·
Activation of renin-angiotensin system in maintenance of high blood pressure in uncomplicated pheochromocytoma--a case report. Author(s): Muratani H, Kawasaki T, Kawano Y, Abe I, Kumamoto K, Omae T. Source: Jpn J Med. 1983 August; 22(3): 227-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6353013&dopt=Abstract
·
Adherence to management of high blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Author(s): Chockalingam A, Bacher M, Campbell N, Cutler H, Drover A, Feldman R, Fodor G, Irvine J, Ramsden V, Thivierge R, Tremblay G. Source: Canadian Journal of Public Health. Revue Canadienne De Sante Publique. 1998 September-October; 89(5): I5-11. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9813919&dopt=Abstract
·
Adverse treatment effects in the trial of the European Working Party on High Blood Pressure in the Elderly. Author(s): Fletcher AE. Source: The American Journal of Medicine. 1991 March; 90(3A): 42S-44S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006659&dopt=Abstract
·
Affective, substance use, and anxiety disorders in persons with arthritis, diabetes, heart disease, high blood pressure, or chronic lung conditions. Author(s): Wells KB, Golding JM, Burnam MA. Source: General Hospital Psychiatry. 1989 September; 11(5): 320-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2792744&dopt=Abstract
36 High Blood Pressure
·
African Americans and high blood pressure: the role of stereotype threat. Author(s): Blascovich J, Spencer SJ, Quinn D, Steele C. Source: Psychological Science : a Journal of the American Psychological Society / Aps. 2001 May; 12(3): 225-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11437305&dopt=Abstract
·
Age-related hypotensive effect of placebo and active treatment in patients older than 60 years. European Working Party on High Blood Pressure in the Elderly. Author(s): Thijs L. Source: The American Journal of Medicine. 1991 March; 90(3A): 24S-26S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006656&dopt=Abstract
·
Alcohol and obesity: a new look at high blood pressure and stroke. An epidemiological study in preventive neurology. Author(s): Kornhuber HH, Lisson G, Suschka-Sauermann L. Source: Eur Arch Psychiatry Neurol Sci. 1985; 234(6): 357-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3896816&dopt=Abstract
·
Alcohol consumption as a risk factor for high blood pressure from the Cardiovascular Diseases and Alimentary Comparison Study. CARDIAC Cooperative Research Group). Author(s): Mizushima S, Nara Y, Mano M, Sawamura M, Horie R, Yamori Y. Source: Journal of Cardiovascular Pharmacology. 1990; 16 Suppl 8: S35-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1706027&dopt=Abstract
·
Alcohol consumption as a risk factor for high blood pressure. Munich Blood Pressure Study. Author(s): Cairns V, Keil U, Kleinbaum D, Doering A, Stieber J. Source: Hypertension. 1984 January-February; 6(1): 124-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6693142&dopt=Abstract
·
Alcohol drinking and high blood pressure: data from a 1980 national cardiovascular survey of Japan. Author(s): Ueshima H, Ozawa H, Baba S, Nakamoto Y, Omae T, Shimamoto T, Komachi Y. Source: Journal of Clinical Epidemiology. 1992 June; 45(6): 667-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1607906&dopt=Abstract
·
Alcohol, high blood pressure, and serum gamma-glutamyl transpeptidase level. Author(s): Yamada Y, Ishizaki M, Kido T, Honda R, Tsuritani I, Ikai E, Yamaya H. Source: Hypertension. 1991 December; 18(6): 819-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1683858&dopt=Abstract
Studies
37
·
Alteration in the carotid artery wall properties with ageing and high blood pressure level. Author(s): Benetos A, Laurent S, Boutouyrie P, Safar M. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1991 December; 9(6): S112-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1818905&dopt=Abstract
·
An approach to primary preventive treatment for children with high blood pressure in a total community. Author(s): Frank GC, Farris RP, Ditmarsen P, Voors AW, Berenson GS. Source: Journal of the American College of Nutrition. 1982; 1(4): 357-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7185868&dopt=Abstract
·
An evaluation of the utility of high blood pressure detection fairs. Author(s): Wassertheil-Smoller S, Bijur P, Blaufox MD. Source: American Journal of Public Health. 1978 August; 68(8): 765-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=686203&dopt=Abstract
·
An osteopathic cardiologist's review of hypertension: beyond the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Williams AM. Source: J Am Osteopath Assoc. 1994 October; 94(10): 833-47. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7814277&dopt=Abstract
·
Angiotensin converting enzyme inhibition reveals an important role for the renin system in the control of normal and high blood pressure in man. Author(s): MacGregor GA, Markandu ND, Smith SJ, Sagnella GA, Morton JJ. Source: Clin Exp Hypertens A. 1983; 5(7-8): 1367-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6315274&dopt=Abstract
·
Anticipatory blood pressure response to exercise predicts future high blood pressure in middle-aged men. Author(s): Everson SA, Kaplan GA, Goldberg DE, Salonen JT. Source: Hypertension. 1996 May; 27(5): 1059-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8621197&dopt=Abstract
38 High Blood Pressure
·
Antihypertensive therapy in patients above age 60 with systolic hypertension. A progress report of the European Working Party on High Blood Pressure in the Elderly (EWPHE). Author(s): Amery A, Birkenhager W, Bogaert M, Brixko P, Bulpitt C, Clement D, De Leeuw P, De Plaen JF, Deruyttere M, De Schaepdryver A, Fagard R, Forette F, Forte J, Hamdy R, Hellemans J, Henry JF, Koistinen A, Laaser U, Laher M, Leonetti G, Lewis P, Lund-Johansen P, MacFarlane J, Meurer K, Miguel P, Morris J, Mutsers A, Nissinen A, O'Brien E, Ohm OJ, O'Malley K, Pelemans W, Perera N, Tuomilehto J, Verschueren LJ, Willemse P, Williams B, Zanchetti A. Source: Clin Exp Hypertens A. 1982; 4(7): 1151-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7116662&dopt=Abstract
·
Antihypertensive therapy in patients above age 60 years (Fourth Interim report of the European Working Party on High Blood pressure in Elderly: EWPHE). Author(s): Amery A, Berthaux P, Birkenhager W, Boel A, Brixko P, Bulpitt C, Clement D, De Padua F, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Henry JF, Hellemans J, Koistinen A, Laaser U, Lund-Johansen P, MacFarlane J, Miguel P, Mutsers A, Nissinen A, Ohm OT, Pelemans W, Suchett-Kaye AI, Tuomilehto J, Willems J, Willemse P. Source: Clin Sci Mol Med Suppl. 1978 December; 4: 263S-270S. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=365433&dopt=Abstract
·
Antihypertensive therapy in patients above age 60. Third interim report of the European Working Party on High blood pressure in Elderly (EWPHE). Author(s): Amery A, Berthaux P, Birkenhager W, Boel A, Brixko P, Bulpitt C, Clement D, Deruyttere M, de Schaepdryver A, Dollery C, Fagard R, Forette F, Henry JF, Hellemans J, Laaser U, Lund-Johansen P, MacFarlane J, Maling T, Mutsers A, Nissinen A, Ohn OH, Pelemans J, Suchettkaye AI, Tuomilehto J, Willems J. Source: Acta Cardiol. 1978; 33(2): 113-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=356497&dopt=Abstract
·
Are there interactions and relations between genetic and environmental factors predisposing to high blood pressure? Author(s): Williams RR, Hunt SC, Hasstedt SJ, Hopkins PN, Wu LL, Berry TD, Stults BM, Barlow GK, Schumacher MC, Lifton RP, et al. Source: Hypertension. 1991 September; 18(3 Suppl): I29-37. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1889856&dopt=Abstract
·
Arterial alterations with aging and high blood pressure. A noninvasive study of carotid and femoral arteries. Author(s): Benetos A, Laurent S, Hoeks AP, Boutouyrie PH, Safar ME. Source: Arterioscler Thromb. 1993 January; 13(1): 90-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8422344&dopt=Abstract
Studies
39
·
Ask the doctor. For years, I have been taking reserpine for my high blood pressure. A younger doctor I recently saw had never met anyone taking it. Should I be switched to something new? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1999 September; 10(1): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10446024&dopt=Abstract
·
Ask the doctor. I am a 70-year-old man with high blood pressure that I control with medication, diet, and exercise. My mother, aunt, and maternal grandfather all died in their 50s after a single stroke. Is there an inherited tendency to hemorrhagic stroke? Are there any precautions I can take? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 2002 June; 12(10): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12079827&dopt=Abstract
·
Ask the doctor. I am a 78-year-old woman and have been taking high blood pressure medications for many years. Maybe it s because I've lost a lot of weight I used to be quite heavy but my blood pressure has fallen to about 110/70 mm Hg. My doctor tells me that the lower my blood pressure, the better. But I worry that it's getting too low. What do you think? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 2001 October; 12(2): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11684496&dopt=Abstract
·
Ask the doctor. I am trying to decide whether to buy a home blood pressure monitor. I have mild high blood pressure (my doctor has recorded some readings lately in the vicinity of 170/90 mm Hg). He is starting me on medicines now. Should I lay out the money for a monitor? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 2000 November; 11(3): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11063532&dopt=Abstract
·
Ask the doctor. I first learned I had high blood pressure in the 1970s. Back then, I was told that the bottom number was the important one. Now I am hearing the opposite. Which is right? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1999 June; 9(10): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10233792&dopt=Abstract
40 High Blood Pressure
·
Ask the doctor. I have tried - and stopped - almost every medication known to man for treatment of high blood pressure. All of them have caused a serious side effect, impotence. Is there any medication out there or coming soon that can control blood pressure without causing impotence? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1999 July; 9(11): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10368530&dopt=Abstract
·
Ask the doctor. I have used a medication called Aldomet for many years for my high blood pressure. Recently, I had to go to the hospital, and the young intern said that he had never heard of anyone using this drug and that it was something out of the history books. Should I be on another drug? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1999 July; 9(11): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10369656&dopt=Abstract
·
Ask the doctor: I take a water pill for my high blood pressure, but just hate taking my potassium supplement - two teaspoons of a bitter liquid per day. Is there any better way to keep my potassium up? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1999 August; 9(12): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10402355&dopt=Abstract
·
Assessment of the association between habitual salt intake and high blood pressure: methodological problems. Author(s): Liu K, Cooper R, McKeever J, McKeever P, Byington R, Soltero I, Stamler R, Gosch F, Stevens E, Stamler J. Source: American Journal of Epidemiology. 1979 August; 110(2): 219-26. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=463875&dopt=Abstract
·
Association between obesity and high blood pressure: reporting bias related to gender and age. Author(s): Chen Y, Rennie DC, Lockinger LA, Dosman JA. Source: International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity. 1998 August; 22(8): 771-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9725637&dopt=Abstract
·
Association of the human Y chromosome with high blood pressure in the general population. Author(s): Ellis JA, Stebbing M, Harrap SB. Source: Hypertension. 2000 November; 36(5): 731-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11082135&dopt=Abstract
Studies
41
·
Atrial natriuretic factor, the kidney and high blood pressure. Author(s): Hamet P, Tremblay J. Source: Clinical and Investigative Medicine. Medecine Clinique Et Experimentale. 1989 October; 12(5): 329-35. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2532087&dopt=Abstract
·
Autometrically and automatically monitored, iatrogenous, inhalant-decongestantassociated high blood pressure quantified by rhythmometry. Author(s): Scarpelli PT, Scarpelli L, Livi R, Groppi E, Cornelissen G, Romano S, Cagnoni M, Halberg F. Source: Prog Clin Biol Res. 1987; 227B: 183-200. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2442774&dopt=Abstract
·
Autoregulation as a factor in peripheral resistance and flow: clinical implications for analysis of high blood pressure. Author(s): Pickering TG, Laragh JH. Source: The American Journal of Medicine. 1980 June; 68(6): 801-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7386486&dopt=Abstract
·
Awareness of high blood pressure increases arterial plasma catecholamines, platelet noradrenaline and adrenergic responses to mental stress. Author(s): Rostrup M, Mundal HH, Westheim A, Eide I. Source: Journal of Hypertension. 1991 February; 9(2): 159-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1849532&dopt=Abstract
·
Awareness of high blood pressure influences on psychological and sympathetic responses. Author(s): Rostrup M, Ekeberg O. Source: Journal of Psychosomatic Research. 1992 February; 36(2): 117-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1560424&dopt=Abstract
·
Awareness of high blood pressure stimulates platelet release reaction. Author(s): Rostrup M, Mundal HH, Kjeldsen SE, Gjesdal K, Eide I. Source: Thrombosis and Haemostasis. 1990 June 28; 63(3): 367-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2144919&dopt=Abstract
·
Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. Author(s): Hill MN, Levine DM, Whelton PK. Source: American Journal of Public Health. 1988 September; 78(9): 1190-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3407818&dopt=Abstract
42 High Blood Pressure
·
Beating high blood pressure with low-sodium DASH. Author(s): Greenland P. Source: The New England Journal of Medicine. 2001 January 4; 344(1): 53-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11136961&dopt=Abstract
·
Behavior changes and the prevention of high blood pressure. Workshop II. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health. Author(s): Levine DM, Cohen JD, Dustan HP, Falkner B, Flora JA, Lefebvre RC, Morisky DE, Oberman A, Pickering TG, Roccella EJ, et al. Source: Circulation. 1993 September; 88(3): 1387-90. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8353905&dopt=Abstract
·
Behavioral treatment of high blood pressure II. Acute and sustained effects of relaxation and systolic blood pressure biofeedback. Author(s): Glasgow MS, Gaarder KR, Engel BT. Source: Psychosomatic Medicine. 1982 May; 44(2): 155-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7045912&dopt=Abstract
·
Behavioral treatment of high blood pressure. I. Analyses of intra- and interdaily variations of blood pressure during a one-month, baseline period. Author(s): Engel BT, Gaarder KR, Glasgow MS. Source: Psychosomatic Medicine. 1981 June; 43(3): 255-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7255637&dopt=Abstract
·
Behavioral treatment of high blood pressure: III. Follow-up results and treatment recommendations. Author(s): Engel BT, Glasgow MS, Gaarder KR. Source: Psychosomatic Medicine. 1983 March; 45(1): 23-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6342016&dopt=Abstract
·
Beliefs about high blood pressure prevention in a survey of blacks and Hispanics. Author(s): Kumanyika S, Savage DD, Ramirez AG, Hutchinson J, Trevino FM, AdamsCampbell LL, Watkins LO. Source: American Journal of Preventive Medicine. 1989 January-February; 5(1): 21-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2742786&dopt=Abstract
·
Benefits and potential harm of lowering high blood pressure. Author(s): Cruickshank JM, Thorp JM, Zacharias FJ. Source: Lancet. 1987 March 14; 1(8533): 581-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2881129&dopt=Abstract
Studies
43
·
Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure. Author(s): Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. Source: The American Journal of Cardiology. 1990 November 6; 66(16): 12G-14G. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1978545&dopt=Abstract
·
Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure. Author(s): Psaty BM, Koepsell TD, LoGerfo JP, Wagner EH, Inui TS. Source: Jama : the Journal of the American Medical Association. 1989 April 14; 261(14): 2087-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2564445&dopt=Abstract
·
Biased appraisal of high blood pressure. Author(s): Croyle RT. Source: Preventive Medicine. 1990 January; 19(1): 40-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2320558&dopt=Abstract
·
Biosocial aspects of high blood pressure in people of the Bahamas. Author(s): Halberstein RA, Davies JE. Source: Human Biology; an International Record of Research. 1984 May; 56(2): 317-28. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6489982&dopt=Abstract
·
Blacks and high blood pressure. Author(s): Hogan A. Source: J Tenn Med Assoc. 1990 September; 83(9): 466-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2214756&dopt=Abstract
·
Blood platelet responses to laboratory stress in young men. The effect of awareness of high blood pressure. Author(s): Mundal HH, Rostrup M. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1996 January; 9(1): 12-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8834701&dopt=Abstract
·
Blood pressure and high blood pressure. Aspects of risk. Author(s): Stamler J. Source: Hypertension. 1991 September; 18(3 Suppl): I95-107. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1889862&dopt=Abstract
44 High Blood Pressure
·
Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day. Author(s): Rodriguez-Roa E, Octavio A, Mayorca E, Castro P, Miranda R, Valecillo E, Gonzalez M. Source: Journal of Human Hypertension. 2002 March; 16 Suppl 1: S151-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11986915&dopt=Abstract
·
Blood pressure response to an angiotensin II antagonist in thyrotoxic patients with and without high blood pressure. Author(s): Ogihara T, Hata T, Maruyama A, Mikami H, Nakamaru M, Naka T, Kumahara Y, Kuma K. Source: Endocrinol Jpn. 1980 April; 27(2): 223-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7408785&dopt=Abstract
·
Blood pressure variability at normal and high blood pressure. Author(s): Mancia G. Source: Chest. 1983 February; 83(2 Suppl): 317-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6822125&dopt=Abstract
·
Blood pressure variability in man: its relation to high blood pressure, age and baroreflex sensitivity. Author(s): Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, Zanchetti A. Source: Clinical Science (London, England : 1979). 1980 December; 59 Suppl 6: 401S404S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7449290&dopt=Abstract
·
Blurred vision and high blood pressure in a young woman. Author(s): Flanagan DE, Cole C, Crick MD, Kerr D. Source: Postgraduate Medical Journal. 1998 October; 74(876): 614-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10211361&dopt=Abstract
·
Body mass index and prognosis in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly. Author(s): Tuomilehto J. Source: The American Journal of Medicine. 1991 March; 90(3A): 34S-41S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006658&dopt=Abstract
·
But, on the other hand: high blood pressure, economics and equity. Author(s): Fein R. Source: The New England Journal of Medicine. 1977 March 31; 296(13): 751-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=402578&dopt=Abstract
Studies
45
·
By the way, doctor. I recently read that Tylenol and anti-inflammatory drugs can cause high blood pressure. This doesn't leave me with many pain relief options. What do you suggest? Author(s): Robb-Nicholson C. Source: Harvard Women's Health Watch. 2003 February; 10(6): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12604441&dopt=Abstract
·
By the way, doctor. I am 87 and have been taking blood pressure medications for years. In the past, side effects were a problem, but for about the last year I've done very well taking valsartan (Diovan) and hydrochlorothiazide (Esidrex). Now My blood pressure is about 165/72 mm hg. The top number seems high. One doctor told me that as long as the bottom number is low, I shouldn't be concerned. But I am. My father died from a stroke many years ago, and I'm pretty sure he had high blood pressure. Author(s): Lee TH. Source: Harvard Health Letter / from Harvard Medical School. 2000 February; 25(4): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10637019&dopt=Abstract
·
By the way, doctor.I have high blood pressure and arthritis, but otherwise am healthy. Recently, my doctor told me that my creatinine level was up to 1.9. Is that high? And is there anything I can do to lower it? Author(s): Lee TH. Source: Harvard Health Letter / from Harvard Medical School. 2002 May; 27(7): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12034559&dopt=Abstract
·
Can high blood pressure alone increase erythrocytic intracellular sodium concentration? Author(s): Matsuura H, Oshima T, Inoue I, Shingu T, Fujii T, Kato Y, Kajiyama G. Source: Japanese Circulation Journal. 1992 December; 56(12): 1234-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1336074&dopt=Abstract
·
Can high blood pressure mask severe aortic stenosis? Author(s): Chambers J. Source: J Heart Valve Dis. 1999 May; 8(3): 277-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10399660&dopt=Abstract
·
Canadian Consensus Conference on Nonpharmacological Approaches to the Management of High Blood Pressure: postconference initiatives. Author(s): Chockalingam A. Source: Journal of Cardiovascular Pharmacology. 1990; 16 Suppl 8: S51-3. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1706032&dopt=Abstract
46 High Blood Pressure
·
Canadian Consensus Conference on Nonpharmacological Approaches to the Management of High Blood Pressure: recommendations. Author(s): Laidlaw JC, Chockalingam A. Source: Journal of Cardiovascular Pharmacology. 1990; 16 Suppl 8: S48-50. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1706031&dopt=Abstract
·
Canadian national high blood pressure prevention and control strategy. Author(s): Chockalingam A, Campbell N, Ruddy T, Taylor G, Stewart P; Expert Working Group. Source: The Canadian Journal of Cardiology. 2000 September; 16(9): 1087-93. Review. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11021952&dopt=Abstract
·
Cardiac status after four years in a trial on nutritional therapy for high blood pressure. Author(s): Stamler R, Grimm RH Jr, Dyer AR, Talano JV, Prineas R, Crow R, Berman R, Gosch FC, Elmer P, Stamler J. Source: Archives of Internal Medicine. 1989 March; 149(3): 661-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2645845&dopt=Abstract
·
Cardiovascular outcomes of treating high blood pressure. Author(s): Weber MA. Source: American Heart Journal. 1987 October; 114(4 Pt 2): 964-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3310572&dopt=Abstract
·
Cardiovascular perspectives of reducing high blood pressure. Author(s): Birkenhager WH, de Leeuw PW. Source: The Netherlands Journal of Medicine. 1989 June; 34(5-6): 229-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2770936&dopt=Abstract
·
Caring for older patients with high blood pressure. Author(s): Burris JF. Source: American Family Physician. 1991 July; 44(1): 137-44. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2058528&dopt=Abstract
·
Cation imbalance in erythrocytes, serum and 24-hour urine from patients with essential hypertension and adolescents with high blood pressure. Author(s): Tochikubo O, Sasaki O, Umemura S, Goto E, Fujishima S, Kaneko Y. Source: Japanese Circulation Journal. 1982 May; 46(5): 512-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7077814&dopt=Abstract
Studies
47
·
Causes and effects of high blood pressure: a longitudinal approach to genetic cosegregational analysis. Author(s): Harrap SB. Source: Journal of Cardiovascular Pharmacology. 1988; 12 Suppl 3: S99-109. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2467113&dopt=Abstract
·
Changes in average blood pressure and incidence of high blood pressure 1983-1984 to 1987-1988 in four population cohorts in the People's Republic of China. The PRCUSA Cardiovascular and Cardiopulmonary Epidemiology Research Group. Author(s): Wu X, Huang Z, Stamler J, Wu Y, Li Y, Folsom AR, Tao S, Rao X, Zhang H, Cen R, Wang S, Shen L, Liu S, Chen H, Yu X, Tian X, Huang M, He Y. Source: Journal of Hypertension. 1996 November; 14(11): 1267-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8934353&dopt=Abstract
·
Changes in cardiovascular responsiveness caused by age and high blood pressure: implications for therapy. Author(s): Buhler FR, Bolli P. Source: Journal of Cardiovascular Pharmacology. 1985; 7 Suppl 3: S206-15. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2409395&dopt=Abstract
·
Childhood high blood pressure: a new emphasis. Author(s): Heavenrich RM, Cinque TJ. Source: Pediatric Annals. 1977 June; 6(6): 363-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=865906&dopt=Abstract
·
Childhood precursors of high blood pressure and elevated cholesterol. Author(s): Labarthe DR, Eissa M, Varas C. Source: Annual Review of Public Health. 1991; 12: 519-41. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2049146&dopt=Abstract
·
Childhood predictors of high blood pressure. Author(s): Mahoney LT, Clarke WR, Burns TL, Lauer RM. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1991 November; 4(11): 608S-610S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1789940&dopt=Abstract
·
Children can have high blood pressure, too. Author(s): Greenfield D, Grant R, Lieberman E. Source: The American Journal of Nursing. 1976 May; 76(5): 770-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1046898&dopt=Abstract
48 High Blood Pressure
·
Chronic control of high blood pressure in the spontaneously hypertensive rat by delivery of angiotensin type 1 receptor antisense. Author(s): Iyer SN, Lu D, Katovich MJ, Raizada MK. Source: Proceedings of the National Academy of Sciences of the United States of America. 1996 September 3; 93(18): 9960-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8790439&dopt=Abstract
·
Circannual modulation of blood pressure enhanced by paternal history of high blood pressure. Author(s): Saito Y, Cornelissen G, Hillman D, Tarquini B, Mainardi G, Syutkina EV, Safin SR, Grigoriev AE, Abramian AS, Yatsyk GV, et al. Source: Chronobiologia. 1992 January-March; 19(1-2): 75-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1628524&dopt=Abstract
·
Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Author(s): Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A. Source: Neurology. 1999 December 10; 53(9): 1948-52. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10599763&dopt=Abstract
·
Combined hemodynamic overload of the left and right ventricles as a possible cause of interventricular septum preponderance in high blood pressure. Author(s): Fiorentini C, Galli C, Tamborini G, Moruzzi P, Berti M, Riva S, Guazzi MD. Source: American Heart Journal. 1988 August; 116(2 Pt 1): 509-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3400570&dopt=Abstract
·
Combined high blood pressure and glucose in type 2 diabetes: double jeopardy. British trial shows clear effects of treatment, especially blood pressure reduction. Author(s): Mogensen CE. Source: Bmj (Clinical Research Ed.). 1998 September 12; 317(7160): 693-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9732334&dopt=Abstract
·
Combined low-dose medication and primary intervention over a 30-month period for sustained high blood pressure in childhood. Author(s): Berenson GS, Shear CL, Chiang YK, Webber LS, Voors AW. Source: The American Journal of the Medical Sciences. 1990 February; 299(2): 79-86. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2301454&dopt=Abstract
·
Combining repeated blood pressure measurements to obtain prevalences of high blood pressure. Author(s): Wietlisbach V, Rickenbach M, Burnand B, Hausser D, Gutzwiller F. Source: Acta Med Scand Suppl. 1988; 728: 165-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3202026&dopt=Abstract
Studies
49
·
Common questions and answers in the management of hypertension: Am I more likely to develop diabetes if I have high blood pressure? Author(s): Townsend RR. Source: Journal of Clinical Hypertension (Greenwich, Conn.). 2003 March-April; 5(2): 175-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12671335&dopt=Abstract
·
Community control of high blood pressure in Portugal. Author(s): Mota JC, Miguel JP, Nunes AC, Caeiro JM. Source: Bibl Cardiol. 1987; (42): 77-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3632621&dopt=Abstract
·
Community control of high blood pressure. Author(s): Steinbach M, Constantineanu M, Harnagea P, Theodorini S. Source: Med Interne. 1978 October-December; 16(4): 425-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=749180&dopt=Abstract
·
Community involvement in high blood pressure control--the Bamberg model. Author(s): Watson MC. Source: J S C Med Assoc. 1980 September; 76(9 Suppl): 83-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6933297&dopt=Abstract
·
Community-based high blood pressure programs in sub-Saharan Africa. Author(s): Pobee JO. Source: Ethn Dis. 1993; 3 Suppl: S38-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8087022&dopt=Abstract
·
Comparison of blood pressure, sodium intake, and other variables in offspring with and without a family history of high blood pressure. Author(s): Watt GC, Foy CJ, Hart JT. Source: Lancet. 1983 June 4; 1(8336): 1245-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6134040&dopt=Abstract
·
Comparison of high-risk and mass strategies for the prevention of high blood pressure. Author(s): Watt G. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1989 February; 7(1): S29-32. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2651612&dopt=Abstract
50 High Blood Pressure
·
Comparison of nasal pH values in black and white individuals with normal and high blood pressure. Author(s): Ireson NJ, Tait JS, MacGregor GA, Baker EH. Source: Clinical Science (London, England : 1979). 2001 March; 100(3): 327-33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11222120&dopt=Abstract
·
Comparison of the hemodynamic and metabolic effects of low-dose hydrochlorothiazide and lisinopril treatment in obese patients with high blood pressure. Author(s): Reaven GM, Clinkingbeard C, Jeppesen J, Maheux P, Pei D, Foote J, Hollenbeck CB, Chen YD. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1995 May; 8(5 Pt 1): 461-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7662221&dopt=Abstract
·
Connecticut high blood pressure program: the first three years. Author(s): D'Atri DA. Source: Conn Med. 1978 December; 42(12): 795-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=720050&dopt=Abstract
·
Considerations for evaluating community high blood pressure control programmes. Author(s): Roccella EJ. Source: Journal of Human Hypertension. 1996 February; 10 Suppl 1: S17-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8965281&dopt=Abstract
·
Continuous recording of direct arterial pressure in unrestricted patients. Its role in the diagnosis and management of high blood pressure. Author(s): Littler WA, Honour AJ, Pugsley DJ, Sleight P. Source: Circulation. 1975 June; 51(6): 1101-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1132100&dopt=Abstract
·
Contribution of parental blood pressures to association between low birth weight and adult high blood pressure: cross sectional study. Author(s): Walker BR, McConnachie A, Noon JP, Webb DJ, Watt GC. Source: Bmj (Clinical Research Ed.). 1998 March 14; 316(7134): 834-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9549456&dopt=Abstract
·
Controlling high blood pressure. Author(s): Giblin E. Source: The American Journal of Nursing. 1978 May; 78(5): 824. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=247897&dopt=Abstract
Studies
51
·
Controlling high blood pressure. Author(s): Zellmer WA. Source: Am J Hosp Pharm. 1977 May; 34(5): 461. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=868887&dopt=Abstract
·
Controlling high blood pressure: a simple and effective approach. Author(s): Freis ED. Source: Compr Ther. 2001 Fall; 27(3): 209-12. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11569321&dopt=Abstract
·
Controversies regarding the recommendations of the Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Elliott WJ. Source: Compr Ther. 1994; 20(3): 181-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8187460&dopt=Abstract
·
Cost effective analyses in the treatment of high blood pressure. Author(s): Fletcher A. Source: Journal of Human Hypertension. 1992 December; 6(6): 437-45. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1296007&dopt=Abstract
·
Cost-effectiveness analysis: role in evaluation of alternatives for improving high blood pressure control. Author(s): Steinwachs DM. Source: Md State Med J. 1984 March; 33(3): 225-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6717085&dopt=Abstract
·
Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensive patients. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Elliott WJ, Weir DR, Black HR. Source: Archives of Internal Medicine. 2000 May 8; 160(9): 1277-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10809030&dopt=Abstract
·
Critical patient behaviors in high blood pressure control. Author(s): McCombs J, Fink J, Bandy P. Source: Cardiovasc Nurs. 1980 July-August; 16(4): 19-23. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6903146&dopt=Abstract
52 High Blood Pressure
·
Culture and high blood pressure: understandings of a chronic illness in an Ojibwa community. Author(s): Garro LC. Source: Arctic Med Res. 1988; 47 Suppl 1: 70-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3272720&dopt=Abstract
·
Current aspects of high blood pressure research in Africa. Author(s): Akinkugbe OO. Source: Clin Cardiol. 1989 December; 12(12 Suppl 4): Iv87-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2620476&dopt=Abstract
·
Current recommendations of the joint national high blood pressure committee. Author(s): Carter BL. Source: Clin Pharm. 1993 January; 12(1): 53-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8428433&dopt=Abstract
·
Current status of high blood pressure control. Author(s): Cunningham S, Hill M. Source: The Nurse Practitioner. 1982 March; 7(3): 37-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7063158&dopt=Abstract
·
Cyclosporine-associated hypertension. National High Blood Pressure Education Program. Author(s): Porter GA, Bennett WM, Sheps SG. Source: Archives of Internal Medicine. 1990 February; 150(2): 280-3. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2405801&dopt=Abstract
·
Definition of high blood pressure, epidemiology and goals of hypertension treatment. Author(s): Dahlof B. Source: Int J Clin Pract Suppl. 1998 November; 98: 3-5. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10344023&dopt=Abstract
·
Dental treatment in a patient with malignant pheochromocytoma and severe uncontrolled high blood pressure. Author(s): Findler M, Mazor Z, Galili D, Garfunkel AA. Source: Oral Surg Oral Med Oral Pathol. 1993 March; 75(3): 290-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8097035&dopt=Abstract
Studies
53
·
Dentists and high blood pressure control: an opportunity for service and growth. Author(s): Abbey LM. Source: J Prev Dent. 1978 March-April; 5(2): 17, 19, 22. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=286796&dopt=Abstract
·
Deoxyribonucleic acid repair synthesis: a new factor for defining high blood pressure. Author(s): Thulin T, Pero RW, Bryngelsson C, Mitelman F, Norden A, Schersten B. Source: Clin Sci Mol Med Suppl. 1976 December; 3: 695S-696S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1071712&dopt=Abstract
·
Design and interpretation of studies comparing individuals with and without a family history of high blood pressure. Author(s): Watt G. Source: Journal of Hypertension. 1986 February; 4(1): 1-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3958483&dopt=Abstract
·
Designation of children with high blood pressure--considerations on percentile cut points and subsequent high blood pressure: the Bogalusa Heart Study. Author(s): Shear CL, Burke GL, Freedman DS, Webber LS, Berenson GS. Source: American Journal of Epidemiology. 1987 January; 125(1): 73-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3788956&dopt=Abstract
·
Detecting high blood pressure in an industrial population. Report on a hypertension screening program at Merck & Co., Inc. Author(s): Davidson WL. Source: Occup Health Nurs. 1975 May; 23(5): 10-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1169726&dopt=Abstract
·
Detection and control of high blood pressure in the community : Do we need a wakeup call? Author(s): Meissner I, Whisnant JP, Sheps SG, Schwartz GL, O'Fallon WM, Covalt JL, Sicks JD, Bailey KR, Wiebers DO. Source: Hypertension. 1999 September; 34(3): 466-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10489395&dopt=Abstract
·
Detection, evaluation, and treatment of high blood pressure. Author(s): Moser M. Source: N Y State J Med. 1977 September; 77(11): 1753-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=268506&dopt=Abstract
54 High Blood Pressure
·
Detection, evaluation, and treatment of hypertension: JNC-5 (Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure) Author(s): Frohlich ED. Source: Heart Dis Stroke. 1993 November-December; 2(6): 459-60. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8137049&dopt=Abstract
·
Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. Author(s): Kim MT, Hill MN, Bone LR, Levine DM. Source: Progress in Cardiovascular Nursing. 2000 Summer; 15(3): 90-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10951950&dopt=Abstract
·
Devices used for self-measurement of blood pressure. Revised statement of the National High Blood Pressure Education Program. Author(s): Hunt JC, Frohlich ED, Moser M, Roccella EJ, Keighley EA. Source: Archives of Internal Medicine. 1985 December; 145(12): 2231-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4074037&dopt=Abstract
·
Diabetes technology news. Calcium antagonists aid high blood pressure control. Author(s): Walczak IM. Source: Diabetes Technology & Therapeutics. 2003; 5(3): 510-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12838935&dopt=Abstract
·
Diabetic retinopathy and high blood pressure: defining the risk. Author(s): Kohner EM. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1997 September; 10(9 Pt 2): 181S-183S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9324119&dopt=Abstract
·
Diabetics' high blood pressure is often undertreated, study says. Author(s): Levenson D. Source: Rep Med Guidel Outcomes Res. 2002 January 25; 13(2): 7-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12425320&dopt=Abstract
·
Diagnosis and treatment of high blood pressure. New directions and new approaches: 1999 Canadian recommendations for management of hypertension. Author(s): Petrella RJ. Source: Can Fam Physician. 2000 July; 46: 1479-84. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10925762&dopt=Abstract
Studies
55
·
Diagnosis of high blood pressure in children by means of ambulatory blood pressure monitoring. Author(s): Lurbe E, Redon J. Source: Current Hypertension Reports. 2001 April; 3(2): 89-90. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11276387&dopt=Abstract
·
Dietary sodium and blood pressure in young people with and without familial predisposition to high blood pressure. Author(s): Watt GC, Foy CJ, Hart JT. Source: J Clin Hypertens. 1986 June; 2(2): 141-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3489817&dopt=Abstract
·
Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Levy D. Source: Hypertension. 1999 September; 34(3): 381-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10489380&dopt=Abstract
·
Diminished baroreflex sensitivity in high blood pressure and ageing man. Author(s): Bristow JD, Gribbin B, Honour AJ, Pickering TG, Sleight P. Source: The Journal of Physiology. 1969 May; 202(1): 45P-46P. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5770914&dopt=Abstract
·
Diminished baroreflex sensitivity in high blood pressure. Author(s): Bristow JD, Honour AJ, Pickering GW, Sleight P, Smyth HS. Source: Circulation. 1969 January; 39(1): 48-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4302539&dopt=Abstract
·
Diminished pulse pressure under mental stress characterizes normotensive adolescents with parental high blood pressure. Author(s): Ewart CK, Harris WL, Zeger S, Russell GA. Source: Psychosomatic Medicine. 1986 September-October; 48(7): 489-501. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3763788&dopt=Abstract
·
Directory of high blood pressure resources available to physicians. Author(s): Lewis C, Amador EC, Ward BL, Russell RP. Source: Md State Med J. 1984 March; 33(3): 216-23. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6371394&dopt=Abstract
56 High Blood Pressure
·
Diseases of the urinary system. High blood pressure and renal disease. Author(s): MacGregor GA. Source: British Medical Journal. 1977 September 3; 2(6087): 624-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=20193&dopt=Abstract
·
Divergent responses of common carotid artery intimal-medial thickness to high blood pressure and hypercholesterolaemia in relation to age. Author(s): Ludwig MM, Jorger U, Lund S, Stumpe KO. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1993 December; 11 Suppl 5: S130-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8158310&dopt=Abstract
·
Do subjects with stiff arteries have high blood pressure? Author(s): Cox JP, England R, Cox T, Walsh JB, Coakley D, Feely J, O'Malley K, O'Brien E. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1989 December; 7(6): S82-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2632754&dopt=Abstract
·
Does oral calcium supplementation lower high blood pressure? A double blind study. Author(s): Cappuccio FP, Markandu ND, Singer DR, Smith SJ, Shore AC, MacGregor GA. Source: Journal of Hypertension. 1987 February; 5(1): 67-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3295037&dopt=Abstract
·
Doing something about high blood pressure. Author(s): Robertson JI. Source: Indian Journal of Medical Sciences. 1978 March-April; 32(3-4): 35-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=32135&dopt=Abstract
·
Doing something about high blood pressure. Author(s): Robertson JI. Source: Ciciams Nouv. 1978; 1: 6-9, 16-8. English, French. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=246790&dopt=Abstract
·
Down with high blood pressure! Author(s): Mahler H. Source: Ciciams Nouv. 1978; (1): 3-4, 10-1. English, French. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=246785&dopt=Abstract
Studies
57
·
Down with high blood pressure, World Health Day, 7 April 1978: hypertension in Africa. Author(s): Akinkugbe OO. Source: Indian Journal of Medical Sciences. 1978 May-June; 32(5-6): 61-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=753759&dopt=Abstract
·
Down with high blood pressure. Author(s): Lovell RR. Source: The Medical Journal of Australia. 1978 April 8; 1(7): 365-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=672719&dopt=Abstract
·
Down with high blood pressure. Author(s): Chaudhuri BR. Source: J Indian Med Assoc. 1978 April 1; 70(7): 166-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=690462&dopt=Abstract
·
Down with high blood pressure: World Health Day, 7 April 1978. Cuba fights hypertension. Author(s): Castro IM. Source: Indian Journal of Medical Sciences. 1978 July-August; 32(7-8): 83-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=753761&dopt=Abstract
·
Drug treatment of high blood pressure in the community--experience in eastern Finland. Author(s): Nissinen A, Tuomilehto J, Pekkanen J, Enlund H, Gunther A. Source: Journal of Human Hypertension. 1989 June; 3(3): 165-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2769674&dopt=Abstract
·
Drug treatment of high blood pressure. Author(s): Hutchins LN. Source: Nurs Clin North Am. 1981; 16(2): 365-76. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6167937&dopt=Abstract
·
Drugs for rapid treatment of very high blood pressure during pregnancy. Author(s): Duley L, Henderson-Smart DJ. Source: Cochrane Database Syst Rev. 2000; (2): Cd001449. Review. Update In: http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10796261&dopt=Abstract
·
Drugs for treatment of very high blood pressure during pregnancy. Author(s): Duley L, Henderson-Smart DJ. Source: Cochrane Database Syst Rev. 2002; (4): Cd001449. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12519557&dopt=Abstract
58 High Blood Pressure
·
Dyslexia and familial high blood pressure: an observational pilot study. Author(s): Taylor K, Stein J. Source: Archives of Disease in Childhood. 2002 January; 86(1): 30-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11806878&dopt=Abstract
·
Early cardiovascular changes in adolescents with high blood pressure values. Author(s): Seguro C, Sau F, Ruscazio M, Sias M, Cherchi A Jr, Mercuro G, Cherchi A. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1986 December; 4(6): S34-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3475422&dopt=Abstract
·
Editorial: Ethics and high blood pressure. Author(s): Ingelfinger FJ. Source: The New England Journal of Medicine. 1975 January 2; 292(1): 43-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1109189&dopt=Abstract
·
Editorial: High blood pressure in Georgia. Author(s): Wilber JA. Source: J Med Assoc Ga. 1976 May; 65(5): 155-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=932580&dopt=Abstract
·
Editorial: High blood pressure month--different perspectives. Author(s): Chissell JT. Source: Journal of the National Medical Association. 1978 June; 70(6): 393. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=702576&dopt=Abstract
·
Editorial: High blood pressure: as a physician sees it. Author(s): Tatum FE. Source: J Miss State Med Assoc. 1974 February; 15(2): 59-60. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4815791&dopt=Abstract
·
Editorial: High blood pressure--blood banks. Author(s): Barclay WR, Macenski CW. Source: Jama : the Journal of the American Medical Association. 1973 October 29; 226(5): 561-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4800308&dopt=Abstract
·
Editorial: the National High Blood Pressure Education Program. Author(s): Zellmer WA. Source: Am J Hosp Pharm. 1975 May; 32(5): 465. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1146816&dopt=Abstract
Studies
59
·
Effect of a structured health education program on reducing morbidity and mortality from high blood pressure. Author(s): Levine DM, Green LW, Morisky D. Source: Bibl Cardiol. 1987; (42): 8-16. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3307759&dopt=Abstract
·
Effect of age and high blood pressure on baroreflex sensitivity in man. Author(s): Gribbin B, Pickering TG, Sleight P, Peto R. Source: Circulation Research. 1971 October; 29(4): 424-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5110922&dopt=Abstract
·
Effect of physical exercise on high blood pressure. Author(s): Lund-Johansen P. Source: Contrib Nephrol. 1982; 30: 98-100. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7116868&dopt=Abstract
·
Effects of age and high blood pressure on intelligence. Author(s): Elias MF. Source: Experimental Aging Research. 1991 Summer; 17(2): 96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1794406&dopt=Abstract
·
Effects of exercise and weight loss on mental stress-induced cardiovascular responses in individuals with high blood pressure. Author(s): Georgiades A, Sherwood A, Gullette EC, Babyak MA, Hinderliter A, Waugh R, Tweedy D, Craighead L, Bloomer R, Blumenthal JA. Source: Hypertension. 2000 August; 36(2): 171-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10948073&dopt=Abstract
·
Effects of sex on differences in awareness, treatment, and control of high blood pressure. Author(s): Plasencia A, Ostfeld AM, Gruber SB. Source: American Journal of Preventive Medicine. 1988 November-December; 4(6): 31526. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3228527&dopt=Abstract
·
Elevated risk of high blood pressure: climate and the inverse housing law. Author(s): Mitchell R, Blane D, Bartley M. Source: International Journal of Epidemiology. 2002 August; 31(4): 831-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12177031&dopt=Abstract
60 High Blood Pressure
·
Emergency department detection and follow-up of high blood pressure: use and effectiveness of community health workers. Author(s): Bone LR, Mamon J, Levine DM, Walrath JM, Nanda J, Gurley HT, Noji EK, Ward E. Source: The American Journal of Emergency Medicine. 1989 January; 7(1): 16-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2914043&dopt=Abstract
·
Emergency treatment of high blood pressure with oral atenolol. Author(s): Bannan LT, Beevers DG. Source: British Medical Journal (Clinical Research Ed.). 1981 May 30; 282(6278): 1757-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6786611&dopt=Abstract
·
Employment status and high blood pressure in women: variations by time and by sociodemographic characteristics. Author(s): Rose KM, Newman B, Bennett T, Tyroler HA. Source: Annals of Epidemiology. 1997 February; 7(2): 107-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9099398&dopt=Abstract
·
Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension. Author(s): Olsen MH, Wachtell K, Aalkjaer C, Devereux RB, Dige-Petersen H, Ibsen H. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 2001 September; 14(9 Pt 1): 861-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11587150&dopt=Abstract
·
Endothelium and high blood pressure. Author(s): Noll G, Tschudi M, Nava E, Luscher TF. Source: Int J Microcirc Clin Exp. 1997 October; 17(5): 273-9. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9370127&dopt=Abstract
·
Enhancement of the pulmonary vasoconstriction reaction to alveolar hypoxia in systemic high blood pressure. Author(s): Guazzi MD, Berti M, Doria E, Fiorentini C, Galli C, Pepi M, Tamborini G. Source: Clinical Science (London, England : 1979). 1989 June; 76(6): 589-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2736878&dopt=Abstract
·
Epidemiology of high blood pressure and obesity. Author(s): Martinez FJ, Sancho-Rof JM. Source: Drugs. 1993; 46 Suppl 2: 160-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7512470&dopt=Abstract
Studies
61
·
Epidemiology of high blood pressure. Author(s): Whelton PK, Klag MJ. Source: Clinics in Geriatric Medicine. 1989 November; 5(4): 639-55. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2691056&dopt=Abstract
·
European working party on high blood pressure in elderly (EWPHE): organization of a double-blind multicentre trial on antihypertensive therapy in elderly patients. Author(s): Amery A, De Schaepdrijver A. Source: Clin Sci Mol Med Suppl. 1973 August; 45 Suppl 1: 71S-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4593570&dopt=Abstract
·
Evaluation of family health education to build social support for long-term control of high blood pressure. Author(s): Morisky DE, DeMuth NM, Field-Fass M, Green LW, Levine DM. Source: Health Educ Q. 1985 Spring; 12(1): 35-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3980239&dopt=Abstract
·
Evidence for an association of high blood pressure and hyperinsulinemia in obese man. Author(s): Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E. Source: The Journal of Clinical Endocrinology and Metabolism. 1986 June; 62(6): 1302-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3517032&dopt=Abstract
·
Evidence-based medicine: worship of form and treatment of high blood pressure. Author(s): Psaty BM, Rhoads C, Furberg CD. Source: Journal of General Internal Medicine : Official Journal of the Society for Research and Education in Primary Care Internal Medicine. 2000 October; 15(10): 755-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11089721&dopt=Abstract
·
Exercise guidelines for patients with high blood pressure: an update. Author(s): Pescatello LS, Buckley T. Source: Journal of Cardiopulmonary Rehabilitation. 1995 May-June; 15(3): 239-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8542529&dopt=Abstract
·
Factors associated with changes in body weight during a five-year follow-up of a population with high blood pressure. Author(s): Tuomilehto J, Jalkanen L, Salonen JT, Nissinen A. Source: Scand J Soc Med. 1985; 13(4): 173-80. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4089572&dopt=Abstract
62 High Blood Pressure
·
Factors associated with stable high blood pressure in adolescents. Author(s): Torok E, Gyarfas I, Csukas M. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1985 December; 3 Suppl 3: S389-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2856747&dopt=Abstract
·
Factors predisposing to postural hypotensive symptoms in the treatment of high blood pressure. Author(s): Talbot S, Smith AJ. Source: British Heart Journal. 1975 October; 37(10): 1059-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=127594&dopt=Abstract
·
Factors that appear as obstacles to the control of high blood pressure. Author(s): Lang T. Source: Ethn Dis. 2000 Winter; 10(1): 125-30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10764138&dopt=Abstract
·
Familial risk of high blood pressure in the Canadian population. Author(s): Katzmarzyk PT, Rankinen T, Perusse L, Rao DC, Bouchard C. Source: American Journal of Human Biology : the Official Journal of the Human Biology Council. 2001 September-October; 13(5): 620-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11505470&dopt=Abstract
·
Financing treatment for high blood pressure. Author(s): Gorman M. Source: Urban Health. 1979 June; 8(5): 8-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10242739&dopt=Abstract
·
Folk beliefs about high blood pressure in Hispanic immigrants. Author(s): Ailinger RL. Source: Western Journal of Nursing Research. 1988 October; 10(5): 629-36. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3188520&dopt=Abstract
·
Further learnings from the European Working Party on High Blood Pressure in the Elderly (EWPHE) study: focus on systolic hypertension. Author(s): O'Malley K, Cox JP, O'Brien E. Source: Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 1991 January; 4 Suppl 6: 1249-51. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2009248&dopt=Abstract
Studies
63
·
Future management of high blood pressure. Author(s): Johnston CI. Source: Journal of Cardiovascular Pharmacology. 1996; 27 Suppl 3: S55-60. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8872300&dopt=Abstract
·
Genetic and sociocultural components of high blood pressure. Author(s): Ward RH. Source: American Journal of Physical Anthropology. 1983 September; 62(1): 91-105. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6624904&dopt=Abstract
·
Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. Author(s): Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans A, Nicaud V, Cambien F. Source: Journal of Hypertension. 1995 March; 13(3): 311-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7622852&dopt=Abstract
·
Geographical and socioeconomic distribution of high blood pressure and borderline high blood pressure in a Swedish rural county. Author(s): Haglund BJ. Source: Scand J Soc Med. 1985; 13(2): 53-66. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3874420&dopt=Abstract
·
Ginseng and high blood pressure. Author(s): Siegel RK. Source: Jama : the Journal of the American Medical Association. 1980 January 4; 243(1): 32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7350333&dopt=Abstract
·
Glomerular hyperfiltration, high renin, and low- extracellular volume in high blood pressure. Author(s): Cochrane Database Syst Rev. 2002;(4):CD001449 Source: Hypertension. 2000 April; 35(4): 952-7. /entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12519557
·
Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE). Author(s): Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De Schaepdryver A, Fagard R, Forette F, Forte J, et al. Source: Postgraduate Medical Journal. 1986 October; 62(732): 919-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3534842&dopt=Abstract
64 High Blood Pressure
·
Guidelines for a dental office high blood pressure screening program. Author(s): Abbey LM, Hargrave B. Source: Va Dent J. 1974 August; 51(4): 52-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4529089&dopt=Abstract
·
Guidelines for measurement of blood pressure, follow-up, and lifestyle counselling. Canadian Coalition for High Blood Pressure Prevention and Control. Author(s): Abbott D, Campbell N, Carruthers-Czyzewski P, Chockalingam A, David M, Dunkley G, Ellis E, Fodor JG, McKay D, Ramsden VR. Source: Canadian Journal of Public Health. Revue Canadienne De Sante Publique. 1994 September-October; 85 Suppl 2: S29-43. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7804948&dopt=Abstract
·
Guidelines on high blood pressure in pregnancy give new classifications of disease. Author(s): Rollins G. Source: Rep Med Guidel Outcomes Res. 2000 December 18; 11(24): 5-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11902247&dopt=Abstract
·
Health awareness and treatment compliance of high blood pressure among women in a peri-urban colony of Chandigarh, India. Author(s): Thakur K, Malhotra P, Walia I, Kumar R. Source: J Indian Med Assoc. 1999 June; 97(6): 217-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10645694&dopt=Abstract
·
Help lower the mercury and control high blood pressure. Author(s): Classe JG, Marshall EC. Source: J Am Optom Assoc. 1996 May; 67(5): 245-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8888835&dopt=Abstract
·
High blood pressure (hypertension). Author(s): Woods A. Source: Nursing. 2002 April; 32(4): 54-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11969020&dopt=Abstract
·
High blood pressure and associated cardiovascular risk factors in France. Author(s): Asmar R, Vol S, Pannier B, Brisac AM, Tichet J, El Hasnaoui A. Source: Journal of Hypertension. 2001 October; 19(10): 1727-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11593091&dopt=Abstract
Studies
65
·
High blood pressure and bone-mineral loss in elderly white women: a prospective study. Study of Osteoporotic Fractures Research Group. Author(s): Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. Source: Lancet. 1999 September 18; 354(9183): 971-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10501357&dopt=Abstract
·
High blood pressure and cardiovascular risk factors in an adult population of Mexico City. Characteristics of the studied population. Author(s): Yamamoto-Kimura L, Zamora-Gonzalez J, Huerta-Alvarado S, FajardoGutierrez A, Cardoso-Saldana G, Posadas-Romero C. Source: Archives of Medical Research. 1996 Summer; 27(2): 213-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8696067&dopt=Abstract
·
High blood pressure and decreased heart rate variability in the Cuban epidemic neuropathy. Author(s): Gutierrez J, Santiesteban R, Garcia H, Voustianiouk A, Freeman R, Kaufmann H. Source: Journal of Neurology, Neurosurgery, and Psychiatry. 2002 July; 73(1): 71-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12082051&dopt=Abstract
·
High blood pressure and dementia. Author(s): Rockwood K, Lindsay J, McDowell I. Source: Lancet. 1996 July 6; 348(9019): 65; Author Reply 65-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8691960&dopt=Abstract
·
High blood pressure and dementia. Author(s): Korczyn AD. Source: Lancet. 1996 July 6; 348(9019): 65; Author Reply 65-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8691959&dopt=Abstract
·
High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Author(s): Grossman E, Messerli FH, Goldbourt U. Source: Archives of Internal Medicine. 2000 September 11; 160(16): 2447-52. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10979055&dopt=Abstract
·
High blood pressure and muscle morphology/metabolism--causal relationship or only associated factors? Author(s): Krotkiewski M, Lithell H, Shono N, Wysocki M, Holm G. Source: Clinical Physiology (Oxford, England). 1998 May; 18(3): 203-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9649908&dopt=Abstract
66 High Blood Pressure
·
High blood pressure and the incidence of non-insulin dependent diabetes mellitus: findings in a 11.5 year follow-up study in The Netherlands. Author(s): Stolk RP, van Splunder IP, Schouten JS, Witteman JC, Hofman A, Grobbee DE. Source: European Journal of Epidemiology. 1993 March; 9(2): 134-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8519350&dopt=Abstract
·
High blood pressure and the kidney. Author(s): Goldsmith D. Source: Kidney International. 2000 September; 58(3): 1358. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10972703&dopt=Abstract
·
High blood pressure and the kidney: the forgotten contribution of William Senhouse Kirkes. Author(s): Cameron JS, Hicks J. Source: Kidney International. 2000 February; 57(2): 724-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10652052&dopt=Abstract
·
High blood pressure and ventricular arrhythmias. Author(s): Sideris DA. Source: European Heart Journal. 1993 November; 14(11): 1548-53. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8299639&dopt=Abstract
·
High blood pressure attack mounted in Pennsylvania. Author(s): Spring WC Jr, Ranberg RA. Source: Pa Med. 1978 April; 81(4): 24-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=634618&dopt=Abstract
·
High blood pressure control: put the champagne away. Author(s): Lenfant C. Source: Journal of Clinical Hypertension (Greenwich, Conn.). 2002 NovemberDecember; 4(6): 391-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12461300&dopt=Abstract
·
High blood pressure due to alcohol. A rapidly reversible effect. Author(s): Maheswaran R, Gill JS, Davies P, Beevers DG. Source: Hypertension. 1991 June; 17(6 Pt 1): 787-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2045140&dopt=Abstract
Studies
67
·
High blood pressure during pregnancy and working conditions among hospital personnel. Author(s): Saurel-Cubizolles MJ, Kaminski M, Du Mazaubrun C, Llado J, Estryn-Behar M. Source: European Journal of Obstetrics, Gynecology, and Reproductive Biology. 1991 June 5; 40(1): 29-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1855606&dopt=Abstract
·
High blood pressure in African Americans. Author(s): Materson BJ. Source: Archives of Internal Medicine. 2003 March 10; 163(5): 521-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622599&dopt=Abstract
·
High blood pressure in older persons: a high risk special population. Author(s): Flack JM. Source: Canadian Journal of Public Health. Revue Canadienne De Sante Publique. 1994 September-October; 85 Suppl 2: S9-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7804955&dopt=Abstract
·
High blood pressure in pregnancy. Author(s): Iffy L, Ganesh V. Source: American Journal of Obstetrics and Gynecology. 1991 July; 165(1): 236-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1853906&dopt=Abstract
·
High blood pressure in pregnancy. Author(s): Green LA. Source: American Family Physician. 2001 July 15; 64(2): 225, 228. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11476270&dopt=Abstract
·
High blood pressure in pregnancy: effects of Ca2+ and Mg2+. Author(s): Kisters K, Louwen F, Witteler R, Hausberg M, Barenbrock M, Rahn KH. Source: Journal of Hypertension. 1998 October; 16(10): 1561-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9814631&dopt=Abstract
·
High blood pressure in the geriatric population: treatment considerations. Author(s): Sander GE. Source: The American Journal of Geriatric Cardiology. 2002 July-August; 11(4): 223-32. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12091771&dopt=Abstract
68 High Blood Pressure
·
High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus. Author(s): Haneda M, Kikkawa R, Togawa M, Koya D, Kajiwara N, Uzu T, Shigeta Y. Source: Journal of Diabetes and Its Complications. 1992 July-September; 6(3): 181-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1472744&dopt=Abstract
·
High blood pressure knowledge in an urban African-American community. Author(s): Martins D, Gor D, Teklehaimanot S, Norris K. Source: Ethn Dis. 2001 Winter; 11(1): 90-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11289257&dopt=Abstract
·
High blood pressure lowered by pregnancy. Author(s): Murakami T, Watanabe Ogura E, Tanaka Y, Yamamoto M. Source: Lancet. 2000 December 9; 356(9246): 1980. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11130528&dopt=Abstract
·
High blood pressure management: potential benefits of I1 agents. Author(s): Esler M. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1998 August; 16(3): S19-24. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9747906&dopt=Abstract
·
High blood pressure research in Australian general practice. Author(s): Nelson M. Source: Aust Fam Physician. 2003 April; 32(4): 277. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12735270&dopt=Abstract
·
High blood pressure screening in the dental office: a survey among Dutch dentists. Author(s): Gortzak RA, Abraham-Inpijn L, ter Horst G, Peters G. Source: Gen Dent. 1993 May-June; 41(3): 246-51. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8243963&dopt=Abstract
·
High blood pressure treatment in the elderly. Author(s): Applegate WB. Source: Clinics in Geriatric Medicine. 1992 February; 8(1): 103-17. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1576569&dopt=Abstract
·
High blood pressure, oxygen radicals and antioxidants: etiological relationships. Author(s): Romero-Alvira D, Roche E. Source: Medical Hypotheses. 1996 April; 46(4): 414-20. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8733174&dopt=Abstract
Studies
69
·
High blood pressure. A side effect of drugs, poisons, and food. Author(s): Grossman E, Messerli FH. Source: Archives of Internal Medicine. 1995 March 13; 155(5): 450-60. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7864701&dopt=Abstract
·
High blood pressure: definitions, prognostic, and therapeutic implications. Author(s): Birbari AE. Source: J Med Liban. 2001 November-December; 49(6): 338-41. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12744637&dopt=Abstract
·
High blood pressure: hunting the genes. Author(s): Leckie BJ. Source: Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 1992 January; 14(1): 37-41. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1347682&dopt=Abstract
·
High blood pressure: new efforts in primary prevention and disease management. Author(s): Zelizer G. Source: J Tenn Med Assoc. 1993 April; 86(4): 157-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8479185&dopt=Abstract
·
High blood pressure: some answers, new questions, continuing challenges. Author(s): Lenfant C. Source: Jama : the Journal of the American Medical Association. 1996 May 22-29; 275(20): 1604-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8622253&dopt=Abstract
·
High blood pressure--current state of play. Author(s): Shaw J. Source: Aust Fam Physician. 1993 May; 22(5): 702-6. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8517812&dopt=Abstract
·
Highlights of the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Carter BL. Source: American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 1998 February 15; 55(4): 382-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9504199&dopt=Abstract
70 High Blood Pressure
·
How common is high blood pressure? Author(s): Beard TC. Source: Aust Fam Physician. 1994 February; 23(2): 93-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8161317&dopt=Abstract
·
How do we treat, or not treat, high blood pressure in the oldest old? A practice study in Swedish geriatricians. Author(s): Kilander L, Boberg M, Lithell H. Source: Blood Pressure. 1997 November; 6(6): 372-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9495664&dopt=Abstract
·
How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Author(s): Singh V, Christiana J, Frishman WH. Source: Drugs. 1999 October; 58(4): 579-87. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10551431&dopt=Abstract
·
Hypertension and the brain. The National High Blood Pressure Education Program. Author(s): Phillips SJ, Whisnant JP. Source: Archives of Internal Medicine. 1992 May; 152(5): 938-45. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1580719&dopt=Abstract
·
Hypertension and the eye: applications of the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Marshall EC, Malinovsky VE. Source: J Am Optom Assoc. 1998 May; 69(5): 281-91. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9610036&dopt=Abstract
·
Hypertension in a black population: prevalence and biosocial determinants of high blood pressure in a group of urban Nigerians. Author(s): Olatunbosun ST, Kaufman JS, Cooper RS, Bella AF. Source: Journal of Human Hypertension. 2000 April; 14(4): 249-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10805050&dopt=Abstract
·
Hypertension syndrome and cardiovascular events. High blood pressure is only one risk factor. Author(s): Glasser SP. Source: Postgraduate Medicine. 2001 November; 110(5): 29-36. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11727651&dopt=Abstract
Studies
71
·
Hypertension--new drug therapies. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Author(s): Solomon J. Source: Rn. 1994 January; 57(1): 26-32; Quiz 33. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7905659&dopt=Abstract
·
Hypertensive patients' knowledge of high blood pressure. Author(s): Kjellgren KI, Svensson S, Ahlner J, Saljo R. Source: Scandinavian Journal of Primary Health Care. 1997 December; 15(4): 188-92. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9444722&dopt=Abstract
·
Hypertensive update: highlights from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Author(s): Fitzgerald MA. Source: Clin Excell Nurse Pract. 1998 July; 2(4): 197-201. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10455561&dopt=Abstract
·
I am a 64-year-old man with high blood pressure. My doctor always checks my pressure in my right arm, but I've started checking both arms with my own blood pressure machine. My right arm is always 6-10 points higher than my left. Is this normal? Author(s): Simon HB. Source: Harvard Men's Health Watch. 1999 April; 3(9): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10095273&dopt=Abstract
·
I like to run for exercise and fitness but have never been a speed demon. I used to run my four-mile route in 35 minutes, but since I started taking a beta blocker for high blood pressure, my time has stretched to more than 40 minutes. Should I stop taking this medication? Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1999 January; 9(5): 7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9916565&dopt=Abstract
·
I take Adalat (or nifedipine, also sold as Procardia) and captopril tablets daily for my high blood pressure. My physician told me not to take aspirin because of the possibility of drug interactions. From what I have read about aspirin, I hate to miss out on the benefits. Author(s): Lee TH. Source: Harvard Heart Letter : from Harvard Medical School. 1998 October; 9(2): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9780876&dopt=Abstract
72 High Blood Pressure
·
I would like to know if it is ever too late to begin hormone replacement therapy to protect against heart disease and osteoporosis. My 84-year-old mother has high blood pressure and has never drunk much milk, so is she at risk of both these conditions? Wouldn't she benefit from estrogen? Author(s): Robb-Nicholson C. Source: Harvard Women's Health Watch. 1998 June; 5(10): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9663016&dopt=Abstract
·
I'm a 65-year-old man with high blood pressure and a family history of stroke. Which stroke-prevention medication would be better for me--aspirin or clopidogrel (Plavix)? Author(s): Ornato JP. Source: Health News. 2003 February; 9(2): 12. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12632550&dopt=Abstract
·
Immunological factors and high blood pressure in man. Systemic hypertension and raised levels of immunoglobulins in the serum. Author(s): Olsen F. Source: Acta Pathol Microbiol Scand [a]. 1972; 80(2): 257-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5028055&dopt=Abstract
·
Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. Author(s): Kotchen JM, McKean HE, Jackson-Thayer S, Moore RW, Straus R, Kotchen TA. Source: Jama : the Journal of the American Medical Association. 1986 April 25; 255(16): 2177-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3959301&dopt=Abstract
·
Impact of hypertension information on high blood pressure control between 1973 and 1978. Author(s): Apostolides AY, Cutter G, Kraus JF, Oberman A, Blaszkowski T, Borhani NO, Entwisle G. Source: Hypertension. 1980 September-October; 2(5): 708-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7419272&dopt=Abstract
·
Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. Author(s): Noon JP, Walker BR, Webb DJ, Shore AC, Holton DW, Edwards HV, Watt GC. Source: The Journal of Clinical Investigation. 1997 April 15; 99(8): 1873-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9109431&dopt=Abstract
Studies
73
·
Implementing high blood pressure control activities in South Carolina. Author(s): Shepard DM. Source: Urban Health. 1985 September; 14(9): 29, 34, 48. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10278799&dopt=Abstract
·
Independent association of high blood pressure and aortic atherosclerosis: A population-based study. Author(s): Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Petterson TM, O'Fallon WM, Gentile F, Whisnant JP, Wiebers DO, Seward JB. Source: Circulation. 2000 October 24; 102(17): 2087-93. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11044425&dopt=Abstract
·
Inference of the existence of high blood pressure as a cause of renal disease in the mid-19th century: observations on vascular structures in the kidney. Author(s): Newton NM, Fine LG. Source: American Journal of Nephrology. 1999; 19(2): 323-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10213836&dopt=Abstract
·
Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. Author(s): Bautista LE. Source: Journal of Human Hypertension. 2003 April; 17(4): 223-30. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12692566&dopt=Abstract
·
Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification. Author(s): Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, de Leeuw P, de Plaen JF, Deruyttere M, De Schaepdryver A, Dollery C, et al. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1986 December; 4(6): S642-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3475430&dopt=Abstract
·
Influence of anti-hypertensive therapy on serum cholesterol in elderly hypertensive patients. Results of trial by the European Working Party on High blood pressure in the Elderly (EWPHE). Author(s): Amery A, Birkenhager W, Bulpitt C, Clement D, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F, Forte J, Hamdy R, Leonetti G, LundJohansen P, MacFarlane JP, Mutsers A, O'Malley K, Tuomilehto J. Source: Acta Cardiol. 1982; 37(4): 235-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6751003&dopt=Abstract
74 High Blood Pressure
·
Influence of hypotensive drug treatment in elderly hypertensives: study terminating events in the trial of the European Working Party on High Blood Pressure in the Elderly. Author(s): Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, de Leeuw P, De Plaen JF, Deruyttere M, De Schaepdryver A, Dollery C, et al. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1985 December; 3 Suppl 3: S501-11. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2856778&dopt=Abstract
·
Inhibited power motivation and high blood pressure in men. Author(s): McClelland DC. Source: Journal of Abnormal Psychology. 1979 April; 88(2): 182-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=447901&dopt=Abstract
·
Initial medication selection for treatment of high blood pressure. Author(s): Oparil S. Source: The Journal of the American Board of Family Practice / American Board of Family Practice. 1995 January-February; 8(1): 70-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7701966&dopt=Abstract
·
Insufficient duration of action of antihypertensive drugs mediates high blood pressure in the morning in hypertensive population: the Ohasama study. Author(s): Chonan K, Hashimoto J, Ohkubo T, Tsuji I, Nagai K, Kikuya M, Hozawa A, Matsubara M, Suzuki M, Fujiwara T, Araki T, Satoh H, Hisamichi S, Imai Y. Source: Clinical and Experimental Hypertension (New York, N.Y. : 1993). 2002 May; 24(4): 261-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12069357&dopt=Abstract
·
Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Author(s): Sheu WH, Jeng CY, Shieh SM, Fuh MM, Shen DD, Chen YD, Reaven GM. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1992 July; 5(7): 444-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1637516&dopt=Abstract
·
Insulin therapy could prevent salt-induced high blood pressure in diabetes mellitus. Author(s): Orie NN, Osirim FE. Source: East Afr Med J. 1997 September; 74(9): 579-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9487435&dopt=Abstract
Studies
75
·
Intensifying the fight against high blood pressure. Author(s): Oganov RG, Glasunov IS, Britov AN, Chazova LV, Sapozhnikov II, Deev AD. Source: World Health Forum. 1988; 9(1): 88-91. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3254207&dopt=Abstract
·
Inverse association of Chlamydia pneumoniae infection with high blood pressure in Japanese adults. Author(s): Nishimura M, Ushiyama M, Nanbu A, Mashida C, Kawagoe K, Yoshimura M. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 2001 January; 14(1): 20-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11206673&dopt=Abstract
·
Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma. Author(s): Maruishi M, Shima T, Okada Y, Nishida M, Yamane K. Source: Neurol Med Chir (Tokyo). 2001 June; 41(6): 300-4; Discussion 304-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11458742&dopt=Abstract
·
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For EndpointReduction in Hypertension. Author(s): Olsen MH, Wachtell K, Hermann KL, Frandsen E, Dige-Petersen H, Rokkedal J, Devereux RB, Ibsen H. Source: American Heart Journal. 2002 September; 144(3): 530-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12228792&dopt=Abstract
·
Is exercise good for high blood pressure? Author(s): Wilcox RG, Bennett T, Brown AM, Macdonald IA. Source: British Medical Journal (Clinical Research Ed.). 1982 September 18; 285(6344): 767-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6810991&dopt=Abstract
·
Is high blood pressure a late manifestation of the hypertension syndrome? Author(s): Neutel JM, Smith DH, Weber MA. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1999 December; 12(12 Pt 3): 215S-223S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10619574&dopt=Abstract
·
Is high blood pressure a psychosomatic disorder? A critical review of the evidence. Author(s): Davies MH. Source: J Chronic Dis. 1971 July; 24(4): 239-58. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4398526&dopt=Abstract
76 High Blood Pressure
·
Is high blood pressure an aetiological factor in epistaxis? Author(s): Petruson B, Rudin R, Svardsudd K. Source: Orl; Journal for Oto-Rhino-Laryngology and Its Related Specialties. 1977; 39(3): 155-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=339142&dopt=Abstract
·
Is high too low? A commentary by the Wisconsin State High Blood Pressure Advisory Committee. Author(s): Gutmann FD. Source: Wis Med J. 1985 January; 84(1): 31-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3976246&dopt=Abstract
·
Is increased plasma viscosity a risk factor for high blood pressure? Author(s): Koenig W, Sund M, Ernst E, Matrai A, Keil U, Rosenthal J. Source: Angiology. 1989 March; 40(3): 153-63. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2916766&dopt=Abstract
·
Is the effect of low birth weight on cardiovascular mortality mediated through high blood pressure? Author(s): Koupilova I, Leon DA, McKeigue PM, Lithell HO. Source: Journal of Hypertension. 1999 January; 17(1): 19-25. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10100089&dopt=Abstract
·
Is there a different dietetic pattern depending on self-knowledge of high blood pressure? Author(s): Tormo MJ, Navarro C, Chirlaque MD, Barber X; EPIC Group of Spain. European Prospective Investigation on Cancer. Source: European Journal of Epidemiology. 2000; 16(10): 963-71. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11338129&dopt=Abstract
·
Isolated systolic hypertension: a different kind of high blood pressure. Author(s): Maio A. Source: Nebr Med J. 1994 April; 79(4): 105-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8008149&dopt=Abstract
·
Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. Author(s): O'Malley K, McCormack P, O'Brien ET. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1988 November; 6(1): S105-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3063783&dopt=Abstract
Studies
77
·
JNC 7--it's more than high blood pressure. Author(s): Kottke TE, Stroebel RJ, Hoffman RS. Source: Jama : the Journal of the American Medical Association. 2003 May 21; 289(19): 2573-5. Epub 2003 May 14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12748200&dopt=Abstract
·
JNC guidelines: is the message getting through? Joint National Commission on Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Lenfant C. Source: Jama : the Journal of the American Medical Association. 1997 December 3; 278(21): 1778-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9388157&dopt=Abstract
·
Keeping high blood pressure on the run. Pharmacy's big part in hypertension control. Author(s): Williams RL. Source: Am Pharm. 1980 February; Ns20(2): 26-35. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7355709&dopt=Abstract
·
Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings. Author(s): Lefebvre RC, Hursey KG, Carleton RA. Source: Archives of Internal Medicine. 1988 September; 148(9): 1993-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3046540&dopt=Abstract
·
Laboratory assessment of the hypertensive individual. Value of the main guidelines for high blood pressure. Author(s): Reis RS, Bensenor IJ, Lotufo PA. Source: Arquivos Brasileiros De Cardiologia. 1999 August; 73(2): 201-10. English, Portuguese. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10752189&dopt=Abstract
·
Lack of control of high blood pressure and treatment recommendations in Canada. Author(s): Khan N, Chockalingam A, Campbell NR. Source: The Canadian Journal of Cardiology. 2002 June; 18(6): 657-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12107423&dopt=Abstract
·
Lack of effect of oral magnesium on high blood pressure: a double blind study. Author(s): Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Source: British Medical Journal (Clinical Research Ed.). 1985 July 27; 291(6490): 235-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3926135&dopt=Abstract
78 High Blood Pressure
·
Latest guidelines on the treatment of high blood pressure. Author(s): Thomson GE. Source: Journal of the National Medical Association. 1985 May; 77 Suppl: 7-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3999157&dopt=Abstract
·
Learned control of blood pressure in patients with high blood pressure. Author(s): Kristt DA, Engel BT. Source: Circulation. 1975 February; 51(2): 370-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1112018&dopt=Abstract
·
Left ventricular diastolic function of children in high blood pressure tracking group. Author(s): Harada Y, Mori C, Watanabe K, Kishida K, Haneda N, Iwatani H, Nishio T. Source: Acta Paediatr Jpn. 1990 October; 32(5): 530-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2284930&dopt=Abstract
·
Left ventricular hypertrophy in elderly hypertensive patients: a report from the European Working Party on High Blood Pressure in the Elderly trial. Author(s): Van Hoof R. Source: The American Journal of Medicine. 1991 March; 90(3A): 55S-59S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1826071&dopt=Abstract
·
Lessons from the real world about patients with high blood pressure. Author(s): Dorsey JL. Source: American Journal of Public Health. 1979 January; 69(1): 11-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=420349&dopt=Abstract
·
Lessons taught by experimental high blood pressure research. Author(s): Weiner H. Source: Psychosomatic Medicine. 1976 September-October; 38(5): 297-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=981489&dopt=Abstract
·
Letter: National high blood pressure month. Author(s): Ward GW. Source: Am J Hosp Pharm. 1975 November; 32(11): 1094. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1190224&dopt=Abstract
·
Letter: Obesity and high blood pressure. Author(s): Jones J. Source: Cent Afr J Med. 1974 September; 20(9): 197. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4420010&dopt=Abstract
Studies
79
·
Letter: On high blood pressure. Author(s): Berman CL, Guarino MA, Giovannelli SM. Source: The Journal of the American Dental Association. 1974 June; 88(6): 1242. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4524443&dopt=Abstract
·
Letter: Urges action by dentist on high blood pressure. Author(s): Berman CL. Source: The Journal of the American Dental Association. 1975 May; 90(5): 907. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1055158&dopt=Abstract
·
Lifestyle approaches to managing high blood pressure. New Canadian guidelines. Author(s): Petrella RJ. Source: Can Fam Physician. 1999 July; 45: 1750-5, 1760-5. English, French. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10424275&dopt=Abstract
·
Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Campbell NR, Burgess E, Choi BC, Taylor G, Wilson E, Cleroux J, Fodor JG, Leiter LA, Spence D. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S1-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333847&dopt=Abstract
·
Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Leiter LA, Abbott D, Campbell NR, Mendelson R, Ogilvie RI, Chockalingam A. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S7-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333848&dopt=Abstract
·
Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Campbell NR, Ashley MJ, Carruthers SG, Lacourciere Y, McKay DW. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S13-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333849&dopt=Abstract
80 High Blood Pressure
·
Lifestyle modifications to prevent and control hypertension. 4. Recommendations on physical exercise training. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Cleroux J, Feldman RD, Petrella RJ. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S21-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333850&dopt=Abstract
·
Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Fodor JG, Whitmore B, Leenen F, Larochelle P. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S29-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333851&dopt=Abstract
·
Lifestyle modifications to prevent and control hypertension. 6. Recommendations on potassium, magnesium and calcium. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Burgess E, Lewanczuk R, Bolli P, Chockalingam A, Cutler H, Taylor G, Hamet P. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S35-45. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333852&dopt=Abstract
·
Lifestyle modifications to prevent and control hypertension. 7. Recommendations on stress management. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. Author(s): Spence JD, Barnett PA, Linden W, Ramsden V, Taenzer P. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1999 May 4; 160(9 Suppl): S46-50. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10333853&dopt=Abstract
·
Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing. Author(s): Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1998 March; 11(3 Pt 1): 272-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9544866&dopt=Abstract
Studies
81
·
Living with high blood pressure. Author(s): van Wissen K, Litchfield M, Maling T. Source: Journal of Advanced Nursing. 1998 March; 27(3): 567-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9543043&dopt=Abstract
·
Localization of cytoplasmic collagen mRNA in human aortic coarctation: mRNA enhancement in high blood pressure-induced intimal and medial thickening. Author(s): Jaeger E, Rust S, Scharffetter K, Roessner A, Winter J, Buchholz B, Althaus M, Rauterberg J. Source: The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 1990 September; 38(9): 1365-75. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2387988&dopt=Abstract
·
Long term effects of guar gum on metabolic control, serum cholesterol and blood pressure levels in type 2 (non-insulin-dependent) diabetic patients with high blood pressure. Author(s): Uusitupa M, Tuomilehto J, Karttunen P, Wolf E. Source: Ann Clin Res. 1984; 16 Suppl 43: 126-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6398982&dopt=Abstract
·
Long-term effects of cessation of smoking on body weight, blood pressure and serum cholesterol in the middle-aged population with high blood pressure. Author(s): Tuomilehto J, Nissinen A, Puska P, Salonen JT, Jalkanen L. Source: Addictive Behaviors. 1986; 11(1): 1-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3716910&dopt=Abstract
·
Long-term evaluation of group education for high blood pressure control. Author(s): Wyka-Fitzgerald C, Levesque P, Panciera T, Vendettoli D, Mattea E. Source: Cardiovasc Nurs. 1984 May-June; 20(3): 13-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6370434&dopt=Abstract
·
Louisiana high blood pressure control program. Author(s): Huber ML, Lambert L, Trahan B, Gottlieb MS. Source: J La State Med Soc. 1984 May; 136(5): 11-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6563051&dopt=Abstract
·
Low birth weight and risk of high blood pressure in adulthood. Author(s): Gennser G, Rymark P, Isberg PE. Source: British Medical Journal (Clinical Research Ed.). 1988 May 28; 296(6635): 1498500. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3134084&dopt=Abstract
82 High Blood Pressure
·
Management guidelines for optometric screening for high blood pressure. Author(s): Eisenberg S, Posner J, Salomon E. Source: J Am Optom Assoc. 1978 June; 49(6): 685-91. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=681678&dopt=Abstract
·
Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Author(s): Douglas JG, Bakris GL, Epstein M, Ferdinand KC, Ferrario C, Flack JM, Jamerson KA, Jones WE, Haywood J, Maxey R, Ofili EO, Saunders E, Schiffrin EL, Sica DA, Sowers JR, Vidt DG; Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Source: Archives of Internal Medicine. 2003 March 10; 163(5): 525-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12622600&dopt=Abstract
·
Management of high blood pressure in general practice. Author(s): O'Hanrahan M, Laher M, O'Boyle C, O'Malley K, O'Brien ET. Source: Ir Med J. 1982 April; 75(4): 102-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7076475&dopt=Abstract
·
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Author(s): Jones D, Basile J, Cushman W, Egan B, Ferrario C, Hill M, Lackland D, Mensah G, Moore M, Ofili E, Roccella EJ, Smith R, Taylor H. Source: The American Journal of the Medical Sciences. 1999 December; 318(6): 357-64. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10616159&dopt=Abstract
·
Managing worry, stress and high blood pressure: African-American women holding it together through 'family'. Author(s): Boutain DM. Source: Ethn Dis. 2001 Fall; 11(4): 773-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11763301&dopt=Abstract
·
Maternal hypertension during pregnancy and high blood pressure in children. Preliminary communication. Author(s): Svensson A, Sigstrom L, Andersch B, Hansson L. Source: Clin Exp Hypertens B. 1983; 2(2): 203-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6872283&dopt=Abstract
Studies
83
·
Mechanisms contributing to high blood pressure. Author(s): Frohlich ED. Source: Annals of Internal Medicine. 1983 May; 98(5 Pt 2): 709-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6847008&dopt=Abstract
·
Mechanisms in obesity-related high blood pressure. Author(s): Dustan HP. Source: Ala J Med Sci. 1984 January; 21(1): 18-20. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6703244&dopt=Abstract
·
Meeting the National Service Framework for coronary heart disease: which patients have untreated high blood pressure? Author(s): Marshall T, Rouse A. Source: The British Journal of General Practice : the Journal of the Royal College of General Practitioners. 2001 July; 51(468): 571-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11462320&dopt=Abstract
·
Mercury sphygmomanometers should not be abandoned: An advisory statement from the Council for High Blood Pressure Research, American Heart Association. Author(s): Jones DW, Frohlich ED, Grim CM, Grim CE, Taubert KA. Source: Hypertension. 2001 February; 37(2): 185-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11230268&dopt=Abstract
·
Microalbuminuria in subjects with no history of diabetes mellitus and hypertension: the relationship with hyperglycemia and high blood pressure at non-diagnostic level. Author(s): Ishibashi F, Ishida K, Takashina S. Source: Hiroshima J Med Sci. 1990 June; 39(2): 57-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2228727&dopt=Abstract
·
Microalbuminuria, high blood pressure burden, and nondipper phenomenon: an interaction in normotensive type 1 diabetic patients. Author(s): Cohen CN, Albanesi FM, Goncalves MF, Gomes MB. Source: Diabetes Care. 2001 April; 24(4): 790-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11315854&dopt=Abstract
·
Mineralocorticoids, salt and high blood pressure. Author(s): Gomez-Sanchez EP, Zhou M, Gomez-Sanchez CE. Source: Steroids. 1996 April; 61(4): 184-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8732997&dopt=Abstract
84 High Blood Pressure
·
Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: a primary role for beta blocking drugs such as propranolol. Author(s): Laragh JH. Source: The American Journal of Medicine. 1976 November; 61(5): 797-810. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10730&dopt=Abstract
·
Modification of high blood pressure after myocardial infarction. Author(s): Kario K, Pickering TG. Source: The Medical Clinics of North America. 2000 January; 84(1): 1-21, Vii. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10685125&dopt=Abstract
·
More bang for the buck in managing high blood pressure. Author(s): Smith MD, McGhan W. Source: Bus Health. 1996 May; 14(5): 44-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10157918&dopt=Abstract
·
More on high blood pressure. Author(s): Kahn A Jr. Source: J Ark Med Soc. 1979 September; 76(4): 179-80. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=159282&dopt=Abstract
·
More on the dentist's role in the prevention of high blood pressure. Author(s): Raab F, Schaffer E, Cornelissen G, Halberg F. Source: Chronobiologia. 1993 July-December; 20(3-4): 245-50. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8131673&dopt=Abstract
·
Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Author(s): Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, De Schaepdryver A, Dollery C, Fagard R, Forette F, et al. Source: Lancet. 1985 June 15; 1(8442): 1349-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2861311&dopt=Abstract
·
Mortality and treated blood pressure in patients of the European Working Party on High Blood Pressure in the Elderly. Author(s): Staessen J. Source: The American Journal of Medicine. 1991 March; 90(3A): 60S-61S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006663&dopt=Abstract
Studies
85
·
National high blood pressure conference. Author(s): Levy RI. Source: Urban Health. 1978 June; 7(5): 10, 12, 27 Passim. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10308601&dopt=Abstract
·
National High Blood Pressure Education Program (NHBPEP) review paper on complications of shock wave lithotripsy for urinary calculi. Author(s): Smith LH, Drach G, Hall P, Lingeman J, Preminger G, Resnick MI, Segura JW. Source: The American Journal of Medicine. 1991 December; 91(6): 635-41. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1750434&dopt=Abstract
·
National High Blood Pressure Education Program. Author(s): Lenfant C, Roccella EJ. Source: J Am Optom Assoc. 1986 May; 57(5): 347-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3711571&dopt=Abstract
·
National High Blood Pressure Education Programme using data to focus communications to minority populations. Author(s): Roccella EJ, Lenfant C. Source: Journal of Human Hypertension. 1995 January; 9(1): 53-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7731003&dopt=Abstract
·
Natural history of male psychological health, XIII: Who develops high blood pressure and who responds to treatment. Author(s): Vaillant GE, Gerber PD. Source: The American Journal of Psychiatry. 1996 July; 153(7 Suppl): 24-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8659638&dopt=Abstract
·
Need to prevent and control high-normal and high blood pressure, particularly socalled “mild” hypertension: epidemiological and clinical data. Author(s): Giumetti D, Liu K, Stamler R, Schoenberger JA, Shekelle RB, Stamler J. Source: Preventive Medicine. 1985 July; 14(4): 396-412. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3877923&dopt=Abstract
·
Needed: pharmacists in high blood pressure control. Author(s): Williams RL. Source: Am Pharm. 1978 May; 18(5): 32-3, 40. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=655122&dopt=Abstract
86 High Blood Pressure
·
Neonatal cardiovascular dynamics in relation to matroclinous and patroclinous history of high blood pressure. Author(s): Hermida RC, Fernandez JR, Ayala DE, Mojon A, Rey A, Rodriguez-Cervilla J, Fernandez-Lorenzo JR, Fraga JM. Source: Chronobiology International. 1993 June; 10(3): 214-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8319320&dopt=Abstract
·
Neuroticism and the discovery of high blood pressure. Author(s): Cochrane R. Source: Journal of Psychosomatic Research. 1969 March; 13(1): 21-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5776998&dopt=Abstract
·
New expression profiles of voltage-gated ion channels in arteries exposed to high blood pressure. Author(s): Cox RH, Rusch NJ. Source: Microcirculation (New York, N.Y. : 1994). 2002; 9(4): 243-57. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12152102&dopt=Abstract
·
New guidelines for prevention, detection, evaluation and treatment of high blood pressure. Author(s): Glick M. Source: The Journal of the American Dental Association. 1998 November; 129(11): 158894. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9818576&dopt=Abstract
·
New hypertension guidelines set aggressive goals based on risk factors. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Gifford RW Jr. Source: Cleve Clin J Med. 1998 January; 65(1): 18-24. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9465452&dopt=Abstract
·
New hypertension guidelines. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Hurley ML. Source: Rn. 1998 March; 61(3): 25-8. Erratum In: Rn 1998 April; 61(4): 9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9544090&dopt=Abstract
·
New oral salt in treatment of high blood pressure. Author(s): Karppanen H. Source: Magnesium. 1989; 8(5-6): 274-87. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2693847&dopt=Abstract
Studies
87
·
New predictive test for high blood pressure. Author(s): Habeck M. Source: Molecular Medicine Today. 2000 March; 6(3): 94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10689308&dopt=Abstract
·
New recommendations for high blood pressure control: guidelines for all NPs. Author(s): Hill MN, Cunningham SG. Source: The Nurse Practitioner. 1985 July; 10(7): 35. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4022467&dopt=Abstract
·
New rules for high blood pressure. Author(s): SoRelle R. Source: Circulation. 1998 February 3; 97(4): 307-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9468200&dopt=Abstract
·
New staging system of the fifth Joint National Committee report on the detection, evaluation, and treatment of high blood pressure (JNC-V) alters assessment of the severity and treatment of hypertension. Author(s): Pogue VA, Ellis C, Michel J, Francis CK. Source: Hypertension. 1996 November; 28(5): 713-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8901813&dopt=Abstract
·
NHBPEP report on high blood pressure in pregnancy: a summary for family physicians. Author(s): Zamorski MA, Green LA. Source: American Family Physician. 2001 July 15; 64(2): 263-70, 216. Erratum In: Am Fam Physician 2002 February 15; 65(4): 560. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11476271&dopt=Abstract
·
NHBPEP: working to reduce death and disability from high blood pressure. National High Blood Pressure Education Program. Author(s): Cziraky MJ. Source: Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 2002 November-December; 42(6): 886-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12482016&dopt=Abstract
·
NHLBI releases new high blood pressure guidelines. Author(s): Ressel GW; NHLBI. Source: American Family Physician. 2003 July 15; 68(2): 376, 379. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12892357&dopt=Abstract
88 High Blood Pressure
·
NIH priorities in high blood pressure control. Author(s): Ware DR. Source: Urban Health. 1977 June; 6(4): 18, 56. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10305892&dopt=Abstract
·
No correlation between insulin levels and high blood pressure in obese subjects. Author(s): Grugni G, Ardizzi A, Dubini A, Guzzaloni G, Sartorio A, Morabito F. Source: Hormone and Metabolic Research. Hormon- Und Stoffwechselforschung. Hormones Et Metabolisme. 1990 February; 22(2): 124-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2182501&dopt=Abstract
·
Nobel laureates honored by the council for high blood pressure research. Author(s): Frohlich ED, Navar LG, Re RN. Source: Hypertension. 1999 November; 34(5): 1025. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10567176&dopt=Abstract
·
Noise exposure and prevalence of high blood pressure among weavers in Iran. Author(s): Parvizpoor D. Source: J Occup Med. 1976 November; 18(11): 730-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1032926&dopt=Abstract
·
Noise-induced hearing loss: a possible marker for high blood pressure in older noiseexposed populations. Author(s): Talbott EO, Findlay RC, Kuller LH, Lenkner LA, Matthews KA, Day RD, Ishii EK. Source: J Occup Med. 1990 August; 32(8): 690-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2401923&dopt=Abstract
·
Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research. Author(s): Bumpus FM, Catt KJ, Chiu AT, DeGasparo M, Goodfriend T, Husain A, Peach MJ, Taylor DG Jr, Timmermans PB. Source: Hypertension. 1991 May; 17(5): 720-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2022414&dopt=Abstract
·
Non-invasive 24-hr monitoring of high blood pressure in climacteric outpatients. Author(s): Villecco AS, de Aloysio D, Pilati G, Mauloni M, Roncuzzi A, Bottiglioni F, Pisi E. Source: Maturitas. 1987 November; 9(3): 267-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3431477&dopt=Abstract
Studies
89
·
Nonpharmacologic management of high blood pressure. Author(s): Cunningham SG. Source: Cardiovasc Nurs. 1987 July-August; 23(4): 18-22. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3650125&dopt=Abstract
·
Non-pharmacological approaches to the treatment of high blood pressure. Author(s): Haines AP. Source: J R Coll Gen Pract Occas Pap. 1980 July; (12): 32-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7005434&dopt=Abstract
·
Nonpharmacological control of high blood pressure. Author(s): Kaplan NM. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1989 February; 2(2 Pt 2): 55S-59S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2645907&dopt=Abstract
·
Nonsteroidal anti-inflammatory drugs and high blood pressure. Author(s): Radack K. Source: Annals of Internal Medicine. 1995 March 1; 122(5): 397. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7847663&dopt=Abstract
·
Normal blood pressure and incidence of high blood pressure in the Thai population. Author(s): Jaroonvesama N, Charoenlarp K, Viranuvatti V. Source: J Med Assoc Thai. 1980 July; 63(7): 391-400. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7410987&dopt=Abstract
·
Nurses' role in managing high blood pressure. Author(s): Annand J, Addison C, Martin J, Marsden D. Source: Community Nurse. 1996 October; 2(9): 22-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9450443&dopt=Abstract
·
Nursing assessment of the patient with high blood pressure. Author(s): Grim CM. Source: Nurs Clin North Am. 1981; 16(2): 349-64. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6973749&dopt=Abstract
·
Nursing role in the detection, evaluation and treatment of high blood pressure. Author(s): Grancio SD, Kornacki MJ, Pisarczyk J. Source: Mass Nurse. 1979 June; 48(6): 8-12. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=255731&dopt=Abstract
90 High Blood Pressure
·
Nursing's challenge in high blood pressure control. Author(s): Giblin E. Source: The American Nurse. 1977 May 15; 9(5): 5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=586121&dopt=Abstract
·
Nutritional factors in high blood pressure. Author(s): Zozaya JL. Source: Journal of Human Hypertension. 2000 April; 14 Suppl 1: S100-4. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10854089&dopt=Abstract
·
Nutritional therapy for high blood pressure. Final report of a four-year randomized controlled trial--the Hypertension Control Program. Author(s): Stamler R, Stamler J, Grimm R, Gosch FC, Elmer P, Dyer A, Berman R, Fishman J, Van Heel N, Civinelli J, et al. Source: Jama : the Journal of the American Medical Association. 1987 March 20; 257(11): 1484-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3546747&dopt=Abstract
·
Objectives of high blood pressure treatment: left ventricular hypertrophy, diastolic function, and coronary reserve. Author(s): Strauer BE, Schwartzkopff B. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1998 July; 11(7): 879-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9683053&dopt=Abstract
·
Occupational noise exposure, noise-induced hearing loss, and the epidemiology of high blood pressure. Author(s): Talbott E, Helmkamp J, Matthews K, Kuller L, Cottington E, Redmond G. Source: American Journal of Epidemiology. 1985 April; 121(4): 501-14. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3874543&dopt=Abstract
·
Ocular hypotensive effect of late pregnancy with and without high blood pressure. Author(s): Phillips CI, Gore SM. Source: The British Journal of Ophthalmology. 1985 February; 69(2): 117-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3966998&dopt=Abstract
·
Office evaluation of hypertension. A statement for health professionals by a writing group of the Council for High Blood Pressure Research, American Heart Association. Author(s): Gifford RW Jr, Kirkendall W, O'Connor DT, Weidman W. Source: Circulation. 1989 March; 79(3): 721-31. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2917396&dopt=Abstract
Studies
91
·
On Call. I am a subscriber to Harvard Men's Health Watch, but I am writing about my wife, not myself. She's only 58 and she's always been healthy, but over the past year she's been bothered by shaking and trembling in her hands, particularly when she's pouring tea or eating dinner. Her doctor gave her a blood pressure pill, but she's never had high blood pressure. Does she have Parkinson's? Should I take her to a specialist? Author(s): Simon HB. Source: Harvard Men's Health Watch. 2002 February; 6(7): 8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11869988&dopt=Abstract
·
Opportunities for nurses in high blood pressure control. Author(s): Grancio SD. Source: Nurs Clin North Am. 1981; 16(2): 309-20. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6911619&dopt=Abstract
·
Oral contraceptives and high blood pressure. Author(s): Stokes GS. Source: Aust N Z J Med. 1971 February; 1(1): 99-101. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5284092&dopt=Abstract
·
Oral contraceptives and high blood pressure: a review. Author(s): Fregly MJ, Fregly MS. Source: J Fla Med Assoc. 1977 February; 64(2): 84-91. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=839193&dopt=Abstract
·
Oral contraceptives. Renin, aldosterone, and high blood pressure. Author(s): Laragh JH, Sealey JE, Ledingham JG, Newton MA. Source: Jama : the Journal of the American Medical Association. 1967 September 18; 201(12): 918-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6072629&dopt=Abstract
·
Oral dosing with ketanserin to control high blood pressure in the elderly. Author(s): van Oene JC. Source: Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 1990 January; 4 Suppl 1: 111-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2285639&dopt=Abstract
·
Origins of the NHLBI program on high blood pressure in the young. Author(s): Havlik RJ, Feinleib M. Source: Hypertension. 1980 July-August; 2(4 Pt 2): I1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7399632&dopt=Abstract
92 High Blood Pressure
·
Overestimation of the number of individuals with hypertension who are eligible for treatment according to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Klungel OH, de Boer A, Seidell JC. Source: Archives of Internal Medicine. 2000 May 22; 160(10): 1540. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10826473&dopt=Abstract
·
Paradoxical survival of elderly men with high blood pressure. Author(s): Langer RD, Ganiats TG, Barrett-Connor E. Source: Bmj (Clinical Research Ed.). 1989 May 20; 298(6684): 1356-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2502252&dopt=Abstract
·
Partners for two decades: AOA and the National High Blood Pressure Education Program. Author(s): Nickey WA, Lenfant C. Source: J Am Osteopath Assoc. 1998 March; 98(3): 153-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9558830&dopt=Abstract
·
Partnership caring: a theory of high blood pressure control in Iranian hypertensives. Author(s): Mohammadi E, Abedi HA, Gofranipour F, Jalali F. Source: International Journal of Nursing Practice. 2002 December; 8(6): 324-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12390585&dopt=Abstract
·
Pathogenesis of essential hypertension. A link between dietary salt and high blood pressure. Author(s): Blaustein MP, Hamlyn JM. Source: Hypertension. 1991 November; 18(5 Suppl): Iii184-95. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1937683&dopt=Abstract
·
Patient behaviors that promote high blood pressure control. Author(s): McKenney JM, Mara J. Source: Contemp Pharm Pract. 1980 Fall; 3(4): 233-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10248866&dopt=Abstract
·
Patient-reported adherence to guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Cheng JW, Kalis MM, Feifer S. Source: Pharmacotherapy. 2001 July; 21(7): 828-41. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11444579&dopt=Abstract
Studies
93
·
Patients' views of high blood pressure, its treatment and risks. Author(s): Taylor C, Ward A. Source: Aust Fam Physician. 2003 April; 32(4): 278-82. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12735271&dopt=Abstract
·
Persons in the United States with high blood pressure. Author(s): Mann GV. Source: American Journal of Preventive Medicine. 1988 January-February; 4(1): 60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3395490&dopt=Abstract
·
Planning for community high blood pressure control. Author(s): Gima AS, Mundt CJ, Tavill F. Source: Family & Community Health. 1981 May; 4(1): 85-96. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10250957&dopt=Abstract
·
Platelet aggregation in young men with contrasting predisposition to high blood pressure. Author(s): Dockrell ME, Walker BR, Noon JP, Watt GC, Williams BC, Webb DJ. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1999 February; 12(2 Pt 1): 115-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10090337&dopt=Abstract
·
Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. Author(s): Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz E. Source: Journal of Hypertension. 1993 April; 11(4): 345-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8390500&dopt=Abstract
·
Potassium in preventing and treating high blood pressure. Author(s): Whelton PK, He J. Source: Semin Nephrol. 1999 September; 19(5): 494-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10511389&dopt=Abstract
·
Potential of carotid enlargement as a useful indicator affected by high blood pressure in a large general population of a Japanese city: the Suita study. Author(s): Mannami T, Baba S, Ogata J. Source: Stroke; a Journal of Cerebral Circulation. 2000 December; 31(12): 2958-65. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11108756&dopt=Abstract
94 High Blood Pressure
·
Predicting high blood pressure in pregnancy: a multivariate approach. Author(s): Broughton Pipkin F, Sharif J, Lal S. Source: Journal of Hypertension. 1998 February; 16(2): 221-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9535150&dopt=Abstract
·
Prediction of high blood pressure in young people: the limited usefulness of parental blood pressure data. Author(s): Watt GC, Foy CJ, Holton DW, Edwards HE. Source: Journal of Hypertension. 1991 January; 9(1): 55-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1848260&dopt=Abstract
·
Prediction of stable high blood pressure in adolescents. Author(s): Torok E, Gyarfas I, Csukas M. Source: Clin Exp Hypertens A. 1986; 8(4-5): 547-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3757276&dopt=Abstract
·
Preliminary evaluation of the patient with high blood pressure. Author(s): Janney JG Jr, Thurman M, Utley JH, Aykent Y. Source: Mo Med. 1965 September; 62(9): 760-1. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5854884&dopt=Abstract
·
Pretransplant hypertension as the main determinant of postrenal transplant high blood pressure. Author(s): Manfro RC, Thome FS, Schacher SC, Boger J, Goncalves LF, Prompt CA. Source: Transplantation Proceedings. 1992 December; 24(6): 3080-1. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1466064&dopt=Abstract
·
Prevalence and factors associated with high blood pressure in Korean Americans. Author(s): Kim MT, Kim KB, Juon HS, Hill MN. Source: Ethn Dis. 2000 Autumn; 10(3): 364-74. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11110353&dopt=Abstract
·
Prevalence of high blood pressure and associated coronary risk factors in an adult population of Mexico City. Author(s): Yamamoto-Kimura L, Zamora-Gonzalez J, Garcia de la Torre G, CardosoSaldana G, Fajardo-Gutierrez A, Ayala-Barajas C, Posadas-Romero C. Source: Archives of Medical Research. 1998 Winter; 29(4): 341-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9887554&dopt=Abstract
Studies
95
·
Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Author(s): Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ. Source: Archives of Internal Medicine. 2001 May 14; 161(9): 1207-16. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11343443&dopt=Abstract
·
Prevalence of high blood pressure in children and adolescents. Influence of obesity. Author(s): Macedo ME, Trigueiros D, de Freitas F. Source: Rev Port Cardiol. 1997 January; 16(1): 27-30, 7-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9115774&dopt=Abstract
·
Prevalence of high blood pressure in patients submitted to liver transplantation at the ISCMPA. Author(s): Marroni CA, Diehl JL, Leipnitz I, Pires LM, Brandao AB, Cassal AP, Schlindwein E, Zanotelli ML, Cantisani GP. Source: Transplantation Proceedings. 1999 November; 31(7): 3047. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10578387&dopt=Abstract
·
Prevalence of high blood pressure in Qashqai Tribe, Southern Iran, 1973. Author(s): Motabar M, Reiss-Sadat A, Tabatabai A. Source: Acta Med Iran. 1977; 20(1-2): 9-17. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=614776&dopt=Abstract
·
Prevalence of high blood pressure in Vorden. Author(s): Thissen PA. Source: J R Coll Gen Pract Occas Pap. 1980 July; (12): 15-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7452568&dopt=Abstract
·
Prevalence of high blood pressure treated and untreated in an urban adult New Zealand population: Napier 1973. Author(s): Christmas BW, Turner AS. Source: N Z Med J. 1977 November 9; 86(599): 419-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=305552&dopt=Abstract
·
Prevalence of high cholesterol, high blood pressure, and smoking among elementary schoolchildren in North Carolina. Author(s): Bradley CB, Harrell JS, McMurray RG, Bangdiwala SI, Frauman AC, Webb JP. Source: N C Med J. 1997 September-October; 58(5): 362-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9313361&dopt=Abstract
96 High Blood Pressure
·
Prevalence of hyperinsulinaemia in patients with high blood pressure. Author(s): Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passeri M, Reaven GM. Source: Journal of Internal Medicine. 1992 March; 231(3): 235-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1556520&dopt=Abstract
·
Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Author(s): Gonzalez-Villalpando C, Stern MP, Haffner SM, Gonzalez Villapando ME, Gaskill S, Rivera Martinez D. Source: Journal of Cardiovascular Risk. 1999 June; 6(3): 177-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10463145&dopt=Abstract
·
Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. Author(s): Joffres MR, Hamet P, Rabkin SW, Gelskey D, Hogan K, Fodor G. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1992 June 1; 146(11): 1997-2005. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1596849&dopt=Abstract
·
Prevalence, treatment, and control of hypertension in the French population: data from a survey on high blood pressure in general practice, 1994. Author(s): Chamontin B, Poggi L, Lang T, Menard J, Chevalier H, Gallois H, Cremier O. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1998 June; 11(6 Pt 1): 759-62. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9657642&dopt=Abstract
·
Prevalence, treatment, control, and awareness of high blood pressure and the risk of stroke in Northwest England. Author(s): Du X. Source: Preventive Medicine. 2000 April; 30(4): 288-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10731457&dopt=Abstract
·
Preventing CHF is goal of National High Blood Pressure Education Program call to action. Author(s): Carter BL, Roccella EJ. Source: American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 1996 June 15; 53(12): 1381, 1384. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8781682&dopt=Abstract
Studies
97
·
Prevention and control of high blood pressure: challenges and opportunities. Author(s): Campbell NR, Chockalingam A. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1995 June 15; 152(12): 1969-70. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7780906&dopt=Abstract
·
Prevention of high blood pressure and its complications: strategic issues in a local context. Author(s): Watt GC. Source: Journal of Hypertension. 1995 April; 13(4): 377-83. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7629397&dopt=Abstract
·
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. Author(s): Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J; National High Blood Pressure Education Program Coordinating Committee. Source: Jama : the Journal of the American Medical Association. 2002 October 16; 288(15): 1882-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12377087&dopt=Abstract
·
Professional collaboration in high blood pressure control. Author(s): Hill MN. Source: Bibl Cardiol. 1987; (42): 1-7. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3307753&dopt=Abstract
·
Progress in life-style intervention for prevention and treatment of high blood pressure. Author(s): Cutler JA. Source: Annals of Epidemiology. 1995 March; 5(2): 165-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7795835&dopt=Abstract
·
Prolonged exposure to industrial noise causes hearing loss but not high blood pressure: a study of 2124 factory laborers in Japan. Author(s): Hirai A, Takata M, Mikawa M, Yasumoto K, Iida H, Sasayama S, Kagamimori S. Source: Journal of Hypertension. 1991 November; 9(11): 1069-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1661766&dopt=Abstract
98 High Blood Pressure
·
Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Author(s): Lin KF, Chao L, Chao J. Source: Hypertension. 1997 September; 30(3 Pt 1): 307-13. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9314409&dopt=Abstract
·
Prostaglandins and high blood pressure. Author(s): Hornych A. Source: Contrib Nephrol. 1978; 12: 54-68. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=359239&dopt=Abstract
·
Psychodynamics of sustained high blood pressure. Author(s): Hambling J. Source: Psychotherapy and Psychosomatics. 1970; 18(1): 349-54. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5520674&dopt=Abstract
·
Pulmonary vascular supersensitivity to catecholamines in systemic high blood pressure. Author(s): Guazzi MD, De Cesare N, Fiorentini C, Galli C, Montorsi P, Pepi M, Tamborini G. Source: Journal of the American College of Cardiology. 1986 November; 8(5): 1137-44. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3760387&dopt=Abstract
·
Racial and gender discrimination: risk factors for high blood pressure? Author(s): Krieger N. Source: Social Science & Medicine (1982). 1990; 30(12): 1273-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2367873&dopt=Abstract
·
Rapid control of serious high blood pressure with single large oral doses of prazosin. Author(s): Hayes JM. Source: The Medical Journal of Australia. 1980 January 12; 1(1): 31-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7360063&dopt=Abstract
·
Recent changes in recommendations for antihypertensive therapy. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Clem JR. Source: S D J Med. 1993 April; 46(4): 122-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8516678&dopt=Abstract
Studies
99
·
Recent trends in public knowledge, attitudes, and reported behavior with respect to high blood pressure. Author(s): Haines CM, Ward GW. Source: Public Health Reports (Washington, D.C. : 1974). 1981 November-December; 96(6): 514-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7302105&dopt=Abstract
·
Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. Author(s): Chockalingam A, Abbott D, Bass M, Battista R, Cameron R, de Champlain J, Evans CE, Laidlaw J, Lee BL, Leiter L, et al. Source: Cmaj : Canadian Medical Association Journal = Journal De L'association Medicale Canadienne. 1990 June 15; 142(12): 1397-409. Review. Erratum In: Can Med Assoc J 1990 August 1; 143(3): 177. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2190686&dopt=Abstract
·
Reflections on the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Sheps SG, Roccella EJ. Source: Current Hypertension Reports. 1999 August; 1(4): 342-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10981088&dopt=Abstract
·
Regional and local high blood pressure control programs. Author(s): Hines E, Powell CE, Metts JC Jr, Grimes V, Satcher D. Source: J Med Assoc Ga. 1981 May; 70(5): 353-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7264470&dopt=Abstract
·
Regional implementation of the Connecticut High Blood Pressure Program. Author(s): Benn SL, DeMusis E, Klein T. Source: Bibl Cardiol. 1987; (42): 26-31. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3632614&dopt=Abstract
·
Regional implementation of the Connecticut high blood pressure program. Author(s): Benn SL. Source: Urban Health. 1985 September; 14(9): 27-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10278797&dopt=Abstract
100 High Blood Pressure
·
Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly. Author(s): Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A, Forette F, Leonetti G, Nissinen A, O'Malley K, et al. Source: Bmj (Clinical Research Ed.). 1989 June 10; 298(6687): 1552-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2503114&dopt=Abstract
·
Relation of abdominal obesity to hyperinsulinemia and high blood pressure in men. Author(s): Johnson D, Prud'homme D, Despres JP, Nadeau A, Tremblay A, Bouchard C. Source: International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity. 1992 November; 16(11): 881-90. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1337343&dopt=Abstract
·
Relation of high blood pressure to glucose intolerance, plasma lipids and educational status in an Arabian Gulf population. Author(s): Al-Mahroos F, Al-Roomi K, McKeigue PM. Source: International Journal of Epidemiology. 2000 February; 29(1): 71-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10750606&dopt=Abstract
·
Relation of high blood pressure to headache, epistaxis, and selected other symptoms. The United States Health Examination Survey of Adults. Author(s): Weiss NS. Source: The New England Journal of Medicine. 1972 September 28; 287(13): 631-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5076458&dopt=Abstract
·
Relationship between leucocyte sodium content and high blood pressure during development and resolution of pre-eclampsia. Author(s): Seon R, Forrester T. Source: Clinical Science (London, England : 1979). 1989 February; 76(2): 199-203. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2924512&dopt=Abstract
·
Relationship between the genetic and the ecologic factor in the determination of high blood pressure. Author(s): Steinbach M, Constantineanu M, Harnagea P, Theodorini S, Georgescu M, Cretescu R, Manicatide M, Nicolaescu V, Suciu A, Vladescu C, Voiculescu M, Georgescu A, Istrate R. Source: Med Interne. 1975; 13(4): 261-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1243196&dopt=Abstract
Studies 101
·
Relationship of alcohol and illicit drug use with high blood pressure care and control among urban hypertensive Black men. Author(s): Kim MT, Dennison CR, Hill MN, Bone LR, Levine DM. Source: Ethn Dis. 2000 Spring-Summer; 10(2): 175-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10892823&dopt=Abstract
·
Relationship of clinic, ambulatory, and laboratory stress blood pressure to left ventricular mass in overweight men and women with high blood pressure. Author(s): Sherwood A, Gullette EC, Hinderliter AL, Georgiades A, Babyak M, Waugh RA, Blumenthal JA. Source: Psychosomatic Medicine. 2002 March-April; 64(2): 247-57. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11914440&dopt=Abstract
·
Relationship of parental history of high blood pressure to blood pressure: combined findings of three Japanese population samples, the INTERSALT study. Author(s): Naruse Y, Nakagawa H, Kagamimori S, Fujita Y, Hashimoto T, Kasamatsu T, Mikawa K, Ueshima H. Source: Journal of Human Hypertension. 1998 April; 12(4): 215-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9607688&dopt=Abstract
·
Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Author(s): Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Source: Hypertension. 1997 November; 30(5): 1267-73. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9369286&dopt=Abstract
·
Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. Author(s): Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, Barbato A, D'Elia L, Trevisan M, Farinaro E. Source: Journal of Hypertension. 2001 March; 19(3): 399-406. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11288809&dopt=Abstract
·
Relaxation therapy and high blood pressure. Author(s): Taylor CB, Farquhar JW, Nelson E, Agras S. Source: Archives of General Psychiatry. 1977 March; 34(3): 339-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=320955&dopt=Abstract
102 High Blood Pressure
·
Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Author(s): Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Source: Circulation. 2001 October 16; 104(16): 1985-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11602506&dopt=Abstract
·
Renal function in the elderly: results from the European Working Party on High Blood Pressure in the Elderly trial. Author(s): de Leeuw PW. Source: The American Journal of Medicine. 1991 March; 90(3A): 45S-49S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006660&dopt=Abstract
·
Renal reserve in patients with high blood pressure. Author(s): Gabbai FB. Source: Semin Nephrol. 1995 September; 15(5): 482-7. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8525152&dopt=Abstract
·
Renovascular disease and high blood pressure. Author(s): Carr AA. Source: J Med Assoc Ga. 1975 July; 64(7): 272-7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1151188&dopt=Abstract
·
Research on high blood pressure. Author(s): Amery A, Fagard R, Lijnen P, Reybrouck T. Source: Acta Clin Belg. 1977; 32(3): 161-2. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=602603&dopt=Abstract
·
Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in noninsulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease. Author(s): Reaven GM. Source: Diabete Metab. 1991 May; 17(1 Pt 2): 78-86. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1936488&dopt=Abstract
·
Respiratory sleep disorders and high blood pressure. Author(s): Fletcher EC. Source: Cardiologia. 1997 May; 42(5): 469-79. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9225492&dopt=Abstract
Studies 103
·
Response to high blood pressure screening and referral by medical students in rural communities. Author(s): Blankenship B, Barnett AD Jr. Source: J Tenn Med Assoc. 1984 February; 77(2): 82-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6727335&dopt=Abstract
·
Response to the Advisory Statement from the Council for high blood pressure research of the American Heart Association advocating retention of mercury sphygmomanometers. Author(s): O'Brien E. Source: Hypertension. 2001 October; 38(4): E19-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11641320&dopt=Abstract
·
Retinal circulation in high blood pressure. Author(s): Vannas S, Raitta C. Source: International Ophthalmology Clinics. 1968 Summer; 8(2): 291-335. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4894175&dopt=Abstract
·
Revision of guidelines for high blood pressure management: JNC IV. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Author(s): Hill MN, Russell RP. Source: Md Med J. 1988 September; 37(9): 698-701. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3173007&dopt=Abstract
·
Revision of guidelines for high blood pressure therapy. Author(s): Russell RP. Source: Md State Med J. 1984 September; 33(9): 692-3. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6492878&dopt=Abstract
·
Risk factors for high blood pressure among workers in French poultry slaughterhouses and canneries. Author(s): Ledesert B, Saurel-Cubizolles MJ, Bourgine M, Kaminski M, Touranchet A, Verger C. Source: European Journal of Epidemiology. 1994 October; 10(5): 609-20. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7859863&dopt=Abstract
·
Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. Author(s): Fletcher A, Amery A, Birkenhager W, Bulpitt C, Clement D, de Leeuw P, Deruyterre ML, de Schaepdryver A, Dollery C, Fagard R, et al. Source: Journal of Hypertension. 1991 March; 9(3): 225-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1851785&dopt=Abstract
104 High Blood Pressure
·
Role of optometrists in combatting high blood pressure. Author(s): Good GW, Augsburger AR. Source: J Am Optom Assoc. 1989 May; 60(5): 352-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2732415&dopt=Abstract
·
Round table 2. A critique of the Fifth Joint National Committee Report on Detection, Evaluation and Treatment of High Blood Pressure. Author(s): Moser M. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1993 December; 11 Suppl 5: S384-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8158431&dopt=Abstract
·
Salt and high blood pressure. Author(s): McGuffin WL Jr. Source: Ala J Med Sci. 1984 January; 21(1): 20-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6703245&dopt=Abstract
·
Screen detected high blood pressure under 40: a general practice population followed up for 21 years. Author(s): Hart JT, Edwards C, Hart M, Jones J, Jones M, Haines A, Watt G. Source: Bmj (Clinical Research Ed.). 1993 February 13; 306(6875): 437-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8461729&dopt=Abstract
·
Screening for high blood pressure. Author(s): Schwartz SN. Source: Bull Eleventh Dist Dent Soc. 1978 March; 16(3): 14. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=276389&dopt=Abstract
·
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of Australia. Author(s): Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, Johnston CI, McNeil JJ, Marley JE, Morgan TO, Shaw J, Steven ID, West MJ. Source: Clinical and Experimental Hypertension (New York, N.Y. : 1993). 1997 JulyAugust; 19(5-6): 779-91. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9247755&dopt=Abstract
·
Seeking and finding all those patients with high blood pressure. Author(s): Hill MN, Foster SB. Source: Nursing. 1982 February; 12(2): 72-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6915420&dopt=Abstract
Studies 105
·
Selection, training, and utilization of health counselors in the management of high blood pressure. Author(s): Frate DA, Whitehead T, Johnson SA. Source: Urban Health. 1983 May; 12(5): 52-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10262031&dopt=Abstract
·
Self-help for high blood pressure. Author(s): Rogers CS. Source: N C Med J. 1984 March; 45(3): 175-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6585655&dopt=Abstract
·
Self-measurement of blood pressure: assessment of equipment. Canadian Coalition for High Blood Pressure Prevention and Control. Author(s): McKay DW, Campbell NR, Chockalingam A, Ku L, Small C, Wasi S. Source: The Canadian Journal of Cardiology. 1995 November; 11 Suppl H: 29H-34H. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7489541&dopt=Abstract
·
Self-measurement of blood pressure: benefits, risks and interpretation of readings. The Canadian Coalition for High Blood Pressure Prevention and Control. Author(s): Campbell NR, Bass M, Chockalingam A, LeBel M, Milkovich L. Source: The Canadian Journal of Cardiology. 1995 November; 11 Suppl H: 18H-22H. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7489539&dopt=Abstract
·
Self-measurement of blood pressure: issues related to the training of patients. Canadian Coalition for High Blood Pressure Prevention and Control. Author(s): Birkett NJ, Abbott D, Campbell NR, Chockalingam A, Dagenais GR, Hogan K. Source: The Canadian Journal of Cardiology. 1995 November; 11 Suppl H: 23H-27H. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7489540&dopt=Abstract
·
Self-measurement of blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Author(s): Campbell NR, Abbott D, Bass M, Birkett NJ, Chockalingam A, Dagenais GR, Hogan K, Ku L, LeBel M, McKay DW, et al. Source: The Canadian Journal of Cardiology. 1995 November; 11 Suppl H: 5H-17H. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7489545&dopt=Abstract
·
Serum cholesterol levels and survival in elderly hypertensive patients: analysis of data from the European Working Party on High Blood Pressure in the Elderly. Author(s): Fagard R. Source: The American Journal of Medicine. 1991 March; 90(3A): 62S-63S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006664&dopt=Abstract
106 High Blood Pressure
·
Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Author(s): Lenfant C, Chobanian AV, Jones DW, Roccella EJ; Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Source: Hypertension. 2003 June; 41(6): 1178-9. Epub 2003 May 19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12756222&dopt=Abstract
·
Severity of human hypertension in relation to the age in which high blood pressure makes its presumptive appearance. Author(s): Cugini P, Ferrari P, De Rosa R, Caliumi C, Delfini E, Colotto M, Fontana S, Mandolini C, Manetti L, Letizia C. Source: Clin Ter. 2003 January-February; 154(1): 21-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12854280&dopt=Abstract
·
Sexual functioning, health beliefs, and compliance with high blood pressure medications. Author(s): Watts RJ. Source: Nursing Research. 1982 September-October; 31(5): 278-83. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6922469&dopt=Abstract
·
Short-term and long-term effects of a high blood pressure intervention program. Author(s): Frate DA, Johnson SA, Meydrech EF, Frate JB, Walsh DA. Source: J Miss State Med Assoc. 1984 October; 25(10): 267-70. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6492148&dopt=Abstract
·
Should family doctors screen asymptomatic children for high blood pressure? Author(s): St George IM. Source: Family Practice. 1990 September; 7(3): 219-26. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2245893&dopt=Abstract
·
Should we be treating high blood pressure in persons over 65? Author(s): Lichtenstein MJ. Source: Compr Ther. 1988 January; 14(1): 54-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3342604&dopt=Abstract
·
Sick genes, sick individuals or sick populations with chronic disease? The emergence of diabetes and high blood pressure in African-origin populations. Author(s): Cruickshank JK, Mbanya JC, Wilks R, Balkau B, McFarlane-Anderson N, Forrester T. Source: International Journal of Epidemiology. 2001 February; 30(1): 111-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11171870&dopt=Abstract
Studies 107
·
Sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. A summary. Author(s): Rayburn WF. Source: J Reprod Med. 1998 May; 43(5): 444-50. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9610469&dopt=Abstract
·
Sodium and potassium intake and high blood pressure. Author(s): McGregor GA. Source: Acta Cardiol Suppl. 1988; 29: 9-19. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3389028&dopt=Abstract
·
Sodium and potassium intake and high blood pressure. Author(s): MacGregor GA. Source: European Heart Journal. 1987 May; 8 Suppl B: 3-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3301353&dopt=Abstract
·
Sodium and potassium intake in the management of high blood pressure. Author(s): MacGregor GA. Source: J Clin Hypertens. 1986 June; 2(2): 132-40. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3531413&dopt=Abstract
·
Sodium intake, high blood pressure, and calcium channel blockers. Author(s): MacGregor GA, Cappuccio FP, Markandu ND. Source: The American Journal of Medicine. 1987 March 30; 82(3B): 16-22. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3551600&dopt=Abstract
·
Sodium restriction lowers high blood pressure through a decreased response of the renin system--direct evidence using saralasin. Author(s): Cappuccio FP, Markandu ND, Sagnella GA, MacGregor GA. Source: Journal of Hypertension. 1985 June; 3(3): 243-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3894515&dopt=Abstract
·
Sounding board. High blood pressure: do we really know whom to treat and how? Author(s): Alderman MH. Source: The New England Journal of Medicine. 1977 March 31; 296(13): 753-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=840267&dopt=Abstract
·
Specific aspects of high blood pressure in the elderly. Author(s): Blacher J, Safar M. Source: J Renin Angiotensin Aldosterone Syst. 2002 September; 3 Suppl 1: S10-5. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12428216&dopt=Abstract
108 High Blood Pressure
·
Spontaneous changes in very high blood pressure after admission to the hospital and their relation to target organ involvement. Author(s): Ambrosio GB, Pigato R, Zamboni S, Dal Palu C. Source: Cardiology. 1982; 69(2): 104-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7105068&dopt=Abstract
·
Spouse similarities in high blood pressure knowledge: implications for control of high blood pressure. Author(s): Speers MA, Niemcryk SJ, Morter R, Gary HE Jr, Ostfeld AM. Source: American Journal of Preventive Medicine. 1990 January-February; 6(1): 20-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2340188&dopt=Abstract
·
Stabilization of high blood pressure with tricyclic antidepressants and lithium combinations in hypertensive patients. Author(s): Zachariah PK, Rosenbaum AH. Source: Mayo Clinic Proceedings. 1982 October; 57(10): 625-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7121068&dopt=Abstract
·
Standards for accurate measurement of blood pressure: standards of detection, evaluation and management of high blood pressure. Author(s): Grancio SD. Source: Mass Nurse. 1979 March; 48(3): 7-8. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=253880&dopt=Abstract
·
State of the art in high blood pressure control. Author(s): Smith WM. Source: J S C Med Assoc. 1980 September; 76(9 Suppl): 11-5. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6933287&dopt=Abstract
·
Statement from the National High Blood Pressure Education Program: prevalence of hypertension. Author(s): Wolz M, Cutler J, Roccella EJ, Rohde F, Thom T, Burt V. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 2000 January; 13(1 Pt 1): 103-4. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10678279&dopt=Abstract
·
Statewide community high blood pressure control programs. Author(s): Chiappini M, Henson MA, Wilber JA, McClellan W. Source: J Med Assoc Ga. 1981 May; 70(5): 357-60. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7264471&dopt=Abstract
Studies 109
·
Status of high blood pressure control in California: a preliminary report of a statewide survey. Author(s): Leonard AR, Igra A, Hawthorne A. Source: Heart & Lung : the Journal of Critical Care. 1981 March-April; 10(2): 255-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6907260&dopt=Abstract
·
Strengths and weaknesses of family studies of high blood pressure. Author(s): Watt GC. Source: Journal of Human Hypertension. 1994 May; 8(5): 327-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8064778&dopt=Abstract
·
Stress, ACTH, salt intake and high blood pressure. Author(s): Denton DA, Coghlan JP, Fei DT, Mckinley M, Nelson J, Scoggins B, Tarjan E, Tregear GW, Tresham JJ, Weisinger R. Source: Clin Exp Hypertens A. 1984; 6(1-2): 403-15. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6321067&dopt=Abstract
·
Strong association of overweight to high blood pressure in a rural community of central Italy: the 'Di.S.Co.' Project. Author(s): Urbinati GC, Angelico F, Del Ben M, Giampaoli S, Menotti A, Ricci G, Savocchi P, Seccareccia F, Spitoni M, Volpe R. Source: Diabetes Research and Clinical Practice. 1990; 10 Suppl 1: S205-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2286133&dopt=Abstract
·
Studies of blood pressure in Tecumseh, Michigan. II. Antecedents in childhood of high blood pressure in young adults. Author(s): Higgins MW, Keller JB, Metzner HL, Moore FE, Ostrander LD Jr. Source: Hypertension. 1980 July-August; 2(4 Pt 2): 117-23. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7399643&dopt=Abstract
·
Study of noise exposure and high blood pressure in shipyard workers. Author(s): Wu TN, Ko YC, Chang PY. Source: American Journal of Industrial Medicine. 1987; 12(4): 431-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3499819&dopt=Abstract
·
Successful modules of community hypertension control programs--examples from the German National High Blood Pressure Programme. Author(s): Hense HW. Source: Journal of Human Hypertension. 1996 February; 10 Suppl 1: S13-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8965280&dopt=Abstract
110 High Blood Pressure
·
Symposium on high blood pressure: mechanisms and management. Introduction. Author(s): Laragh JH. Source: The American Journal of Cardiology. 1973 September 20; 32(4): 497-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4729720&dopt=Abstract
·
Symptoms and the discovery of high blood pressure. Author(s): Robinson JO. Source: Journal of Psychosomatic Research. 1969 June; 13(2): 157-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=5789608&dopt=Abstract
·
The 2000 Canadian recommendations for the management of hypertension: part two-diagnosis and assessment of people with high blood pressure. Author(s): Zarnke KB, Levine M, McAlister FA, Campbell NR, Myers MG, McKay DW, Bolli P, Honos G, Lebel M, Mann K, Wilson TW, Abbott C, Tobe S, Burgess E, Rabkin S; Canadian Hypertension Recommendations Working Group. Source: The Canadian Journal of Cardiology. 2001 December; 17(12): 1249-63. Review. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11773936&dopt=Abstract
·
The ALLHAT Trial. Diuretics are still the preferred initial drugs for high blood pressure. Author(s): Vidt DG. Source: Cleve Clin J Med. 2003 March; 70(3): 263-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12678218&dopt=Abstract
·
The angiotensin I converting enzyme gene and predisposition to high blood pressure. Author(s): Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC. Source: Hypertension. 1993 April; 21(4): 455-60. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8384602&dopt=Abstract
·
The association between high blood pressure, physical fitness, and body mass index in adolescents. Author(s): Nielsen GA, Andersen LB. Source: Preventive Medicine. 2003 February; 36(2): 229-34. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12590998&dopt=Abstract
·
The association between racism and high blood pressure among African Americans. Author(s): Boutain DM, Cooke C. Source: Ethn Dis. 2001 Fall; 11(4): 793-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11763304&dopt=Abstract
Studies 111
·
The Austin Doyle Lecture, High Blood Pressure Research Council of Australia. Renal disease as a metaphor: towards a more integrated view of aboriginal health. Author(s): Hoy WE. Source: Clinical and Experimental Pharmacology & Physiology. 1998 December; 25(12): 1038-42. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9888003&dopt=Abstract
·
The Canadian consensus report on non-pharmacological approaches to the management of high blood pressure. Author(s): Fodor JG, Chockalingam A. Source: Clin Exp Hypertens A. 1990; 12(5): 729-43. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2208746&dopt=Abstract
·
The complex relationship between nocturnal obstructive apnea and high blood pressure. The eternal question of the chicken and the egg. Author(s): Polonia J. Source: Rev Port Cardiol. 2000 October; 19(10): 1007-12. English, Portuguese. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11126103&dopt=Abstract
·
The consistency of various high blood pressure indicators based on questionnaire and physical measures data from the Canada Health Survey. Author(s): Gentleman JF, Tomiak M. Source: Health Reports / Statistics Canada, Canadian Centre for Health Information = Rapports Sur La Sante / Statistique Canada, Centre Canadien D'information Sur La Sante. 1992; 4(3): 293-311. English, French. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1493199&dopt=Abstract
·
The contexts of adherence for African Americans with high blood pressure. Author(s): Rose LE, Kim MT, Dennison CR, Hill MN. Source: Journal of Advanced Nursing. 2000 September; 32(3): 587-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11012800&dopt=Abstract
·
The Council for High Blood Pressure Research. Its origin and purposes. Author(s): Page IH. Source: Hypertension. 1988 June; 11(6 Pt 2): 763-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3292418&dopt=Abstract
·
The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial. Author(s): Staessen J. Source: The American Journal of Medicine. 1991 March; 90(3A): 50S-54S. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006662&dopt=Abstract
112 High Blood Pressure
·
The Edgecombe County High Blood Pressure Control Program: III. Social support, social stressors, and treatment dropout. Author(s): Williams CA, Beresford SA, James SA, LaCroix AZ, Strogatz DS, Wagner EH, Kleinbaum DG, Cutchin LM, Ibrahim MA. Source: American Journal of Public Health. 1985 May; 75(5): 483-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3872605&dopt=Abstract
·
The Edgecombe County High Blood Pressure Control Program: the process of medical care and blood pressure control. Author(s): Ballard DJ, Strogatz DS, Wagner EH, Siscovick DS, James SA, Kleinbaum DG, Williams CA, Cutchin LM, Ibrahim MA. Source: American Journal of Preventive Medicine. 1986 September-October; 2(5): 278-84. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3453192&dopt=Abstract
·
The effect of long-term verapamil treatment on the secretion of cortisol and aldosterone in subjects with normal and high blood pressure. Author(s): Zofkova I. Source: Exp Clin Endocrinol. 1985 April; 85(2): 217-22. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2990975&dopt=Abstract
·
The effect of regulation of high blood pressure on plasma endothelin-1 levels in blacks with hypertension. Author(s): Ergul S, Ergul A, Hudson JA, Puett D, Wieman BM, Durham MD, Parish DC. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1998 November; 11(11 Pt 1): 1381-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9832184&dopt=Abstract
·
The European Working Party on High Blood Pressure in the Elderly. Author(s): Amery A, De Schaepdryver A. Source: The American Journal of Medicine. 1991 March; 90(3A): 1S-4S. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2006651&dopt=Abstract
·
The fifth Joint National Committee report on the detection, evaluation and treatment of high blood pressure. Author(s): Frohlich ED. Source: Journal of the American College of Cardiology. 1993 August; 22(2): 621-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8335838&dopt=Abstract
Studies 113
·
The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: a resource for occupational health. Author(s): Young JM. Source: Aaohn Journal : Official Journal of the American Association of Occupational Health Nurses. 1995 June; 43(6): 301-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7772208&dopt=Abstract
·
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: insights and highlights from the chairman. Author(s): Gifford RW Jr. Source: Cleve Clin J Med. 1993 July-August; 60(4): 273-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8339452&dopt=Abstract
·
The HEDIS performance NAVIGATOR for controlling high blood pressure: a resource to assist health plans improve patient adherence. Author(s): Turpin R, Jungkind K, Salvucci L. Source: Disease Management : Dm. 2003 Spring; 6(1): 43-51. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12899567&dopt=Abstract
·
The High Blood Pressure and You Education Program. Author(s): Hale CD, Richards N, Belcuore T, Rains CS, Davis RC. Source: The Journal of School Health. 1988 August; 58(6): 251-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3216633&dopt=Abstract
·
The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and Obstructive Sleep Apnea: let their silence not be matched by the silence of the ordinary physician. Author(s): Silverberg D, Oksenberg A, Iaina A. Source: Archives of Internal Medicine. 1998 June 8; 158(11): 1272-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9625409&dopt=Abstract
·
The National High Blood Pressure Education Program reaches maturity. Author(s): Cooper T. Source: Chest. 1984 September; 86(3): 346. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6467994&dopt=Abstract
·
The National High Blood Pressure Education Program: longtime partners with new strategies. Author(s): Nickey WA, Lenfant C, Chobanian AV, Roccella EJ. Source: J Am Osteopath Assoc. 2003 June; 103(6): 297-9. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12834103&dopt=Abstract
114 High Blood Pressure
·
The National High Blood Pressure Education Program: measuring progress and assessing its impact. Author(s): Roccella EJ, Horan MJ. Source: Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association. 1988; 7 Suppl: 297-303. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3243223&dopt=Abstract
·
The national high blood pressure education program: thirty years and counting. Author(s): Jones DW, Hall JE. Source: Hypertension. 2002 May; 39(5): 941-2. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12019273&dopt=Abstract
·
The National High Blood Pressure Program. Author(s): Frohlich E. Source: Journal of the American College of Cardiology. 1988 September; 12(3): 812-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3403842&dopt=Abstract
·
The nature and efficacy of intervention studies in the National High Blood Pressure Education Research Program. Author(s): Garrity TF, Garrity AR. Source: Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 1985 April; 3(1): S91-5. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3916445&dopt=Abstract
·
The primary prevention of high blood pressure: a population approach. Author(s): Blackburn H, Grimm R Jr, Luepker RV, Mittelmark M. Source: Preventive Medicine. 1985 July; 14(4): 466-81. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=4070185&dopt=Abstract
·
The relation between coronary heart disease and high blood pressure. Author(s): Hilden T. Source: Acta Med Scand Suppl. 1986; 714: 159-63. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3472439&dopt=Abstract
·
The relative risk of myocardial infarction in patients who have high blood pressure and non-cardiac pain. Author(s): Psaty BM, Koepsell TD, LoGerfo JP, Wagner EH, Inui TS. Source: Journal of General Internal Medicine : Official Journal of the Society for Research and Education in Primary Care Internal Medicine. 1987 November-December; 2(6): 3817. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3694297&dopt=Abstract
Studies 115
·
The Report of Fifth Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure: a “loose” constructionist view. Author(s): Black HR. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1995 March; 8(3): 331-3, 334-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=7794586&dopt=Abstract
·
The risks of hypertension: a renewed call for high blood pressure control. Author(s): Lackland DT. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 2000 June; 13(6 Pt 1): 736-8. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10912762&dopt=Abstract
·
The role of dietary sodium intake in the control of high blood pressure. A short review. Author(s): Cappuccio FP, MacGregor GA. Source: Contrib Nephrol. 1994; 106: 148-52. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8174362&dopt=Abstract
·
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Author(s): Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. Source: Jama : the Journal of the American Medical Association. 2003 May 21; 289(19): 2560-72. Epub 2003 May 14. Erratum In: Jama. 2003 July 9; 290(2): 197. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12748199&dopt=Abstract
·
The sixth report of the Joint National Committee: an appropriate celebration of the 25th anniversary of the National High Blood Pressure Education Program. Author(s): Frohlich ED. Source: Hypertension. 1997 December; 30(6): 1305-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9403545&dopt=Abstract
·
The stability of high blood pressure in Dunedin children: an eight year longitudinal study. Author(s): St George IM, Williams SM, Silva PA. Source: N Z Med J. 1990 March 28; 103(886): 115-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2320336&dopt=Abstract
116 High Blood Pressure
·
The use of volunteers in mass screening for high blood pressure. Author(s): Elder JP, McKenna CA, Lazieh M, Ferreira A, Lasater TM, Carleton RA. Source: American Journal of Preventive Medicine. 1986 September-October; 2(5): 268-72. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3453190&dopt=Abstract
·
Therapeutic approach to patients complaining of high blood pressure in a cardiological emergency room. Author(s): Gus M, Andrighetto AG, Balle VR, Pilla MB. Source: Arquivos Brasileiros De Cardiologia. 1999 March; 72(3): 321-6. English, Portuguese. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10513043&dopt=Abstract
·
Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Author(s): Psaty BM, Manolio TA, Smith NL, Heckbert SR, Gottdiener JS, Burke GL, Weissfeld J, Enright P, Lumley T, Powe N, Furberg CD; Cardiovascular Health Study. Source: Archives of Internal Medicine. 2002 November 11; 162(20): 2325-32. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12418946&dopt=Abstract
·
Treat high blood pressure sooner: tougher, simpler JNC 7 guidelines. Author(s): Vidt DG, Borazanian RA. Source: Cleve Clin J Med. 2003 August; 70(8): 721-8. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12959399&dopt=Abstract
·
Treating high blood pressure following acute stroke. Author(s): Keir SL, Murphy PJ, MacMahon M. Source: Journal of the Royal College of Physicians of London. 1996 May-June; 30(3): 26970. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8811609&dopt=Abstract
·
Treatment of high blood pressure in Germany. Author(s): Faulhaber HD, Luft FC. Source: American Journal of Hypertension : Journal of the American Society of Hypertension. 1998 June; 11(6 Pt 1): 750-3. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9657639&dopt=Abstract
·
Treatment of high blood pressure in overweight patients. Author(s): MacMahon S, Macdonald G. Source: Nephron. 1987; 47 Suppl 1: 8-12. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2962005&dopt=Abstract
Studies 117
·
Treatment of high blood pressure in the young. Author(s): Kotchen JM, Holley J, Kotchen TA. Source: Semin Nephrol. 1989 September; 9(3): 296-303. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2675247&dopt=Abstract
·
Treatment of high blood pressure. From diuretics to the present and future. Author(s): Nogueira da Costa J. Source: Cardiologia. 1995 December; 40(12): 893-8. Review. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=8901039&dopt=Abstract
·
Treatment of high blood pressure: should clinical practice be based on results of clinical trials? Author(s): Wilcox RG, Mitchell JR, Hampton JR. Source: British Medical Journal (Clinical Research Ed.). 1986 August 16; 293(6544): 433-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3091147&dopt=Abstract
·
Treatment of high blood pressure--the effect on coronary morbidity and mortality. Author(s): Reid JL, Curzio JL, Kennedy S, Elliott HL. Source: Journal of Human Hypertension. 1989 December; 3 Suppl 2: 35-8; Discussion 3940. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2691693&dopt=Abstract
·
Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure. Author(s): Siegel D, Lopez J. Source: Jama : the Journal of the American Medical Association. 1997 December 3; 278(21): 1745-8. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9388150&dopt=Abstract
·
Unrecognized high blood pressure. A major public health issue for the workplace. Author(s): Capriotti T, Kirby LG, Smeltzer SC. Source: Aaohn Journal : Official Journal of the American Association of Occupational Health Nurses. 2000 July; 48(7): 338-43. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11261183&dopt=Abstract
·
Update on high blood pressure: highlights from the 1988 national report. Author(s): Fontana SA. Source: The Nurse Practitioner. 1988 December; 13(12): 8, 10-2, 15 Passim. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3231362&dopt=Abstract
118 High Blood Pressure
·
Update on the factors associated with high blood pressure compliance. Author(s): Bone LR, Levine DM, Parry RE, Morisky DE, Green LW. Source: Md State Med J. 1984 March; 33(3): 201-4. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6717083&dopt=Abstract
·
Using the emergency department as a screening site for high blood pressure. A method for improving hypertension detection and appropriate referral. Author(s): Mamon J, Green L, Levine DM, Gibson G, Gurley HT. Source: Medical Care. 1987 August; 25(8): 770-80. Erratum In: Med Care 1987 October; 25(10): 1018. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3695673&dopt=Abstract
·
Validation of self diagnosis of high blood pressure in a sample of the Spanish EPIC cohort: overall agreement and predictive values. EPIC Group of Spain. Author(s): Tormo MJ, Navarro C, Chirlaque MD, Barber X. Source: Journal of Epidemiology and Community Health. 2000 March; 54(3): 221-6. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10746117&dopt=Abstract
·
Very high blood pressure in acute stroke. Author(s): Britton M, Carlsson A. Source: Journal of Internal Medicine. 1990 December; 228(6): 611-5. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=2280238&dopt=Abstract
·
Villain and victim: the kidney and high blood pressure in the nineteenth century. Author(s): Cameron JS. Source: Journal of the Royal College of Physicians of London. 1999 July-August; 33(4): 382-94. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=10472029&dopt=Abstract
·
Visual diagnosis: a child who has a nosebleed and high blood pressure. Author(s): Herman A. Source: Pediatrics in Review / American Academy of Pediatrics. 2001 March; 22(3): 1047. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11230629&dopt=Abstract
·
Warning--the physician's clinical judgement can be hazardous to your health: withdrawing drugs in patients with high blood pressure. Author(s): Grimm RH Jr. Source: The Journal of the American Board of Family Practice / American Board of Family Practice. 1997 July-August; 10(4): 305-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=9228628&dopt=Abstract
Studies 119
·
Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. Author(s): Fagerberg B, Berglund A, Andersson OK, Berglund G. Source: Journal of Hypertension. 1992 September; 10(9): 1053-61. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=1328365&dopt=Abstract
·
What does the public know about high blood pressure? Author(s): Levy RI, Ward GW. Source: Am Pharm. 1979 May; 19(5): 39-41. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=474392&dopt=Abstract
·
What is high blood pressure and why is it important? Author(s): Hill M. Source: Pa Nurse. 1982 May; 37(5): 7. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6918898&dopt=Abstract
·
When your patients ask about salt and high blood pressure. Author(s): Trimmer E. Source: Midwife Health Visit Community Nurse. 1985 November; 21(11): 394. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3853741&dopt=Abstract
·
Wisconsin high blood pressure control program--involving the physician. Author(s): Handy GH, Dart R, Koehn A. Source: Wis Med J. 1979 November; 78(11): 14-6. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=516783&dopt=Abstract
·
Workup and evaluation of the patient with high blood pressure. Author(s): Propert DB, Anderson MA. Source: J S C Med Assoc. 1980 September; 76(9 Suppl): 44-53. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=6933292&dopt=Abstract
·
World Health Day 1978: down with high blood pressure. Author(s): Mahler H. Source: Xianggang Hu Li Za Zhi. 1978 November; (25): 28. No Abstract Available. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=311319&dopt=Abstract
·
Young men with high blood pressure report few recent life events. Author(s): Theorell T, Svensson J, Knox S, Waller D, Alvarez M. Source: Journal of Psychosomatic Research. 1986; 30(2): 243-9. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=3723455&dopt=Abstract
121
CHAPTER 2. NUTRITION AND HIGH BLOOD PRESSURE Overview In this chapter, we will show you how to find studies dedicated specifically to nutrition and high blood pressure.
Finding Nutrition Studies on High Blood Pressure The National Institutes of Health’s Office of Dietary Supplements (ODS) offers a searchable bibliographic database called the IBIDS (International Bibliographic Information on Dietary Supplements; National Institutes of Health, Building 31, Room 1B29, 31 Center Drive, MSC 2086, Bethesda, Maryland 20892-2086, Tel: 301-435-2920, Fax: 301-480-1845, E-mail:
[email protected]). The IBIDS contains over 460,000 scientific citations and summaries about dietary supplements and nutrition as well as references to published international, scientific literature on dietary supplements such as vitamins, minerals, and botanicals.7 The IBIDS includes references and citations to both human and animal research studies. As a service of the ODS, access to the IBIDS database is available free of charge at the following Web address: http://ods.od.nih.gov/databases/ibids.html. After entering the search area, you have three choices: (1) IBIDS Consumer Database, (2) Full IBIDS Database, or (3) Peer Reviewed Citations Only. Now that you have selected a database, click on the “Advanced” tab. An advanced search allows you to retrieve up to 100 fully explained references in a comprehensive format. Type “high blood pressure” (or synonyms) into the search box, and click “Go.” To narrow the search, you can also select the “Title” field.
7
Adapted from http://ods.od.nih.gov. IBIDS is produced by the Office of Dietary Supplements (ODS) at the National Institutes of Health to assist the public, healthcare providers, educators, and researchers in locating credible, scientific information on dietary supplements. IBIDS was developed and will be maintained through an interagency partnership with the Food and Nutrition Information Center of the National Agricultural Library, U.S. Department of Agriculture.
122 High Blood Pressure
The following is a typical result when searching for recently indexed consumer information on high blood pressure: ·
Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day. Author(s): Hospital Jose Ignacio Baldo, Caracas, Venezuela. Source: Rodriguez Roa, E Octavio, A Mayorca, E Castro, P Miranda, R Valecillo, E Gonzalez, M J-Hum-Hypertens. 2002 March; 16 Suppl 1: S151-5 0950-9240
·
High blood pressure: the end of an epidemic. Source: Liebman, B. Nutr-action-health-lett. [Washington, D.C. : Center for Science in the Public Interest,. December 2000. volume 27 (10) page 1, 3-9. 0885-7792
The following information is typical of that found when using the “Full IBIDS Database” to search for “high blood pressure” (or a synonym): ·
Blood pressure response in 24 hours in patients with high blood pressure treated with two nifedipine formulations once a day. Author(s): Hospital Jose Ignacio Baldo, Caracas, Venezuela. Source: Rodriguez Roa, E Octavio, A Mayorca, E Castro, P Miranda, R Valecillo, E Gonzalez, M J-Hum-Hypertens. 2002 March; 16 Suppl 1: S151-5 0950-9240
·
High blood pressure: the end of an epidemic. Source: Liebman, B. Nutr-action-health-lett. [Washington, D.C. : Center for Science in the Public Interest,. December 2000. volume 27 (10) page 1, 3-9. 0885-7792
Federal Resources on Nutrition In addition to the IBIDS, the United States Department of Health and Human Services (HHS) and the United States Department of Agriculture (USDA) provide many sources of information on general nutrition and health. Recommended resources include: ·
healthfinder®, HHS’s gateway to health information, including diet and nutrition: http://www.healthfinder.gov/scripts/SearchContext.asp?topic=238&page=0
·
The United States Department of Agriculture’s Web site dedicated to nutrition information: www.nutrition.gov
·
The Food and Drug Administration’s Web site for federal food safety information: www.foodsafety.gov
·
The National Action Plan on Overweight and Obesity sponsored by the United States Surgeon General: http://www.surgeongeneral.gov/topics/obesity/
·
The Center for Food Safety and Applied Nutrition has an Internet site sponsored by the Food and Drug Administration and the Department of Health and Human Services: http://vm.cfsan.fda.gov/
·
Center for Nutrition Policy and Promotion sponsored by the United States Department of Agriculture: http://www.usda.gov/cnpp/
·
Food and Nutrition Information Center, National Agricultural Library sponsored by the United States Department of Agriculture: http://www.nal.usda.gov/fnic/
·
Food and Nutrition Service sponsored by the United States Department of Agriculture: http://www.fns.usda.gov/fns/
Nutrition 123
Additional Web Resources A number of additional Web sites offer encyclopedic information covering food and nutrition. The following is a representative sample: ·
AOL: http://search.aol.com/cat.adp?id=174&layer=&from=subcats
·
Family Village: http://www.familyvillage.wisc.edu/med_nutrition.html
·
Google: http://directory.google.com/Top/Health/Nutrition/
·
Healthnotes: http://www.healthnotes.com/
·
Open Directory Project: http://dmoz.org/Health/Nutrition/
·
Yahoo.com: http://dir.yahoo.com/Health/Nutrition/
·
WebMDÒHealth: http://my.webmd.com/nutrition
·
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
The following is a specific Web list relating to high blood pressure; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: ·
Vitamins Pyridoxine Alternative names: Vitamin B6 (Pyridoxine) Source: Integrative Medicine Communications; www.drkoop.com Vitamin B6 Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin B6 (pyridoxine) Alternative names: Pyridoxine Source: Integrative Medicine Communications; www.drkoop.com Vitamin C Source: Healthnotes, Inc.; www.healthnotes.com Vitamin C Source: Prima Communications, Inc.www.personalhealthzone.com Vitamin D Alternative names: Calciferol Source: Integrative Medicine Communications; www.drkoop.com Vitamin D Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,905,00.html
124 High Blood Pressure
Vitamin E Alternative names: Alpha-Tocopherol, Beta-Tocopherol, D-Alpha-Tocopherol, Delta-Tocopherol, Gamma-Tocopherol Source: Integrative Medicine Communications; www.drkoop.com Vitamin E Source: Prima Communications, Inc.www.personalhealthzone.com ·
Minerals Alpha-tocopherol Source: Integrative Medicine Communications; www.drkoop.com Angiotensin-converting Enzyme (ace) Inhibitors Source: Healthnotes, Inc.; www.healthnotes.com Beta-tocopherol Source: Integrative Medicine Communications; www.drkoop.com Calcium Source: Healthnotes, Inc.; www.healthnotes.com Calcium Source: Integrative Medicine Communications; www.drkoop.com Calcium Source: Prima Communications, Inc.www.personalhealthzone.com Calcium Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,884,00.html Calcium/magnesium Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,937,00.html Calcium-channel Blockers Source: Healthnotes, Inc.; www.healthnotes.com Chromium Source: Prima Communications, Inc.www.personalhealthzone.com Copper Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,886,00.html D-alpha-tocopherol Source: Integrative Medicine Communications; www.drkoop.com
Nutrition 125
Delta-tocopherol Source: Integrative Medicine Communications; www.drkoop.com Gamma-tocopherol Source: Integrative Medicine Communications; www.drkoop.com Hmg-coa Reductase Inhibitors (statins) Source: Integrative Medicine Communications; www.drkoop.com Iron Alternative names: Ferrous Sulfate Source: Integrative Medicine Communications; www.drkoop.com L-carnitine Source: Healthnotes, Inc.; www.healthnotes.com Magnesium Source: Healthnotes, Inc.; www.healthnotes.com Magnesium Source: Prima Communications, Inc.www.personalhealthzone.com Magnesium Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,890,00.html Manganese Source: Integrative Medicine Communications; www.drkoop.com Potassium Source: Integrative Medicine Communications; www.drkoop.com Potassium Source: Prima Communications, Inc.www.personalhealthzone.com Potassium Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10086,00.html Potassium Chloride Source: Healthnotes, Inc.; www.healthnotes.com Spironolactone Source: Healthnotes, Inc.; www.healthnotes.com Zinc Source: Integrative Medicine Communications; www.drkoop.com
126 High Blood Pressure
·
Food and Diet Athletic Performance Source: Healthnotes, Inc.; www.healthnotes.com Coffee Source: Healthnotes, Inc.; www.healthnotes.com Ferrous Sulfate Alternative names: Iron Source: Integrative Medicine Communications; www.drkoop.com Garlic Alternative names: Allium sativum Source: Healthnotes, Inc.; www.healthnotes.com Garlic Source: Prima Communications, Inc.www.personalhealthzone.com Garlic Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,786,00.html Hypertension Source: Healthnotes, Inc.; www.healthnotes.com Low Back Pain Source: Healthnotes, Inc.; www.healthnotes.com Low-fat Diet Source: Healthnotes, Inc.; www.healthnotes.com Low-salt Diet Source: Healthnotes, Inc.; www.healthnotes.com Omega-6 Fatty Acids Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,1037,00.html Tea Source: Healthnotes, Inc.; www.healthnotes.com The Dean Ornish Diet Source: Healthnotes, Inc.; www.healthnotes.com Tyramine-free Diet Source: Healthnotes, Inc.; www.healthnotes.com Vegetarian Diet Source: Healthnotes, Inc.; www.healthnotes.com
127
CHAPTER 3. ALTERNATIVE MEDICINE AND HIGH BLOOD PRESSURE Overview In this chapter, we will begin by introducing you to official information sources on complementary and alternative medicine (CAM) relating to high blood pressure. At the conclusion of this chapter, we will provide additional sources.
National Center for Complementary and Alternative Medicine The National Center for Complementary and Alternative Medicine (NCCAM) of the National Institutes of Health (http://nccam.nih.gov/) has created a link to the National Library of Medicine’s databases to facilitate research for articles that specifically relate to high blood pressure and complementary medicine. To search the database, go to the following Web site: http://www.nlm.nih.gov/nccam/camonpubmed.html. Select “CAM on PubMed.” Enter “high blood pressure” (or synonyms) into the search box. Click “Go.” The following references provide information on particular aspects of complementary and alternative medicine that are related to high blood pressure: ·
Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Author(s): Egan BM, Lackland DT, Cutler NE. Source: Archives of Internal Medicine. 2003 March 24; 163(6): 681-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12639200&dopt=Abstract
·
Common Questions and Answers in the Management of Hypertension - Everyday Practice in Hypertension: Herbal Remedies for High Blood Pressure. Author(s): Townsend RR. Source: Journal of Clinical Hypertension (Greenwich, Conn.). 2000 January; 2(1): 54-55. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11416627&dopt=Abstract
128 High Blood Pressure
·
Discourses of worry, stress, and high blood pressure in rural south Louisiana. Author(s): Boutain DM. Source: Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing / Sigma Theta Tau. 2001; 33(3): 225-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11552548&dopt=Abstract
·
Initial cost of care results in medically supervised water-only fasting for treating high blood pressure and diabetes. Author(s): Goldhamer AC. Source: Journal of Alternative and Complementary Medicine (New York, N.Y.). 2002 December; 8(6): 696-7. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12614522&dopt=Abstract
·
Lay beliefs about high blood pressure in a low- to middle-income urban AfricanAmerican community: an opportunity for improving hypertension control. Author(s): Wilson RP, Freeman A, Kazda MJ, Andrews TC, Berry L, Vaeth PA, Victor RG. Source: The American Journal of Medicine. 2002 January; 112(1): 26-30. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11812403&dopt=Abstract
·
Lifestyle modification as a means to prevent and treat high blood pressure. Author(s): Appel LJ. Source: Journal of the American Society of Nephrology : Jasn. 2003 July; 14(7 Suppl 2): S99-S102. Review. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=12819311&dopt=Abstract
·
Working group report on high blood pressure in pregnancy. Author(s): Lenfant C; National Education Program Working Group on High Blood Pressure in Pregnancy. Source: Journal of Clinical Hypertension (Greenwich, Conn.). 2001 March-April; 3(2): 7588. http://www.ncbi.nlm.nih.gov:80/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ uids=11416689&dopt=Abstract
Additional Web Resources A number of additional Web sites offer encyclopedic information covering CAM and related topics. The following is a representative sample: ·
Alternative Medicine Foundation, Inc.: http://www.herbmed.org/
·
AOL: http://search.aol.com/cat.adp?id=169&layer=&from=subcats
·
Chinese Medicine: http://www.newcenturynutrition.com/
·
drkoop.comÒ: http://www.drkoop.com/InteractiveMedicine/IndexC.html
·
Family Village: http://www.familyvillage.wisc.edu/med_altn.htm
Alternative Medicine 129
·
Google: http://directory.google.com/Top/Health/Alternative/
·
Healthnotes: http://www.healthnotes.com/
·
MedWebPlus: http://medwebplus.com/subject/Alternative_and_Complementary_Medicine
·
Open Directory Project: http://dmoz.org/Health/Alternative/
·
HealthGate: http://www.tnp.com/
·
WebMDÒHealth: http://my.webmd.com/drugs_and_herbs
·
WholeHealthMD.com: http://www.wholehealthmd.com/reflib/0,1529,00.html
·
Yahoo.com: http://dir.yahoo.com/Health/Alternative_Medicine/
The following is a specific Web list relating to high blood pressure; please note that any particular subject below may indicate either a therapeutic use, or a contraindication (potential danger), and does not reflect an official recommendation: ·
General Overview Allergies Alternative names: Hay Fever Source: Prima Communications, Inc.www.personalhealthzone.com Alzheimer's Disease Source: Integrative Medicine Communications; www.drkoop.com Amenorrhea Source: Integrative Medicine Communications; www.drkoop.com Anaphylaxis Source: Integrative Medicine Communications; www.drkoop.com Angina Source: Healthnotes, Inc.; www.healthnotes.com Angina Source: Integrative Medicine Communications; www.drkoop.com Angioedema Source: Integrative Medicine Communications; www.drkoop.com Arteriosclerosis Source: Integrative Medicine Communications; www.drkoop.com Asthma Source: Integrative Medicine Communications; www.drkoop.com Asthma Source: Prima Communications, Inc.www.personalhealthzone.com
130 High Blood Pressure
Atherosclerosis Source: Integrative Medicine Communications; www.drkoop.com Atherosclerosis and Heart Disease Prevention Source: Prima Communications, Inc.www.personalhealthzone.com Benign Prostatic Hyperplasia Alternative names: Prostate Enlargement Source: Prima Communications, Inc.www.personalhealthzone.com Bone Marrow Disorders Source: Integrative Medicine Communications; www.drkoop.com Bronchitis Source: Integrative Medicine Communications; www.drkoop.com Candidiasis Source: Integrative Medicine Communications; www.drkoop.com Cardiac Arrhythmia Source: Healthnotes, Inc.; www.healthnotes.com Cardiovascular Disease Overview Source: Healthnotes, Inc.; www.healthnotes.com Chickenpox and Shingles Source: Integrative Medicine Communications; www.drkoop.com Chronic Fatigue Syndrome Source: Integrative Medicine Communications; www.drkoop.com Chronic Myelogenous Leukemia Source: Integrative Medicine Communications; www.drkoop.com Cold Sores Source: Integrative Medicine Communications; www.drkoop.com Congestive Heart Failure Source: Healthnotes, Inc.; www.healthnotes.com Congestive Heart Failure Source: Integrative Medicine Communications; www.drkoop.com Constipation Source: Integrative Medicine Communications; www.drkoop.com Coronary Artery Disease Source: Integrative Medicine Communications; www.drkoop.com Depression Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 131
Diabetes Mellitus Source: Integrative Medicine Communications; www.drkoop.com Dysphagia Source: Integrative Medicine Communications; www.drkoop.com Erythema Source: Integrative Medicine Communications; www.drkoop.com Fainting Source: Integrative Medicine Communications; www.drkoop.com Gastritis Source: Integrative Medicine Communications; www.drkoop.com Gastroesophageal Reflux Disease Source: Integrative Medicine Communications; www.drkoop.com Gestational Hypertension Source: Healthnotes, Inc.; www.healthnotes.com Glaucoma Source: Integrative Medicine Communications; www.drkoop.com Gout Source: Healthnotes, Inc.; www.healthnotes.com Gout Source: Integrative Medicine Communications; www.drkoop.com Heart Attack Source: Healthnotes, Inc.; www.healthnotes.com Heart Attack Source: Integrative Medicine Communications; www.drkoop.com Heartburn Source: Integrative Medicine Communications; www.drkoop.com Hepatitis Source: Healthnotes, Inc.; www.healthnotes.com Herpes Simplex Virus Source: Integrative Medicine Communications; www.drkoop.com Herpes Zoster and Varicella Viruses Source: Integrative Medicine Communications; www.drkoop.com High Blood Pressure Source: Integrative Medicine Communications; www.drkoop.com
132 High Blood Pressure
High Cholesterol Source: Healthnotes, Inc.; www.healthnotes.com High Cholesterol Source: Integrative Medicine Communications; www.drkoop.com High Cholesterol Source: Prima Communications, Inc.www.personalhealthzone.com Hirsuitism Source: Integrative Medicine Communications; www.drkoop.com Hiv and Aids Support Source: Healthnotes, Inc.; www.healthnotes.com Hypercholesterolemia Source: Integrative Medicine Communications; www.drkoop.com Hyperparathyroidism Source: Integrative Medicine Communications; www.drkoop.com Hypertension Source: Integrative Medicine Communications; www.drkoop.com Hypertension Alternative names: High Blood Pressure Source: Prima Communications, Inc.www.personalhealthzone.com Hyperthyroidism Source: Integrative Medicine Communications; www.drkoop.com Hypoglycemia Source: Integrative Medicine Communications; www.drkoop.com Hypothyroidism Source: Integrative Medicine Communications; www.drkoop.com Insect Bites and Stings Source: Integrative Medicine Communications; www.drkoop.com Insulin Resistance Syndrome Source: Healthnotes, Inc.; www.healthnotes.com Low Blood Sugar Source: Integrative Medicine Communications; www.drkoop.com Macular Degeneration Source: Healthnotes, Inc.; www.healthnotes.com Macular Degeneration Source: Prima Communications, Inc.www.personalhealthzone.com
Alternative Medicine 133
Menopausal Symptoms (other Than Osteoporosis) Source: Prima Communications, Inc.www.personalhealthzone.com Migraine Headache Source: Integrative Medicine Communications; www.drkoop.com Mitral Valve Prolapse Source: Healthnotes, Inc.; www.healthnotes.com Myelofibrosis Source: Integrative Medicine Communications; www.drkoop.com Myeloproliferative Disorders Source: Integrative Medicine Communications; www.drkoop.com Myocardial Infarction Source: Integrative Medicine Communications; www.drkoop.com Obesity Source: Integrative Medicine Communications; www.drkoop.com Parkinson's Disease Source: Integrative Medicine Communications; www.drkoop.com Peptic Ulcer Source: Integrative Medicine Communications; www.drkoop.com Pericarditis Source: Integrative Medicine Communications; www.drkoop.com Pharyngitis Source: Integrative Medicine Communications; www.drkoop.com Polycythemia Vera Source: Integrative Medicine Communications; www.drkoop.com Preeclampsia Source: Healthnotes, Inc.; www.healthnotes.com Preeclampsia Source: Integrative Medicine Communications; www.drkoop.com Pregnancy and Postpartum Support Source: Healthnotes, Inc.; www.healthnotes.com Pulmonary Edema Source: Integrative Medicine Communications; www.drkoop.com Reiter's Syndrome Source: Integrative Medicine Communications; www.drkoop.com
134 High Blood Pressure
Retinopathy Source: Healthnotes, Inc.; www.healthnotes.com Sarcoidosis Source: Integrative Medicine Communications; www.drkoop.com Scleroderma Source: Integrative Medicine Communications; www.drkoop.com Shingles and Chickenpox Source: Integrative Medicine Communications; www.drkoop.com Shock Source: Integrative Medicine Communications; www.drkoop.com Sinus Infection Source: Integrative Medicine Communications; www.drkoop.com Sinusitis Source: Integrative Medicine Communications; www.drkoop.com Sleep Apnea Source: Integrative Medicine Communications; www.drkoop.com Sore Throat Source: Integrative Medicine Communications; www.drkoop.com Stomach Inflammation Source: Integrative Medicine Communications; www.drkoop.com Stroke Source: Healthnotes, Inc.; www.healthnotes.com Syncope Source: Integrative Medicine Communications; www.drkoop.com Tendinitis Source: Integrative Medicine Communications; www.drkoop.com Thrombocytosis Source: Integrative Medicine Communications; www.drkoop.com Tias Source: Integrative Medicine Communications; www.drkoop.com Transient Ischemic Attacks Source: Integrative Medicine Communications; www.drkoop.com Varicella and Herpes Zoster Viruses Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 135
Warts Source: Integrative Medicine Communications; www.drkoop.com Yeast Infection Source: Integrative Medicine Communications; www.drkoop.com ·
Alternative Therapy Acupuncture Source: Healthnotes, Inc.; www.healthnotes.com Aromatherapy Source: Integrative Medicine Communications; www.drkoop.com Ayurveda Source: Integrative Medicine Communications; www.drkoop.com Ayurveda Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,672,00.html Biofeedback Source: Integrative Medicine Communications; www.drkoop.com Biofeedback Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,675,00.html Chiropractic Source: Healthnotes, Inc.; www.healthnotes.com Colon Therapy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,682,00.html Feldenkrais Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,695,00.html Guided Imagery Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,699,00.html Homeopathy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,703,00.html
136 High Blood Pressure
Hydrotherapy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,705,00.html Hypnotherapy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,706,00.html Iridology Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,709,00.html Meditation Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,717,00.html Naturopathy Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,722,00.html Osteopathy Source: Integrative Medicine Communications; www.drkoop.com Prayer Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,728,00.html Qigong Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,729,00.html Relaxation Techniques Source: Integrative Medicine Communications; www.drkoop.com Tai Chi Source: Integrative Medicine Communications; www.drkoop.com Tai Chi Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,737,00.html Traditional Chinese Medicine Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 137
Yoga Source: Integrative Medicine Communications; www.drkoop.com Yoga Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,746,00.html ·
Homeopathy Argentum Nitricum Source: Healthnotes, Inc.; www.healthnotes.com Aurum Metallicum Source: Healthnotes, Inc.; www.healthnotes.com Belladonna Source: Healthnotes, Inc.; www.healthnotes.com Calcarea Carbonica Source: Healthnotes, Inc.; www.healthnotes.com Glonoinum Source: Healthnotes, Inc.; www.healthnotes.com Lachesis Source: Healthnotes, Inc.; www.healthnotes.com Natrum Muriaticum Source: Healthnotes, Inc.; www.healthnotes.com Nux Vomica Source: Healthnotes, Inc.; www.healthnotes.com Phosphorus Source: Healthnotes, Inc.; www.healthnotes.com Plumbum Source: Healthnotes, Inc.; www.healthnotes.com Sanguinaria Source: Healthnotes, Inc.; www.healthnotes.com
·
Herbs and Supplements 5-htp Source: Integrative Medicine Communications; www.drkoop.com 5-hydroxytryptophan (5-htp) Source: Integrative Medicine Communications; www.drkoop.com
138 High Blood Pressure
Acanthopanax Senticosus Source: Integrative Medicine Communications; www.drkoop.com Acebutolol Source: Healthnotes, Inc.; www.healthnotes.com Achillea Millefolium Source: Integrative Medicine Communications; www.drkoop.com Ala Source: Integrative Medicine Communications; www.drkoop.com Alpha2-adrenergic Agonists Source: Integrative Medicine Communications; www.drkoop.com Alpha-linolenic Acid (ala) Source: Integrative Medicine Communications; www.drkoop.com American Ginseng Alternative names: Panax quinquefolium Source: Integrative Medicine Communications; www.drkoop.com Amiloride Source: Healthnotes, Inc.; www.healthnotes.com Amino Acids Overview Source: Healthnotes, Inc.; www.healthnotes.com Aminoglycosides Source: Integrative Medicine Communications; www.drkoop.com Amlodipine Source: Healthnotes, Inc.; www.healthnotes.com Angelica Sinensis Source: Integrative Medicine Communications; www.drkoop.com Angiotensin Ii Receptor Blockers Source: Healthnotes, Inc.; www.healthnotes.com Antioxidants Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10004,00.html Apium Graveolens Source: Integrative Medicine Communications; www.drkoop.com Arctostaphylos Uva Ursi Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 139
Arginine Source: Healthnotes, Inc.; www.healthnotes.com Arginine Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10005,00.html Asian Ginseng Alternative names: Panax ginseng Source: Healthnotes, Inc.; www.healthnotes.com Asian Ginseng Alternative names: Panax ginseng Source: Integrative Medicine Communications; www.drkoop.com Astragalus Source: Prima Communications, Inc.www.personalhealthzone.com Baking Soda Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,835,00.html Bearberry Source: Integrative Medicine Communications; www.drkoop.com Beargrape Source: Integrative Medicine Communications; www.drkoop.com Benazepril Source: Healthnotes, Inc.; www.healthnotes.com Beta-adrenergic Blockers Source: Healthnotes, Inc.; www.healthnotes.com Beta-blockers Source: Integrative Medicine Communications; www.drkoop.com Beta-carotene Source: Prima Communications, Inc.www.personalhealthzone.com Betaxolol Source: Healthnotes, Inc.; www.healthnotes.com Black Cohosh Source: Prima Communications, Inc.www.personalhealthzone.com Blue Cohosh Alternative names: Caulophyllum thalictroides Source: Healthnotes, Inc.; www.healthnotes.com
140 High Blood Pressure
Brahmi Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Butcher's Broom Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10010,00.html Calciferol Alternative names: Vitamin D Source: Integrative Medicine Communications; www.drkoop.com Calcitrol Alternative names: Vitamin D Source: Integrative Medicine Communications; www.drkoop.com Candesartan Source: Healthnotes, Inc.; www.healthnotes.com Captopril Source: Healthnotes, Inc.; www.healthnotes.com Cardiac Glycosides Source: Integrative Medicine Communications; www.drkoop.com Carvedilol Source: Healthnotes, Inc.; www.healthnotes.com Celery Seed Alternative names: Apium graveolens Source: Integrative Medicine Communications; www.drkoop.com Centella Source: Integrative Medicine Communications; www.drkoop.com Centella Asiatica Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Chinese Angelica Source: Integrative Medicine Communications; www.drkoop.com Chitosan Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10016,00.html
Alternative Medicine 141
Cholecalciferol Alternative names: Vitamin D Source: Integrative Medicine Communications; www.drkoop.com Coenzyme Q Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,768,00.html Coenzyme Q10 Source: Healthnotes, Inc.; www.healthnotes.com Coenzyme Q10 Alternative names: CoQ10 Source: Integrative Medicine Communications; www.drkoop.com Coenzyme Q10 (coq10) Source: Prima Communications, Inc.www.personalhealthzone.com Coleus Forskohlii Source: Prima Communications, Inc.www.personalhealthzone.com Coq10 Alternative names: Coenzyme Q10 Source: Integrative Medicine Communications; www.drkoop.com Cyclosporine Source: Healthnotes, Inc.; www.healthnotes.com Cysteine Source: Integrative Medicine Communications; www.drkoop.com Dandelion Alternative names: Taraxacum officinale Source: Integrative Medicine Communications; www.drkoop.com Danggui Alternative names: Angelica sinensis, Chinese Angelica, Dang Gui, Danngui, Dong Qua, Tang Kuei, Tan Kue Bai zhi(Note: Dong quai should not be confused with Angelica root or Angelica seed.) Source: Integrative Medicine Communications; www.drkoop.com Dehydroepiandrosterone (dhea) Source: Healthnotes, Inc.; www.healthnotes.com Dehydroepiandrosterone (dhea) Source: Integrative Medicine Communications; www.drkoop.com Dhea Source: Integrative Medicine Communications; www.drkoop.com
142 High Blood Pressure
Diltiazem Source: Healthnotes, Inc.; www.healthnotes.com Diuretics Source: Healthnotes, Inc.; www.healthnotes.com Dong Quai Alternative names: Angelica sinensis Source: Healthnotes, Inc.; www.healthnotes.com Dong Quai Alternative names: Angelica sinensis, Chinese Angelica, Dang Gui, Danngui, Dong Qua, Tang Kuei, Tan Kue Bai zhi(Note: Dong quai should not be confused with Angelica root or Angelica seed.) Source: Integrative Medicine Communications; www.drkoop.com Dong Quai (angelica) Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,774,00.html Eicosapentaenoic Acid (epa) Source: Integrative Medicine Communications; www.drkoop.com Eleuthero Source: Healthnotes, Inc.; www.healthnotes.com Eleuthero Source: Integrative Medicine Communications; www.drkoop.com Eleutherococcus Senticosus Source: Integrative Medicine Communications; www.drkoop.com Enalapril Source: Healthnotes, Inc.; www.healthnotes.com Epa Source: Integrative Medicine Communications; www.drkoop.com Ephedra Source: Healthnotes, Inc.; www.healthnotes.com Ephedra Alternative names: Ephedra sinensis, Ma huang Source: Integrative Medicine Communications; www.drkoop.com Ephedra Source: Prima Communications, Inc.www.personalhealthzone.com Ephedra (ma Huang) Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com
Alternative Medicine 143
Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,777,00.html Ephedra Sinensis Source: Integrative Medicine Communications; www.drkoop.com Erocalciferol Alternative names: Vitamin D Source: Integrative Medicine Communications; www.drkoop.com Felodipine Source: Healthnotes, Inc.; www.healthnotes.com Fiber Source: Healthnotes, Inc.; www.healthnotes.com Fibric Acid Derivatives Source: Integrative Medicine Communications; www.drkoop.com Forskolin Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10025,00.html Ginkgo Biloba Source: Integrative Medicine Communications; www.drkoop.com Ginseng (panax) Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10029,00.html Glucosamine Source: Healthnotes, Inc.; www.healthnotes.com Glutathione Source: Healthnotes, Inc.; www.healthnotes.com Glycyrrhiza Glabra Alternative names: Licorice Source: Integrative Medicine Communications; www.drkoop.com Glycyrrhiza1 Alternative names: Licorice; Glycyrrhiza glabra L. Source: Alternative Medicine Foundation, Inc.; www.amfoundation.org Goldenseal Alternative names: Hydrastis canadensis Source: Integrative Medicine Communications; www.drkoop.com Goldenseal Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com
144 High Blood Pressure
Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,791,00.html Gotu Kola Alternative names: Centella asiatica Source: Healthnotes, Inc.; www.healthnotes.com Gotu Kola Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Guanfacine Source: Healthnotes, Inc.; www.healthnotes.com Hawthorn Alternative names: Crataegus laevigata, Crataegus oxyacantha, Crataegus monogyna Source: Healthnotes, Inc.; www.healthnotes.com Hawthorn Source: Prima Communications, Inc.www.personalhealthzone.com Hawthorn Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10035,00.html Huperzine a Source: Prima Communications, Inc.www.personalhealthzone.com Huperzine a Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10038,00.html Hydrastis Canadensis Source: Integrative Medicine Communications; www.drkoop.com Hydrocotyle Source: Integrative Medicine Communications; www.drkoop.com Hypericum Perforatum Alternative names: St. John's Wort Source: Integrative Medicine Communications; www.drkoop.com Indapamide Source: Healthnotes, Inc.; www.healthnotes.com Indian Pennywort Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 145
Irbesartan Source: Healthnotes, Inc.; www.healthnotes.com Ispaghula Source: Integrative Medicine Communications; www.drkoop.com Kava Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,798,00.html Klamathweed Alternative names: St. John's Wort Source: Integrative Medicine Communications; www.drkoop.com Kudzu Alternative names: Pueraria lobata Source: Healthnotes, Inc.; www.healthnotes.com Kudzu Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,858,00.html Labetalol Source: Healthnotes, Inc.; www.healthnotes.com Licorice Alternative names: Glycyrrhiza glabra Source: Integrative Medicine Communications; www.drkoop.com Licorice Source: Prima Communications, Inc.www.personalhealthzone.com Licorice Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,801,00.html Lisinopril Source: Healthnotes, Inc.; www.healthnotes.com Lobelia Source: The Canadian Internet Directory for Holistic Help, WellNet, Health and Wellness Network; www.wellnet.ca Loop Diuretics Source: Integrative Medicine Communications; www.drkoop.com Losartan Source: Healthnotes, Inc.; www.healthnotes.com
146 High Blood Pressure
Ma Huang Source: Integrative Medicine Communications; www.drkoop.com Maidenhair Tree Source: Integrative Medicine Communications; www.drkoop.com Maitake Source: Prima Communications, Inc.www.personalhealthzone.com Marsh Pennywort Alternative names: Centella asiatica , Centella, March Pennywort, Indian Pennywort, Hydrocotyle, Brahmi (Sanskrit), Luei Gong Gen (Chinese)(Note: Gotu kola should not be confused with kola nut.) Source: Integrative Medicine Communications; www.drkoop.com Melatonin Source: Integrative Medicine Communications; www.drkoop.com Melatonin Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,804,00.html Methyldopa Source: Healthnotes, Inc.; www.healthnotes.com Miscellaneous Preparations Source: Integrative Medicine Communications; www.drkoop.com Mistletoe Alternative names: Viscum album Source: Healthnotes, Inc.; www.healthnotes.com Mistletoe Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10109,00.html Mixed Amphetamines Source: Healthnotes, Inc.; www.healthnotes.com Moexipril Source: Healthnotes, Inc.; www.healthnotes.com Nadolol Source: Healthnotes, Inc.; www.healthnotes.com Naringin Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10089,00.html
Alternative Medicine 147
Nifedipine Source: Healthnotes, Inc.; www.healthnotes.com Olive Leaf Alternative names: Olea europa Source: Healthnotes, Inc.; www.healthnotes.com Panax Ginseng Source: Integrative Medicine Communications; www.drkoop.com Panax Quinquefolium Source: Integrative Medicine Communications; www.drkoop.com Phenothiazine Derivatives Source: Integrative Medicine Communications; www.drkoop.com Phosphorus Source: Integrative Medicine Communications; www.drkoop.com Plantago Isphagula Source: Integrative Medicine Communications; www.drkoop.com Psyllium Alternative names: Plantago ovata, Plantago ispaghula Source: Healthnotes, Inc.; www.healthnotes.com Psyllium Alternative names: Ispaghula,Plantago isphagula Source: Integrative Medicine Communications; www.drkoop.com Quinapril Source: Healthnotes, Inc.; www.healthnotes.com Ramipril Source: Healthnotes, Inc.; www.healthnotes.com Reishi Alternative names: Ganoderma lucidum Source: Healthnotes, Inc.; www.healthnotes.com Ribes Alternative names: Black Currant; Ribes nigrum L. Source: Alternative Medicine Foundation, Inc.; www.amfoundation.org Siberian Ginseng Alternative names: Eleutherococcus senticosus, Acanthopanax senticosus, Eleuthero Source: Integrative Medicine Communications; www.drkoop.com Siberian Ginseng Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com
148 High Blood Pressure
Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,821,00.html Spanish Licorice Alternative names: Licorice Source: Integrative Medicine Communications; www.drkoop.com St. John's Wort Alternative names: Hypericum perforatum Source: Integrative Medicine Communications; www.drkoop.com Sulfonylureas Source: Integrative Medicine Communications; www.drkoop.com Tang Kuei Source: Integrative Medicine Communications; www.drkoop.com Taraxacum Officinale Source: Integrative Medicine Communications; www.drkoop.com Taurine Source: Healthnotes, Inc.; www.healthnotes.com Taurine Source: Prima Communications, Inc.www.personalhealthzone.com Taurine Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,10059,00.html Thiazide Diuretics Source: Healthnotes, Inc.; www.healthnotes.com Thiazide Diuretics Source: Integrative Medicine Communications; www.drkoop.com Thioxanthene Derivatives Source: Integrative Medicine Communications; www.drkoop.com Triamterene Source: Healthnotes, Inc.; www.healthnotes.com Tricyclic Antidepressants (tcas) Source: Integrative Medicine Communications; www.drkoop.com Triotann-s Pediatric Source: Healthnotes, Inc.; www.healthnotes.com Tyrosine Source: Integrative Medicine Communications; www.drkoop.com
Alternative Medicine 149
Uncaria Asian Alternative names: Asian species; Uncaria sp. Source: Alternative Medicine Foundation, Inc.; www.amfoundation.org Uva Ursi Alternative names: Arctostaphylos uva-ursi Source: Healthnotes, Inc.; www.healthnotes.com Uva Ursi Alternative names: Arctostaphylos uva ursi, Bearberry, Beargrape Source: Integrative Medicine Communications; www.drkoop.com Valsartan Source: Healthnotes, Inc.; www.healthnotes.com Vasodilators Source: Integrative Medicine Communications; www.drkoop.com Verapamil Source: Healthnotes, Inc.; www.healthnotes.com Yarrow Alternative names: Achillea millefolium, Milfoil Source: Integrative Medicine Communications; www.drkoop.com Yohimbe Alternative names: Pausinystalia yohimbe Source: Healthnotes, Inc.; www.healthnotes.com Yohimbe Source: Prima Communications, Inc.www.personalhealthzone.com Yohimbe Source: WholeHealthMD.com, LLC.; www.wholehealthmd.com Hyperlink: http://www.wholehealthmd.com/refshelf/substances_view/0,1525,830,00.html
General References A good place to find general background information on CAM is the National Library of Medicine. It has prepared within the MEDLINEplus system an information topic page dedicated to complementary and alternative medicine. To access this page, go to the MEDLINEplus site at http://www.nlm.nih.gov/medlineplus/alternativemedicine.html. This Web site provides a general overview of various topics and can lead to a number of general sources.
151
CHAPTER 4. DISSERTATIONS ON HIGH BLOOD PRESSURE Overview In this chapter, we will give you a bibliography on recent dissertations relating to high blood pressure. We will also provide you with information on how to use the Internet to stay current on dissertations. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical dissertations that use the generic term “high blood pressure” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on high blood pressure, we have not necessarily excluded non-medical dissertations in this bibliography.
Dissertations on High Blood Pressure ProQuest Digital Dissertations, the largest archive of academic dissertations available, is located at the following Web address: http://wwwlib.umi.com/dissertations. From this archive, we have compiled the following list covering dissertations devoted to high blood pressure. You will see that the information provided includes the dissertation’s title, its author, and the institution with which the author is associated. The following covers recent dissertations found when using this search procedure: ·
A Biosocial Study of High Blood Pressure among Underground Mineworkers in a South African Gold Mine by Molapo, Matsheliso Palesa; Phd from Emory University, 2001, 331 pages http://wwwlib.umi.com/dissertations/fullcit/3018820
·
A High Blood Pressure Education Program for Sixth Graders: Impact on Parents by Walker, Peter, Edd from University of Virginia, 1980, 207 pages http://wwwlib.umi.com/dissertations/fullcit/8102615
·
Implication of Cyclic Amp in the Physiopathology of Labile High Blood Pressure by Hamet, Pavel; Phd from Mcgill University (canada), 1972 http://wwwlib.umi.com/dissertations/fullcit/NK11836
·
Medicinal Plant Use and High Blood Pressure on St. Kitts, West Indies. by Stevenson, David Richter, Phd from The Ohio State University, 1979, 143 pages http://wwwlib.umi.com/dissertations/fullcit/7922566
152 High Blood Pressure
·
The Effects of a Selected Health Education Intervention upon the Compliance Behavior of Individuals Diagnosed As Having High Blood Pressure by Kardas, Edward Joseph, Phd from The Ohio State University, 1987, 137 pages http://wwwlib.umi.com/dissertations/fullcit/8717658
·
The Effects of Expressive Writing on Blood Pressure, Psychosocial Adjustment, and Heart Rate Variability in High Normal to Moderate High Blood Pressure by Beckwith, Kimberly Michelle; Phd from Alliant International University, San Diego, 2003, 164 pages http://wwwlib.umi.com/dissertations/fullcit/3080395
Keeping Current Ask the medical librarian at your library if it has full and unlimited access to the ProQuest Digital Dissertations database. From the library, you should be able to do more complete searches via http://wwwlib.umi.com/dissertations.
153
CHAPTER 5. CLINICAL TRIALS AND HIGH BLOOD PRESSURE Overview In this chapter, we will show you how to keep informed of the latest clinical trials concerning high blood pressure.
Recent Trials on High Blood Pressure The following is a list of recent trials dedicated to high blood pressure.8 Further information on a trial is available at the Web site indicated. ·
A Study to Prevent Complications of High Blood Pressure Caused by Hepatitis in Patients with Cirrhosis Condition(s): Hypertension, Portal; Liver Cirrhosis; Esophageal and Gastric Varices Study Status: This study is no longer recruiting patients. Sponsor(s): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Yale University Purpose - Excerpt: Objectives: I. Evaluate the efficacy of a certain drug in preventing intestinal complications in patients with cirrhosis and high blood pressure in the hepatic portal vein. II. Evaluate vein pressure measurements to predict the development of internal bleeding. Phase(s): Phase II Study Type: Interventional Contact(s): see Web site below Web Site: http://clinicaltrials.gov/ct/show/NCT00004641
8
These are listed at www.ClinicalTrials.gov.
154 High Blood Pressure
·
Effects of Rosiglitazone on Blood Vessels in Patients with High Blood Pressure and High Cholesterol Condition(s): Hypercholestrolemia; Hypertension Study Status: This study is completed. Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) Purpose - Excerpt: Cells in the lining of blood vessels produce various substances that cause the vessels to dilate (relax) and constrict (tighten), thereby regulating blood flow. In patients with high blood pressure and high cholesterol, the blood vessels do not dilate properly. This study will investigate the effects of rosiglitazone-a drug used to improve the action of insulin in diabetic patients-on blood flow by examining its effects on endothelin (a substance that causes vessel constriction), and other substances produced by the vessel-lining cells. Adults with blood pressure recordings of 140/90 mmHg or higher on at least three separate days or with a blood cholesterol level of at least 240 mg/dl may be eligible for this study. Candidates will be screened with a medical history and physical examination, blood pressure recordings, blood and urine tests. This "crossover" study involves two separate treatment periods; that is, participants will take either rosiglitazone or placebo (an inactive look-alike pill) once a day for 8 weeks, then no drug for 4 weeks, and then the alternative treatment for the next 8 weeks. Patients will continue to take their high blood pressure medicines during the first 6 weeks of each treatment period. They will stop the medication 2 weeks before the following procedures, which are done at the end of each 8-week treatment period: Strain gauge plethysmography-A small catheter is placed through a needle into an artery at the bend of the arm for measuring blood pressure and drawing blood samples during the study. Pressure cuffs are placed on the wrist and upper arm, and a strain gauge (a rubber band device) is placed around the forearm to measure forearm blood flow. When the cuffs are inflated, blood flows into the arm, stretching the strain gauge at a rate proportional to the flow, and the measurement is recorded. Small doses of four drugs-acetylcholine, bradykinin, sodium nitroprusside and BQ-123-are given through the catheter. Acetylcholine slows the heart rate. Bradykinin stimulates the release of a substance that causes blood vessels to dilate and can lower blood pressure. Sodium nitroprusside causes blood vessels to dilate and is used to treat high blood pressure and heart failure. BQ-123 blocks the blood vessel-constricting activity of endothelin. Brachial ultrasound reactivity study-A baseline ultrasound image (picture produced using sound waves) of the brachial artery (artery located at the bend of the arm) is taken and blood flow measurements are recorded. Then, a pressure cuff is placed around the upper forearm, inflated for 5 minutes to stop blood flow to the forearm, and then released. Images of the artery and flow measurements are repeated. After a 15-minute rest, new baseline images are taken and flow measurements obtained. A small amount of nitroglycerin is then sprayed under the tongue and after 3 minutes, blood flow measurements and brachial artery images are recorded once more. Study Type: Observational Contact(s): see Web site below Web Site: http://clinicaltrials.gov/ct/show/NCT00006071
·
Effects of Salt Intake on the Nervous Systems of Patients with Salt-Sensitive High Blood Pressure Condition(s): Hyperaldosteronism; Hypertension Study Status: This study is completed.
Clinical Trials 155
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) Purpose - Excerpt: Some patients with high blood pressure can experience an increase of blood pressure by 10 percent or more by taking in salt. These patients are referred to as having "salt-sensitive" (SS) hypertension. Previous studies conducted on patients with salt sensitive hypertension suggest that their portion of the nervous system responsible for maintaining normal blood pressure (autonomic nervous system) may respond differently to salt than patients with non-salt sensitive (NSS) hypertension. This study is designed to examine the response of the nervous system to high doses of salt in patients with salt-sensitive hypertension and patients with non-salt sensitive hypertension. Study Type: Observational Contact(s): see Web site below Web Site: http://clinicaltrials.gov/ct/show/NCT00001176
Keeping Current on Clinical Trials The U.S. National Institutes of Health, through the National Library of Medicine, has developed ClinicalTrials.gov to provide current information about clinical research across the broadest number of diseases and conditions. The site was launched in February 2000 and currently contains approximately 5,700 clinical studies in over 59,000 locations worldwide, with most studies being conducted in the United States. ClinicalTrials.gov receives about 2 million hits per month and hosts approximately 5,400 visitors daily. To access this database, simply go to the Web site at http://www.clinicaltrials.gov/ and search by “high blood pressure” (or synonyms). While ClinicalTrials.gov is the most comprehensive listing of NIH-supported clinical trials available, not all trials are in the database. The database is updated regularly, so clinical trials are continually being added. The following is a list of specialty databases affiliated with the National Institutes of Health that offer additional information on trials: ·
For clinical studies at the Warren Grant Magnuson Clinical Center located in Bethesda, Maryland, visit their Web site: http://clinicalstudies.info.nih.gov/
·
For clinical studies conducted at the Bayview Campus in Baltimore, Maryland, visit their Web site: http://www.jhbmc.jhu.edu/studies/index.html
·
For cancer trials, visit the National Cancer Institute: http://cancertrials.nci.nih.gov/
·
For eye-related trials, visit and search the Web page of the National Eye Institute: http://www.nei.nih.gov/neitrials/index.htm
·
For heart, lung and blood trials, visit the Web page of the National Heart, Lung and Blood Institute: http://www.nhlbi.nih.gov/studies/index.htm
·
For trials on aging, visit and search the Web site of the National Institute on Aging: http://www.grc.nia.nih.gov/studies/index.htm
·
For rare diseases, visit and search the Web site sponsored by the Office of Rare Diseases: http://ord.aspensys.com/asp/resources/rsch_trials.asp
·
For alcoholism, visit the National Institute on Alcohol Abuse and Alcoholism: http://www.niaaa.nih.gov/intramural/Web_dicbr_hp/particip.htm
156 High Blood Pressure
·
For trials on infectious, immune, and allergic diseases, visit the site of the National Institute of Allergy and Infectious Diseases: http://www.niaid.nih.gov/clintrials/
·
For trials on arthritis, musculoskeletal and skin diseases, visit newly revised site of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health: http://www.niams.nih.gov/hi/studies/index.htm
·
For hearing-related trials, visit the National Institute on Deafness and Other Communication Disorders: http://www.nidcd.nih.gov/health/clinical/index.htm
·
For trials on diseases of the digestive system and kidneys, and diabetes, visit the National Institute of Diabetes and Digestive and Kidney Diseases: http://www.niddk.nih.gov/patient/patient.htm
·
For drug abuse trials, visit and search the Web site sponsored by the National Institute on Drug Abuse: http://www.nida.nih.gov/CTN/Index.htm
·
For trials on mental disorders, visit and search the Web site of the National Institute of Mental Health: http://www.nimh.nih.gov/studies/index.cfm
·
For trials on neurological disorders and stroke, visit and search the Web site sponsored by the National Institute of Neurological Disorders and Stroke of the NIH: http://www.ninds.nih.gov/funding/funding_opportunities.htm#Clinical_Trials
157
CHAPTER 6. PATENTS ON HIGH BLOOD PRESSURE Overview Patents can be physical innovations (e.g. chemicals, pharmaceuticals, medical equipment) or processes (e.g. treatments or diagnostic procedures). The United States Patent and Trademark Office defines a patent as a grant of a property right to the inventor, issued by the Patent and Trademark Office.9 Patents, therefore, are intellectual property. For the United States, the term of a new patent is 20 years from the date when the patent application was filed. If the inventor wishes to receive economic benefits, it is likely that the invention will become commercially available within 20 years of the initial filing. It is important to understand, therefore, that an inventor’s patent does not indicate that a product or service is or will be commercially available. The patent implies only that the inventor has “the right to exclude others from making, using, offering for sale, or selling” the invention in the United States. While this relates to U.S. patents, similar rules govern foreign patents. In this chapter, we show you how to locate information on patents and their inventors. If you find a patent that is particularly interesting to you, contact the inventor or the assignee for further information. IMPORTANT NOTE: When following the search strategy described below, you may discover non-medical patents that use the generic term “high blood pressure” (or a synonym) in their titles. To accurately reflect the results that you might find while conducting research on high blood pressure, we have not necessarily excluded non-medical patents in this bibliography.
Patents on High Blood Pressure By performing a patent search focusing on high blood pressure, you can obtain information such as the title of the invention, the names of the inventor(s), the assignee(s) or the company that owns or controls the patent, a short abstract that summarizes the patent, and a few excerpts from the description of the patent. The abstract of a patent tends to be more technical in nature, while the description is often written for the public. Full patent descriptions contain much more information than is presented here (e.g. claims, references, figures, diagrams, etc.). We will tell you how to obtain this information later in the chapter. 9Adapted
from the United States Patent and Trademark Office: http://www.uspto.gov/web/offices/pac/doc/general/whatis.htm.
158 High Blood Pressure
The following is an example of the type of information that you can expect to obtain from a patent search on high blood pressure: ·
2,2'-bi-1H-imidazoles Inventor(s): Whitten; Jeffrey P. (Cincinnati, OH), McCarthy; James R. (West Chester, OH), Matthews; Donald P. (West Chester, OH) Assignee(s): Merrell Dow Pharmaceuticals Inc. (Cincinnati, OH) Patent Number: 5,147,863 Date filed: October 17, 1990 Abstract: This invention relates to novel derivatives of 2,2'-bi-1H-imidazoles, to the processes and intermediates used in their preparation, to their ability to exert the pharmacologic effects of lowering high blood pressure and of increasing heart contractile force and to their use as chemotherpauetic agents useful in treating cardiac insufficiency and hypertension. Excerpt(s): This invention relates to 2,2'-bi-1H-imidazoles and to the processes for their preparation and their use as chemotherapeutic agents. More specifically, this invention relates to novel derivatives of 2,2'-bi-1H-imidazoles, to the processes and intermediates used in their preparation, to their ability to exert the pharmacologic effects of lowering high blood pressure and of increasing heart contractile force and to their use as chemotherapeutic agents useful in treating cardiac insufficiency and hypertension. B is hydrogen or methyl, ethyl, vinyl, phenyl or benzyl with the proviso that at least one of A or B is hydrogen. Web site: http://www.delphion.com/details?pn=US05147863__
·
Benzonaphthyridine Inventor(s): Hatzelmann; Armin (Constance, DE), Flockerzi; Dieter (Allensbach, DE) Assignee(s): Byk Gulden Lomberg Chemische Fabrik GmbH (Constance, DE) Patent Number: 6,384,047 Date filed: December 3, 1999 Abstract: Compounds 8,9-diethoxy-2-methyl-6-[4(p-toluenesulfonamide) phenyl]1,2,3,4,4a,10b-hexahydrobenzo[c][1,6]naphthyridine and 9-ethoxy-8-methoxy-2-methyl6-[4-(p-toluenesulfonamido)phenyl]-1,2,3,4,4a, 10bhexahydrobenzo[c][1,6]naphthyridine and medicament compositions based thereon are useful for treating airway disorders, high blood pressure disorders and concomitant disorders connected therewith. Excerpt(s): The invention relates to novel benzonaphthyridines, a process for their preparation, their use and medicaments containing them. The compounds according to the invention are used in the pharmaceutical industry for the preparation of medicaments. and the salts of these compounds. The compounds of the formula I are chiral compounds having chiral centers in positions 4a and 10b. The Invention therefore both comprises all conceivable pure diastereomers and pure enantiomers, and their mixtures in any mixing ratio, including the racemates. Preferred compounds of the formula I are those in which the hydrogen atoms in the positions 4a and 10b are cis to one another.
Patents 159
Web site: http://www.delphion.com/details?pn=US06384047__ ·
Extract from flowers of Salvia officinalis, process of its preparation and use thereof Inventor(s): Reinhard; Max (Bad Homburg, DE) Assignee(s): Heilmittebetrieb Isernhagen GmbH (Isernhagen, DE) Patent Number: 5,660,831 Date filed: July 24, 1995 Abstract: A method is described for obtaining an extract from the flowers of Salvia officinalis. The extraction process is performed preferably at a temperature of less than 50.degree. C. A preferred extraction agent is supercritical CO.sub.2. The extract thus obtained can be processed, if desired, with the addition of suitable thinners or fillers, in order to obtain a medicament. Medicaments containing the extract of Salvia officinalis flowers can be used to control high blood-pressure, circulatory problems and incomplete cicatrization of wounds. Excerpt(s): The invention relates to an extract of flowers of Salvia officinalis (sage) and a method of producing same. Furthermore, the invention relates to a medicament having a content of extract from flowers of Salvia officinalis and the use thereof in combating circulatory disorders and high blood pressure as well as in improving the healing of wounds. High blood pressure and related cardiovascular diseases, which are not seldomly fatal, represent one of the major problems in medicine. Circulatory disorders are also often associated with serious complications. The problem of inadequate healing of wounds exists particularly with elderly people, so that wounds fail to heal in many cases even after a lengthy period. Although intensive efforts have been made to develop synthetic drugs or natural remedies which are effective in the case of the aforementioned indications, there is ultimately still a continuous need for new medicaments, last but not least due to the side-effects which occur repeatedly. Web site: http://www.delphion.com/details?pn=US05660831__
·
High blood pressure relief method and compositions Inventor(s): Vanmoor; Arthur (153 E. Palmetto Park Rd. #219, Boca Raton, FL 33432) Assignee(s): none reported Patent Number: 5,708,029 Date filed: November 13, 1995 Abstract: Disclosed is the method of determining the effectiveness of an agent for the relief of elevation of the blood pressure, comprising the steps ofa) administering to a susceptible subject a quantity of a trigger substance reproducibly effective in producing within a period of six hours a perceptible increase in blood pressure lasting for at least twenty-four hours in the absence of treatment,b) administering to said subject having received said quantity of trigger substance a predetermined quantity of the agent whose effectiveness is to be determined,c) measuring the duration of said elevation of blood pressure upon administering said agent, andd) comparing the duration of said elevation with and without the administration of said agent.Also disclosed are effective quantities of certain nutrient substances which can reproducibly relieve elevated blood pressure produced in a susceptible subject by the administration of a trigger substance.
160 High Blood Pressure
Excerpt(s): This invention relates to the relief of elevated blood pressure, also known as hypertension. More particularly, this invention relates to the relief of arterial hypertension defined as elevation of systolic and/or diastolic blood pressure, either primary (essential hypertension) or secondary (see Merck Manual, 16th edition, 1992, pages 413-429). As stated in this reference work, "primary or essential hypertension is of unknown etiology, and it seems improbable that a single cause will explain its diverse hemodynamic and pathophysiologic derangements. Heredity undoubtedly predisposes individuals to hypertension, but the exact mechanism is unclear." It has been estimated that there are more than 50 million hypertensives in the United States, that is persons with systolic blood pressure of 140 millimeters of mercury or more and/or diastolic blood pressure of 90 mm or more, or taking antihypertensive medication. Primary hypertension is asymptomatic until complications develop. Symptoms and signs are non-specific and arise from complications in target organs. Complications include left ventricular failure; atherosclerotic heart disease; retinal hemorrhages, exudates, papilledema, and vascular accidents; cerebrovascular insufficiency with or without stroke, and renal failure. As to treatment, the same reference states that "there is no cure for primary hypertension, but therapy can modify its course." In cases of mild hypertension, non-drug therapies such as weight reduction to ideal levels, modest dietary sodium restriction to less than 2000 milligrams per day, limitation of alcohol intake to less than one ounce of ethanol per day and prudent exercise can make drug therapy unnecessary. However, it is recommended that "when complications are present or impending, or when the diastolic blood pressure is greater than 95 mm, drug therapy should not be deferred while awaiting the uncertain results of dietary therapy." The goal of drug therapy is stated to be reducing the blood pressure to normal, ie 140/90 or less. Web site: http://www.delphion.com/details?pn=US05708029__ ·
Medicaments containing doxazosin mesylate of crystalline modification D Inventor(s): Einig; Heinz (Neustadt, DE), Thyes; Marco (Ludwigshafen, DE), Klein; Peter (Birkenheide, DE), Hix; Dieter (Grosskarlbach, DE) Assignee(s): Chemische Fabrik Berg GmbH (Bitterfeld, DE) Patent Number: 6,476,033 Date filed: September 18, 2001 Abstract: Drugs comprising modification D of doxazosin mesylate are described. They are suitable for treating high blood pressure. Excerpt(s): The present invention relates to a drug comprising doxazosin mesylate in crystal modification D. Doxazosin (=4-amino-2-[4-(1,4-benzodioxan-2carbonyl)piperazin-1yl-]6,7-dimethoxyqui nazoline) is a known substance (Merck Index, 12.sup.th edition 1996, No. 3489) which lowers blood pressure. The substance is mainly used in the form of the monomesylate which, in crystalline form, occurs in several modifications. Thus, three crystal modifications which are referred to as modifications A, B and C are described in the Chinese Journal of Medicinal Chemistry 5(4), 266-270 (1995). Modification A is obtained on recrystallization of doxazosin mesylate from ethanol. Modifications B and C result on recrystallization of doxazosin mesylate from chloroform and water respectively. Mention may be made of the fact that the Chinese Journal of Medicinal Chemistry in fact speaks simply of doxazosin. However, according to the published data, the material must be doxazosin mesylate. Modification A is also the subject of EP-A 0 849 266, where it is referred to as form III. Another modification has been described and characterized in EP-A 0 848 001, but it was not given a special
Patents 161
name. EP-A 0 849 264 describes a form I and EP-A 0 849 265 describes a form II of doxazosin mesylate. Web site: http://www.delphion.com/details?pn=US06476033__ ·
Method to determine predisposition to hypertension Inventor(s): Lalouel; Jean-Marc (Salt Lake City, UT), Rohrwasser; Andreas (Salt Lake City, UT) Assignee(s): University of Utah Research Foundation (Salt Lake City, UT) Patent Number: 6,177,252 Date filed: August 27, 1999 Abstract: The T/C(67) AGT gene variant and the association of the molecular variant C(67) with predisposition of an individual to hypertension are disclosed. The determination of this association enables the screening of persons to identify the severity of hypertension or the severity of the risk of a predisposition to high blood pressure. Excerpt(s): The present invention relates to molecular variants of the angiotensinogen gene. The present invention further relates to the diagnosis of these variants for the determination of a predisposition to hypertension, the determination of the prognosis of the predisposition to hypertension, and the management of hypertension. The publications and other materials used herein to illuminate the background of the invention, or provide additional details respecting the practice, are incorporated by reference herein, and for convenience are respectively grouped in the appended List of References. Hypertension is a leading cause of human cardiovascular morbidity and mortality, with a prevalence rate of 25-30% of the adult Caucasian population of the United States (JNC Report, (1985). The primary determinants of essential hypertension, which represents 95% of the hypertensive population, have not been elucidated in spite of numerous investigations undertaken to clarify the various mechanisms involved in the regulation of blood pressure. Studies of large populations of both twins and adoptive siblings, in providing concordant evidence for strong genetic components in the regulation of blood pressure (Ward (1990)), have suggested that molecular determinants contribute to the pathogenesis of hypertension. Web site: http://www.delphion.com/details?pn=US06177252__
·
NADH and NADPH pharmaceuticals for treating hypertension Inventor(s): Birkmayer; Joerg G. D. (Vienna, AT) Assignee(s): Birkmayer Pharmaceuticals (New York, NY) Patent Number: 5,668,114 Date filed: May 8, 1996 Abstract: A method for lowering high blood pressure includes the step of administering the reduced form of nicotinamide adenine dinucleotide (NADH) or the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or physiologically compatible salts of NADH and/or NADPH. Patients so treated exhibit a significant reduction of their elevated blood pressure over time. The method is effective in treating hypertension and chronic hypertension.
162 High Blood Pressure
Excerpt(s): The invention relates to a pharmaceutical and a method for treating patients with high blood pressure and, more particularly, to the use of reduced forms of nicotinamide adenine dinucleotide (NADH), nicotinamide adenine dinucleotide phosphate (NADPH), and physiologically acceptable salts thereof in the treatment of hypertension. Hypertension, a major public health problem, is defined as the condition of having blood pressure (BP) exceeding an upper limit of normality. The upper limit is generally accepted as a systolic BP>140 mg Hg and/or diastolic BP>90 mg Hg. This perturbation is a major risk factor for cardiovascular diseases (CVD) which account for approximately 50% of mortality beyond age 65. It is generally accepted that a significant elevation of blood pressure can accelerate the aging process in the circulatory system. During aging, many factors involved in regulating blood pressure can go awry. Therefore it is not surprising that systolic and diastolic blood pressure increase progressively with aging, a phenomenon which is called "age-related hypertension." Hypertension is found in 50% or more of individuals above age 55 years, and 63% of those age 65 to 74 years. The rate is 76% among persons of African origin over 65 years old in the United States. This age-related hypertension, particularly of the diastolic blood pressure, is most likely due to the reduced elasticity of the blood vessels or, even worse, stiffness of the blood vessels. This reduced elasticity may be caused by damage of the muscle layer of the blood vessels. This damage can be caused by radicals from chemicals, radiation or other toxins. Due to this, these endothelial muscles cannot function properly contracting and relaxing when blood pressure demand makes that necessary. The consequence is a higher diastolic blood pressure. Web site: http://www.delphion.com/details?pn=US05668114__ ·
Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof Inventor(s): Sandrock; Klaus (Langenfeld, DE), Kanzler; Ralf (Leverkusen, DE), Fritschi; Edgar (Schwalmtal-Luttelforst, DE), Feelisch; Martin (Dusseldorf, DE), Noack; Eike (Neuss, DE) Assignee(s): Schwarz Pharma AG (Monheim, DE) Patent Number: 5,284,872 Date filed: April 5, 1991 Abstract: New organic nitrate compounds, formed by condensing a nitrato alkanoic acid with a sulfur-containing amino acid or peptide followed by the reaction of the resulting product with an amino acid, N-acylamino acid, peptide or an N-acyl peptide to produce a thio ester thereof, which prevent nitrate tolerance or overcome existing tolerance and which are useful for the treatment of cardiac diseases including circulatory diseases, coronary dilation, high blood pressure, cardiac insufficiency and for dilating the peripheral vessels. Excerpt(s): This invention is concerned with new nitrato alkanoic acid derivatives, methods for their manufacture, pharmaceutical compositions containing the derivatives and uses thereof for medicinal purposes. Organic nitrates (nitric acid esters) have proven effective in the therapy of heart diseases. They exert their effectiveness through cardiac support as well as by alleviating the before and after effects of a load on the heart as well as through improvement of the oxygen supply to the heart by dilation of the coronary vessels. It has been found in recent years that the organic nitrates which have been previously used in heart therapy, such as glycerol trinitrate (GTN), isosorbid5-mononitrate or isosorbid dinitrate, because of nitrate tolerance, exhibit a clear drop in
Patents 163
efficacy in a relatively short time when continuous high dosages are administered to a patient. Numerous experiments indicate that the presence of sulfhydryl (--SH) groups prevents the development of nitrate tolerance and that an existing tolerance can be reduced by the presence of sulfhydryl groups. Web site: http://www.delphion.com/details?pn=US05284872__ ·
Panax notoginsenoside composition Inventor(s): Pu; De (Industry, CA), Zeng; Lipin (Industry, CA) Assignee(s): Farlong Pharmaceutical, Inc. (City of Industry, CA) Patent Number: 6,500,468 Date filed: January 3, 2002 Abstract: A panax notoginsenoside composition for patients having coronary heart disease, high blood pressure, high blood fat, and high cholesterol, consists of 41% by weight of panax notoginsenoside powder extracted from panax notoginseng (Burk.) F. H. chen ex C. Chow et al, 0.5% by weight of beeswax, 58.48% by weight of peanut oil, and 0.02% by weight of BHT. Excerpt(s): The present invention relates to panax notoginseng, and more particularly to a panax notoginsenoside composition consisting of panax notoginsenoside extracted from panax notoginseng. According to Chinese (herbal) medicine such as Compendium of Materia Medica, panax notoginsenoside extracted from panax notoginseng can help cerebral blood vessel dilatation, increase cerebral blood flow, reduce the oxygen consumption of organism, increase the orgainism's resistance to oxygen shortage, decrease cerebrovascular resistance, enhance immune function of organism, prevent shock caused by bleeding, and provide functions of resisting thrombus, blood coagulation, and atherosclerosis. The main object of the present invention is to provide a panax notoginsenoside compound for patients having coronary heart disease, high blood pressure, high blood fat, and high cholesterol, which consists of 41% by weight of panax notoginsenoside powder extracted from panax notoginseng (Burk.) F. H. chen ex C. Chow et al, 0.5% by weight of beeswax, 58.48% by weight of peanut oil, and 0.02% by weight of BHT (butylated hydroxytoluene). Web site: http://www.delphion.com/details?pn=US06500468__
·
Pharmaceutical composition for the treatment of high blood pressure Inventor(s): Teetz; Volker (Holheim am Taunus, DE), Urbach; Hansjorg (Kronberg/Taunus, DE), Geiger; Rolf (Frankfurt am Main, DE), Henning; Rainer (Hattersheim am Main, DE), Becker; Reinhard (Wiesbaden, DE) Assignee(s): Hoechst Aktiengesellschaft (Frankfurt am Main, DE) Patent Number: 5,256,687 Date filed: November 19, 1992 Abstract: The invention relates to a pharmaceutical composition comprising an angiotensin converting enzyme inhibitor (trandolpril or pamipril) and a loop diuretic (Furosemide or piretanide), and to their use for the treatment of high blood pressure.
164 High Blood Pressure
Excerpt(s): It is known that the high blood pressure of patients with essential hypertension can be reduced using inhibitors of angiotensin converting enzyme (ACE inhibitors), such as captoprit or enalapril (Therapiewoche 29 [1979] 7746; Lancet 2 [1981] 543-546). However, a certain percentage of patients with essential hypertension do not respond to substances of this type (Drug Devel. Eval. 4 [1980] 82-91). It has been disclosed that the antihypertensive action of enalapril or captopril is potentiated by the addition of diuretically effective amounts of a diuretic of the thiazide type of analogous compounds (Brunner et al., Clin. Exp. Hypertension 2 [1980] 639-657; McGregor et al., Br. Med. J. 284 [1982] 693-696). It is generally assumed that this effect is based on stimulation by the diuretic of the renin-angiotensin system via a loss of salt and volume (P. J. S. Chiu et al., J. Pharm. Pharmacol. 37 [1985] 105). There is a report in Arzneim.Forsch./Drug Res. 34 (II) [1984] 1417-1425 of investigations into the cardiovascular action of 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo[3.3. 0]octane-3-carboxylic acid ("ramiprilate"). This entailed animals being pretreated with furosemide or piretanide for several days for the purpose of sodium depletion. Web site: http://www.delphion.com/details?pn=US05256687__ ·
Preparation for diagnosis of the metabolic syndrome and diseases including the syndrome Inventor(s): Marin; Per (Goteberg, SE) Assignee(s): Cortenda AB (Gothenburg, SE) Patent Number: 6,410,339 Date filed: February 26, 1998 Abstract: The use of cortisol agonist for preparing a system for diagnosis of the Metabolic Syndrome and related conditions as belly fatness, insulin resistance including increased risk of developing senile diabetes, i.e., diabetes type II, high blood fats and high blood pressure, in which system the dose of cortisol agonist is in an interval where a difference is obtained in the inhibitory effect of the autoproduction of cortisol in individuals suffering from the Metabolic Syndrome, compared to normal values. Excerpt(s): The metabolic syndrome is characterized by an increased amount of adipose tissue inside the abdominal cavity (popularly called belly fatness), insulin resistance with increased risk of developing senile diabetes, i.e. diabetes type II (=NIDDM, noninsulin dependent diabetes mellitus), high levels of blood fats and high blood pressure. Parallel to this is an increased risk of coronary, apoplexy, sudden death and other arteriosclerotic conditions. A hypothetical explanation to the metabolic syndrome could be an overproduction of cortisol, a stress hormone which causes an accumulation of fat inside the abdominal cavity, and insulin resistance. Theoretically this could, through secondary metabolic effects, explain the other disorders related to the metabolic syndrome. In Metabolism, vol. 41, No 8, 1992, pages 882-886, it is shown that belly fat women have higher secretion of cortisol than "evenly fat" women. The same work describes the effects of acute mental stress on the production of cortisol. It was shown that belly fat women, at a given stress signal, produced more cortisol than `evenly fat` women. This suggested, but did not prove, that there may be a relationship between stress and belly obesity. A dexamethasone inhibitor test was carried out with 1 mg dexamethasone and subsequent measurement of cortisol content in serum. No difference in inhibitory effect on the production of cortisol could be found between the groups of belly fat women and evenly fat women and standard values.
Patents 165
Web site: http://www.delphion.com/details?pn=US06410339__ ·
Substituted N-biphenylyl lactams Inventor(s): Wachter; Michael P. (Bloomsbury, NJ), Murray; William V. (Belle Mead, NJ) Assignee(s): Ortho Pharmaceutical Corporation (Raritan, NJ) Patent Number: 5,246,940 Date filed: January 21, 1993 Abstract: This invention relates to novel N-biphenylyl lactam compounds having a substituted methylidene or methyl moiety adjacent to the lactam nitrogen, and pharmaceutically acceptable salts thereof.The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction or diabetic nephropathy.The invention also relates to a pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin II which comprises administering to the mammal an effective amount of a compound of the invention, and novel processes for preparing the compounds of the invention. Excerpt(s): The invention also relates to a pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin II which comprises administering to the mammal an effective amount of the angiotensin II receptor antagonist which is a compound of the invention, and novel processes for preparing the compounds of the invention. The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction or diabetic nephropathy. The aforesaid references, however, do not disclose the N-biphenylyl lactams of the present invention. Web site: http://www.delphion.com/details?pn=US05246940__
·
Substituted phenylacetamides Inventor(s): Fey; Peter (Wuppertal, DE), Dressel; Jurgen (Wuppertal, DE), Kazda; Stanislav (Wuppertal, DE), Wohlfeil; Stefan (Hilden, DE), Yalkinoglu; Ozkan (Wuppertal, DE), Knorr; Andreas (Erkrath, DE), Stasch; Johannes-Peter (Wuppertal, DE), Hanko; Rudolf (Duesseldorf, DE), Kramer; Thomas (Wuppertal, DE), Beuck; Martin (Erkrath, DE), Hubsch; Walter (Wuppertal, DE), Muller; Ulrich E. (Wuppertal, DE), Muller-Gliemann; Matthias (Solingen Ohligs, DE) Assignee(s): Bayer Aktiengesellschaft (Leverkusen, DE) Patent Number: 5,352,687 Date filed: March 3, 1993 Abstract: Substituted phenylacetamides can be prepared by reaction of appropriately substituted phenylacetic acids with imidazoles and subsequent amidation. The substituted phenylacetic acid derivatives can be employed in medicaments for the treatment of high blood pressure and atherosclerosis.
166 High Blood Pressure
Excerpt(s): The invention relates to substituted phenylacetamides, processes for their preparation, and their use in medicaments, in particular as hypotensive and antiatherosclerotic agents. It is known that renin, a proteolytic enzyme, cleaves the decapeptide angiotensin I, which is in turn degraded in the lungs, the kidneys or other tissues to the hypertensive octapeptide angiotensin II, from angiotensinogen in vivo. The various effects of angiotensin II, such as, for example, vasoconstriction, Na.sup.+ retention in the kidney, aldosterone release in the adrenal gland and increase in tone of the sympathetic nervous system act synergistically in the sense of an increase in blood pressure. Moreover, angiotensin II has the property of promoting the growth and the replication of cells such as, for example, of heart muscle cells and smooth muscle cells, where these grow at an increased rate and proliferate in various disease states (for example hypertension, atherosclerosis and cardiac insufficiency). Web site: http://www.delphion.com/details?pn=US05352687__ ·
Substituted triazoles as angiotensin II inhibitors Inventor(s): Bandurco; Victor T. (Bridgewater, NJ), Schwender; Charles F. (Califon, NJ), Murray; William V. (Belle Mead, NJ), Wachter; Michael P. (Bloomsbury, NJ) Assignee(s): Ortho Pharmaceutical Corporation (Raritan, NJ) Patent Number: 5,508,419 Date filed: September 9, 1994 Abstract: This invention relates to novel bis-biphenyl substituted 3-mercapto-1,2,4tetrazoles and to pharmaceutically acceptable salts thereof.The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction or diabetic nephropathy.The invention also relates to a pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin II which comprises administering to the mammal an effective amount of a compound of the invention, and novel processes for preparing the compounds of the invention. Excerpt(s): The invention also relates to pharmaceutical compositions comprising a compound of the invention as the active ingredient, a method of treating a physiological condition in mammals that is mediated by angiotensin II by administration of a compound of this invention, to novel processes for preparing the compounds of the invention and to pharmaceutically acceptable salts thereof. The novel compounds are angiotensin II receptor antagonists and are useful in treating hypertension (lowering of high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction and diabetic nephropathy. The role of hypertension in cardiac dysfunction is continually evolving. Therefore, the treatment of hypertension continues to be clinically important. The discovery of new agents with fewer undesirable side effects is a therapeutic target since hypertension must be treated chronically. Long term toxicity as well as long term patient compliance are important considerations in the development of new antihypertensive agents. Web site: http://www.delphion.com/details?pn=US05508419__
Patents 167
·
System and method for evaluating the circulatory system of a living subject Inventor(s): Inukai; Hidekatsu (Nagoya, JP), Sakai, deceased; Hiroshi (late of Komaki, JP) Assignee(s): Colin Corporation (Komaki, JP) Patent Number: 5,921,936 Date filed: June 3, 1997 Abstract: A system that accurately evaluates a living subject's circulatory system, even if the living subject is taking high blood pressure medication includes a time-difference determining device that determines a time difference between predetermined periodic points on a subject's electrocardiographic waveform and predetermined periodic points on corresponding oscillatory pressure-pulse waves of the living subject. A strain application device applies a physical strain to the subject's body for a predetermined period of time so that the subject' blood pressure changes. A blood-pressure measurement device measures the subject's blood pressure while the subject's blood pressure is changing. A circulatory-system evaluation device determines a relationship between changes in the subject's blood pressure and corresponding time differences determined by the time-difference determining. The circulatory-system evaluation device evaluates the subject's circulatory system based on the hysteresis present in the relationship. Excerpt(s): This invention relates to medical diagnostic devices. More specifically, this invention is directed to a system and method for evaluating the circulatory system of a living subject. Some circulatory ailments that cause high blood pressure, such as arteriosclerosis, are discovered by measuring the subject's blood pressure with a blood pressure measurement apparatus. One such blood pressure measurement apparatus is disclosed in Japanese Laid-Open Application No. 6-292660. The blood-pressure measurement device measures the blood pressure of a living subject using a cuff that is wrapped around a portion of the living subject. The cuff applies pressure to the living subject. The living subject's blood pressure is measured using a well-known oscillometric method, which is based on detecting changes in the amplitude of a synchronous wave pulsation as the pressure applied by the cuff is gradually released. Web site: http://www.delphion.com/details?pn=US05921936__
·
Transgenic rats containing at least one human gene which participates in blood pressure control Inventor(s): Mullins; John (Edinburgh, GB3), Ganten; Detlev (Tischbeinstr. 5, 6900 Heidelberg, DE), Murakami; Kazuo (Ibaraki-Ken, JP) Assignee(s): Ganten; Detlev (Heidelberg, DE) Patent Number: 5,731,489 Date filed: January 17, 1995 Abstract: The present invention relates to transgenic rats in the genome of which at least one human gene is integrated the gene product of which participates in blood pressure control. More specifically, the invention relates to transgenic rats and their offspring exhibiting increased blood pressure (>90/>140 mm Hg) or high blood pressure (>95/>160 mm Hg). Finally, the invention relates to processes for the production
168 High Blood Pressure
of the transgenic rats of the present invention and their offspring and their use for pharmacological tests. Excerpt(s): The present invention relates to transgenic rats in the genome of which at least one human gene is integrated the gene product of which participates in blood pressure control. More specifically, the invention relates to transgenic rats and their offspring exhibiting increased blood pressure (>90/>140 mm Hg) or high blood pressure (>95/>160 mm Hg). Finally, the invention relates to processes for the production of the transgenic rats of the present invention and their offspring and their use for pharmacological tests. Web site: http://www.delphion.com/details?pn=US05731489__ ·
Use of.gamma.-tocopherol and its oxidative metabolite LLU-.alpha. in the treatment of natriuretic disease Inventor(s): Wechter; William J. (Redlands, CA) Assignee(s): Loma Linda University Medical Center (Loma Linda, CA) Patent Number: 6,048,891 Date filed: December 17, 1998 Abstract: The present invention is generally related to the discovery of the therapeutic benefit of administering.gamma.-tocopherol and.gamma.-tocopherol derivatives. More specifically, the use of.gamma.-tocopherol and racemic LLU-.alpha., (S)-LLU-.alpha., or.gamma.-tocopherol derivatives as antioxidants and nitrogen oxide scavengers which treat and prevent high blood pressure, thromboembolic disease, cardiovascular disease, cancer, natriuretic disease, the formation of neuropathological lesions, and a reduced immune system response are disclosed. Excerpt(s): The present invention is generally related to the discovery of the therapeutic benefit of administering.gamma.-tocopherol and.gamma.-tocopherol derivatives. More specifically, the use of.gamma.-tocopherol and racemic LLU-.alpha., (S)-LLU-.alpha., or other.gamma.-tocopherol derivatives as antioxidants and nitrogen oxide scavengers which treat and prevent high blood pressure, thromboembolic disease, cardiovascular disease, cancer, natriuretic disease, the formation of neuropathological lesions, and a reduced immune system response are disclosed. Vitamin E, an essential fat-soluble vitamin, encompasses eight naturally occurring compounds in two classes. The first class, tocopherols, have four members designated alpha, beta, gamma and delta. The two major forms,.alpha.-tocopherol and.gamma.-tocopherol, differ structurally only by a methyl group substitution at the 5-position. The second class, tocotrienols, are molecules related to the tocopherols and also consist of four members designated alpha, beta, gamma and delta. The tocotrienol structure differs from the tocopherols by possessing three double bonds in their side chain rather than being saturated. One of the important chemical features of the tocopherols is that they are redox agents which act under certain circumstances as antioxidants. In acting as an antioxidant, tocopherols presumably prevent the formation of toxic oxidation products, such as perioxidation products formed from unsaturated fatty acids. Early on, investigators attributed most if not all of the biological activity of the tocopherols to their ability to act as antioxidants. More recently, however, other biological activities have been associated with tocopherols including the modulation of signal transduction, modulation of phospholipid metabolism, inhibition of protein kinase C, inhibition of phospholipase A
Patents 169
and inhibition of prostaglandin production. (Meydani and Mosen, The Lancet 345(8943):170-175 (1995)). Web site: http://www.delphion.com/details?pn=US06048891__ ·
Use of retinoids to treat high blood pressure and other cardiovascular disease Inventor(s): McCarron; David A (2605 SW. Buena Vista St., Portland, OR 97201), Roullet; Jean-Baptiste (4124 Tunnelwood St., Portland, OR 97221) Assignee(s): none reported Patent Number: 6,437,003 Date filed: June 3, 1999 Abstract: This invention provides methods of treating a disease in a mammal where the disease is characterized by a symptom ameliorated by inhibition of cellular calcium influx. The methods involve administering to the mammal an effective amount of a retinoid and a pharmacologically acceptable excipient. Excerpt(s): Calcium channel blockers are a relatively recently discovered class of compounds which possess a wide spectrum of properties useful in the treatment of cardiovascular, cerebrovascular, intraocular, and other disorders. Calcium channel blockers were initially identified as a method for the control of hypertension (Fleckenstein et al. (1967) Z. Kreislaufforsch, 56: 716), and are routinely used in the control of hypertension and other disorders. In particular, calcium blockers have shown some useful therapeutic properties in the treatment of classic exertional angina, vasospastic angina, angina pectoris, acute myocardial infarction, cardiac arrhythmias, systemic arterial hypertension, pulmonary arterial hypertension, and cardiomyopathies. In addition, calcium channel blockers have shown therapeutic properties in the treatment of various cerebrovascular disorders, including but not limited to migraine headaches, and convulsive epilepsy. Several structural classes of compounds are known which exhibit calcium channel blocking utility and have been used as therapeutics in a variety of contexts. The three major classes include dihydropynidines (e.g., nifedipine, felodipine, isradipine, and amlodipine), the benzothiazepines (e.g., diltiazem), and the phenylalkylamines (e.g., verapamil). Three calcium channel blockers are currently of primary clinical significance in the United States, verapamil, nifedipine and diltiazem. All three achieve their antihypertensive effect by inhibiting the entry of calcium ions into vascular smooth muscle. The ultimate effect is vasodilation. These calcium blockers are, however, contraindicated in various circumstances (e.g., where there is impaired left ventricular function). Thus, there is a need for other calcium blocking agents. The present identifies previously unknown calcium channel blocking properties of retinoids, in particular retinol, and provides methods of treating pathological conditions characterized by and ameliorated by inhibition of cellular calcium influx using retinoids. Retinoids (e.g., vitamin A and analogues) are lipid-soluble and can therefore achieve extensive distribution within body tissues. They are also rapidly absorbed after oral or intravenous administration and, because of their affinity for fatty tissues, provide a reservoir that maintains elevated retinoid levels for some time after administration. In addition, the physiological tolerance for many retinoids (e.g., vitamin A) has been repeatedly demonstrated and well characterized. Web site: http://www.delphion.com/details?pn=US06437003__
170 High Blood Pressure
Patent Applications on High Blood Pressure As of December 2000, U.S. patent applications are open to public viewing.10 Applications are patent requests which have yet to be granted. (The process to achieve a patent can take several years.) The following patent applications have been filed since December 2000 relating to high blood pressure: ·
1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them Inventor(s): Wiemer, Gabriele; (Kronberg, DE), Heitsch, Holger; (Mainz-Kastel, DE) Correspondence: FINNEGAN, HENDERSON, FARABOW, GARRETT &; DUNNER LLP; 1300 I STREET, NW; WASHINGTON; DC; 20005; US Patent Application Number: 20010018449 Date filed: March 16, 2001 Abstract: The invention relates to novel 1-(p-thienylbenzyl)imidazoles of formula (I) 1where the radicals R(1) to R(6), X, and Y have the meaning indicated in the description, which are potent agonists of angiotensin (1-7) receptors and owing to the production and release of the vasorelaxant, antithrombotic, and cardioprotective messengers cyclic 3',5'-guanosine monophosphate (cGMP) and nitrogen monoxide (NO) associated with the stimulation of these receptors on endothelial cells are valuable pharmaceuticals for the treatment and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, endothelial dysfunction or endothelial damage, e.g., as a result of arteriosclerotic processes or diabetes mellitus, and also of arterial and venous thromboses. Excerpt(s): which are potent agonists of angiotensin (1-7) receptors and, because of the production and release of the vasorelaxant, antithrombotic, and cardio-protective messengers cyclic 3',5'-guanosine monophosphate (cGMP) and nitrogen monoxide (NO) associated with the stimulation of these receptors on endothelial cells, are valuable pharmaceuticals for the treatment and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, an endothelial dysfunction or endothelial damage, e.g., as a result of arteriosclerotic processes or in diabetes mellitus, and of arterial and venous thrombosis. EP-A 512675 and WO 94/27597 describe thienylbenzyl-substituted imidazoles as angiotensin 11 receptorantagonists and their use for the treatment of hypertension, cardiac insufficiency, migraine, Alzheimer's disease, and as antidepressants. Moreover, thienylbenzylsubstituted imidazopyridines are disclosed in EP-A 513979 as antagonists of angiotensin 11 receptors and their use for the treatment of hypertension, cardiac insufficiency, migraine, and Alzheimer's disease, and in U.S. Pat. No. 5,444,067 as angiotensin 11 agonists and their use for the treatment of hypotension and of hypoaldosteronism. In addition, in EP-A 534706 thienylbenzyl-substituted quinazolinones and pyridopyrimidones and in EP-A 510812 thienylbenzyl-substituted triazoles are disclosed as antagonists of angiotensin II receptors. The 1-(p-thienylbenzyl)imidazoles of formula (I) described here and their use as agonists of angiotensin (1-7) receptors are in this case neither described, anticipated, nor suggested in the applications mentioned. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
10
This has been a common practice outside the United States prior to December 2000.
Patents 171
·
Agents for improving lipid metabolism and reducing high blood pressure Inventor(s): Toba, Yasuhiro; (Tokyo, JP), Morita, Yoshikazu; (Kawagoe-shi, JP), Kawakami, Hiroshi; (Kawagoe-shi, JP), Abe, Takumi; (Kawagoe-shi, JP), Takada, Yukihiro; (Kawagoe-shi, JP) Correspondence: KNOBBE MARTENS OLSON & BEAR LLP; 2040 MAIN STREET; FOURTEENTH FLOOR; IRVINE; CA; 91614; US Patent Application Number: 20030040475 Date filed: January 15, 2002 Abstract: A milk-derived basic protein fraction and a basic peptide fraction are provided for use as an effective component for agents for improving lipid metabolism and reducing high blood pressure which can be administered orally, are effective with a relatively small dosage, have good taste and are stable during storage. Excerpt(s): The present invention relates to agents, drinks and food products for improving lipid metabolism and reducing high blood pressure and the combination thereof that are effective in treating and preventing diseases such as fatty liver, hyperlipidemia, arteriosclerosis, obesity and hypertension. Lipid metabolism refers to catabolic (decomposing) and anabolic (accumulating) processes of lipids, mainly comprising triglicerides derived from food. Lipid metabolism generally includes energy-releasing reaction of lipids, biosynthesis of fatty acids, biosynthesis of acylglycerols, phospholipid metabolism, cholesterol metabolism, and the like ("Biochemistry for Nutrition" by Akira Misaki, Asakura Shoten, 1993, pp. 123-134). In recent years, the mortality rate from cardiovascular disease has been rapidly increasing and the correlation between the risk of getting cardiovascular disease and the blood cholesterol concentration has been pointed out. Meantime, several attempts have been made to reduce the blood cholesterol concentration by using food materials, which can be ingested in daily life. For example, soybean protein (Arteriosclerosis 1988 72:115), whey protein (Agric Biol Chem 1991 55:813; Japanese Patent Application Laid-open No. H5-176713), soybean protein hydrolyzates (J Nutr 1990 120:977), and egg yolk phospholipid (Agric Biol Chem 1989 53:2469) have been tried. Further, a method making use of lactoalbumin, collagen, soybean protein or wheat gluten and soybean lecithin in combination (Nutr Rep Int 1983 28:621) and a method making use of tissue-like soybean protein containing soybean lecithin (Ann Nutr Metab 1985 29:348), and the like have been proposed. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
Biological markers and diagnostic tests for angiotensin converting enzyme inhibitorand vasopeptidase inhibitor-associated angioedema Inventor(s): Brown, Nancy J.; (Nashville, TN) Correspondence: JENKINS & WILSON, PA; 3100 TOWER BLVD; SUITE 1400; DURHAM; NC; 27707; US Patent Application Number: 20030180828 Date filed: April 25, 2003 Abstract: Deficiencies in certain physiological pathways are linked with ACE or vasopeptidase inhibitor associated angioedema. Additionally, detection and/or measurement of dipeptidyl peptidase IV (DPP IV) enzyme activity and aminopeptidase
172 High Blood Pressure
P (APP) enzyme activity is a predictor of this risk. The present invention provides biological markers, diagnostic tests, and pharmaceutical indications that are useful in the diagnosis and treatment of angioedema and in the marketing and safety of certain medications. This ability can be important for the treatment of a subject that is in need of or are taking an angiotensin-converting enzyme (ACE) inhibitor and/or a vasopeptidase inhibitor (combined ACE and neutral endopeptidase (NEP) inhibitor), which are commonly used in the treatment of hypertension (high blood pressure), diabetes, and cardiac and renal diseases. Excerpt(s): The present patent application is based on and claims priority to U.S. Provisional Application Serial No. 60/244,524, entitled "Biological Markers and Diagnostic Tests for Angiotensin Converting Enzyme Inhibitor and Vasopeptidase Inhibitor Associated Angioedema", which was filed Oct. 31, 2000 and is incorporated herein by reference. The present invention relates generally to screening tests to determine which patients are at risk for developing angioedema associated with inhibitors of angiotensin converting enzyme (ACE) and/or combined ACE and neutral endopeptidase (NEP) inhibitors (a combined ACE/NEP inhibitor is referred to herein as a "vasopeptidase inhibitor"). More particularly, the present invention relates to an association between dipeptidyl peptidase IV (DPP IV) and aminopeptidase P (APP) enzymatic activity and ACE and vasopeptidase inhibitor-related angioedema. The present invention also provides screening tests and kits to identify a subject who is at risk for ACE and vasopeptidase inhibitor-associated angioedema. Administration of angiotensin-converting enzyme (ACE) inhibitors is common medical practice for the treatment of a variety of disease conditions, including: cardiac and renal diseases, diabetes, and hypertension (high blood pressure). Several combined ACE and neutral endopeptidase (NEP) inhibitors are presently under investigation or are awaiting regulatory approval for the treatment of the aforementioned disease conditions. However, the administration of an ACE and/or a vasopeptidase inhibitor (referred to herein as an ACE/vasopeptidase inhibitor) is contraindicated for subjects with a history of angioedema due to the potential severity of this side effect, which can be so severe as to result in death. Approximately 0.1% to 1.0% of the population receiving an ACE inhibitor is predicted to be susceptible to developing at least one episode of angioedema during treatment. This percentage might be even higher, especially for subjects taking a vasopeptidase inhibitor. Also, these inhibitors are often administered over long periods of time because the illnesses that they treat are often chronic conditions. This could increase the chances of a subject developing angioedema over a course of treatment. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Composition and method for prevention and treatment of health conditions caused by constriction of smooth muscle cells Inventor(s): Rath, Matthias; (Cupertino, CA) Correspondence: KENYON & KENYON; ONE BROADWAY; NEW YORK; NY; 10004; US Patent Application Number: 20030003162 Date filed: June 19, 2001 Abstract: The invention relates to a method of administering to a human subject a composition comprising a vitamin, an amino acid and a trace element for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body like high blood pressure, asthma, glaucoma and tinnitus. The
Patents 173
composition comprises a vitamin such as ascorbic acid, an amino acid such as arginine, and a trace element such as magnesium. Excerpt(s): The present invention relates generally to the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body. The cause of many diseases remains unknown. Among these diseases with unknown origin are most common diseases including high blood pressure, asthma, glaucoma and tinnitus. In case of high blood pressure, one of the most renowned textbooks in medicine, Harrison's Principles of Internal Medicine, states that the cause of the disease is unknown in about 90% of the patients. Worldwide several hundred million people suffer from these health conditions and the economic damage to society from not being able to treat these health conditions effectively is immeasurable. Worldwide several million people suffer from asthma bronchiale (asthma). In its late stages asthma is a debilitating disease leading to the inability to work and to-social isolation. The cause of this disease remains unknown, even though allergens, genetic disposition and psychological factors have been implicated. The common pathomechanism of this disease is an obstruction of the ventilation channels in the lung (bronchioles) and of the passages to the alveoli where the oxygenation takes place. However, the cellular mechanisms that trigger this obstruction, thereby causing asthma, is not yet understood. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Cryogenic stimulating device of acupuncture points Inventor(s): Ahn, Moon-Hwi; (Chollabuk-do, KR) Correspondence: FROMMER LAWRENCE & HAUG; 745 FIFTH AVENUE; NEW YORK; NY; 10151; US Patent Application Number: 20010023364 Date filed: March 19, 2001 Abstract: The present invention relates to a cryogenic stimulating device of acupuncture points. Previous cryogenic stimulating devices of acupuncture points have limitations in maximizing the effect of lowering blood pressure since such devices do not allow the user to control the cooling temperature of the contact rod according to the individual body temperature.In order to eliminate the drawbacks of the previous cryogenic stimulating devices, the present invention provides a cryogenic stimulating device of acupuncture points with a temperature sensor which senses the cooling temperature of the contact rod in contact with the skin and a temperature controlling means comparing the temperature of the contact rod and the temperature set by the user and then automatically controlling the temperature of the contact rod according to the temperature set by a user to a preferred degree in consideration of his conditions. Consequently, the user can freely set a cooling temperature of the contact rod by using the present inventive cryogenic stimulating device and thus he may obtain the best effect of high blood pressure treatment. Excerpt(s): The present invention relates to a stimulating device of acupuncture points provided with a temperature sensor mounted on a contact rod contacting a user's skin and a temperature controlling means which enables the user to freely set the cooling temperature of the contact rod, whereby according to the difference between the temperature set by the user and that sensed by the temperature sensor the temperature of the contact rod may be automatically adjusted. Therefore, by using the present
174 High Blood Pressure
stimulating device, the user may control the temperature of the contact rod to a preferred degree to give the more effective treatment of acupuncture points in consideration of his conditions. In general, high blood pressure treatments have been largely done with some occidental medicines (e.g. a medicine for internal use, an injection, etc.) and oriental acupuncture, etc. While, the medicines cause side effects and the oriental acupuncture requires expertness, and furthermore, these treatments cannot bring an effect in a short period. According to the research on the acupuncture points in a human body, the inventor learned that low-temperature stimulus on acupuncture points helps high blood pressure decrease and thus the inventor have completed the present invention of the cryogenic stimulating device of acupuncture points enabling the users to treat conveniently high blood pressure, headache, fever, and the likes. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Drinking carbonated water for the use of reducing high blood pressure and edema Inventor(s): Bida, Sam; (Ely, NV) Correspondence: Sam Bida; 2160 Crawford Street; Ely; NV; 89301; US Patent Application Number: 20020098263 Date filed: January 25, 2001 Abstract: By taking carbonated water orally each day it aids in the reduction of high blood pressure and edema. To use this invention a person would orally drink 5 oz. of the carbonated water in the morning and another 5 oz. in the evening for the reduction of high blood pressure and edema. Excerpt(s): This invention pertains to home health remedy. Many prescription drugs are sold each year for the control of high blood pressure and edema. The drugs which are prescribed for these aliments have many unhealthy side effects. My invention entails a person who is plagued by either or both high blood pressure and edema to take along with any medication that they may be on in order to help with the reduction of both high blood pressure and edema. By orally drinking the carbonated water daily, high blood pressure and edema is reduced. The advantage of this invention is that it may be taken along with any and all prescription and non-prescription medications while aiding in the reduction of high blood pressure and edema without the side effects caused by some prescription and non-prescription drugs. Not Applicable. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
ELECTRONIC BEHAVIOR MODIFICATION REMINDER SYSTEM AND METHOD Inventor(s): CLENDENON, JOHN RICHARD; (PALMETTO, FL) Correspondence: DOROTHY S MORSE; 515 PARK DRIVE N W; BRADENTON; FL; 342091847 Patent Application Number: 20020072959 Date filed: June 19, 1999 Abstract: A discrete operator reminder system and method for modifying recognized unwanted behavior. The system uses a combination of manual operator input and prior history to establish the timing of future prompting signals. It does not provide users with programmed schedules of future events, but instead calculates the timing of each
Patents 175
future prompting signal based upon the most recent operator response indicating whether the operator was engaged in the monitored behavior at the time of prompting signal generation. The system comprises a microprocessor housed in a hard outer casing that is compact, lightweight, easily portable, and discretely configured as a writing implement, wristwatch, pocket watch, key chain, piece of jewelry, or pocket-sized trinket, or in the alternative comprises programming for personal computers, electronic notebooks, cell phones, pagers, hand-held organizers, or other similar electronic devices. After initialization, prompting signals are periodically generated. If the operator is engaged in the unwanted activity during a prompting signal and so indicates by response, the next signal interval would be shortened by a variable increment to prevent the operator from anticipating the next prompting signal. If the operator is not thus engaged and so indicates by response, the interval is increased. The system may also display various behavior related data, such as current date, time, progress graph, and average signal interval. Applications may include, but are not limited to, use by people to quit smoking, stop nail biting and hair pulling, improve posture, reduce high blood pressure, improve attitude, enhance concentration, and change other unwanted behavior. Excerpt(s): This invention relates to training and behavior modification devices, specifically to a discrete operator-prompting reminder system and method which uses a combination of manual operator input and prior history to establish the timing of a next prompting signal. The device does not provide its user with a programmed schedule of future events, but instead calculates the timing of each next prompting signal based in part upon the most recent operator entry identifying whether the operator was engaged in the monitored behavior at the time the last prompting signal was generated. Applications may includes, but are not limited to help in changing undesirable or unwanted behavior or such is the correction of poor posture, quitting the use of tobacco products, cessation of nail biting, cessation of hair pulling, reduction of elevated blood pressure levels, overcoming negative reactions to stress, improvement in attitude and a sense of well-being, and enhancing one's ability to concentrate or focus. A parent concerned about a child's future behavior, social acceptability, and general sense of wellbeing and self-worth is a valuable instrument in conditioning the child and shaping the behavioral patterns that the child will carry forward into a, successful adulthood. In essence, the reminding parent can continually assist a child in remembering to pick up and straighten the belongings in his or her room, stand up straight, use good manners while eating, stop nail biting, eat the proper foods for good nutrition, stop squirming, use socially acceptable language, be fiscally conservative, and the like, until the repetition conditions the child over an extended period of time to function in a positive and productive manner. Although children may not always appreciate the constant reinforcement, they rely on it to learn acceptable behavior until they can become sufficiently self-disciplined to correct bad habits and undesirable behavior on their own. However, in spite of the best efforts of even the most concerned parents, most children will experience a variety of bad habits as they grow up and most will enter adulthood with at least a few which they have been unable to overcome. In addition, many adults become so busy in their daily lives that they are not able to find the extra energy or focus necessary to correct such bad habits or other recognized unwanted behavior without some assistance. These adults would benefit from a companion device that would take the place of a reminding or nagging parent and remind them on a periodic basis to stop performing a selected type of behavior which they consider undesirable and sincerely want to correct or improve, but have otherwise been unable to do so. Many conditioning, memory enhancing, and behavior modification devices are known. They have been used for weight control, posture monitoring and training, diabetes
176 High Blood Pressure
management, sports training, timed medication dispensing, prenatal breathing control, pulmonary tract sensitivity testing, and swallowing rehabilitation. Some involve biofeedback where respiration or electrical impulses are measured and used as a basis for timing the next generated signal. Others provide for randomly generated prompting signals after which the operator may be offered one or more alternative choices of response behavior, and still others set target times and schedules for operator performance. The prior art believed to be the most closely related to the present invention is the invention disclosed in U.S. Pat. No. 4,853,854 to Behar (1989). The Behar method and apparatus uses the establishment of baseline behavior for generating a behavior specific and targeted withdrawal schedule for a user. The user is reminded of the schedule through timely audio or visual signals. The Behar device can also have a display which identifies to a user the number of days left in the schedule and the time remaining until the next signal. In contrast, the present invention does not provide a schedule, and in the preferred embodiment the time remaining until the next prompting signal is variable and purposefully not made available to the operator so that the operator is not able to anticipate the next prompting signal and thereby skew the history available for use in determining the timing of future prompting signals. No other behavior modification device is known that functions in the same manner as the present invention and provides all of its advantages. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Method and apparatus for detecting cardiovascular disease Inventor(s): Park, Su-Hong; (Inchon, KR), Kim, Dae-Woo; (Seoul, KR) Correspondence: COLLIER, SHANNON, SCOTT, PLLC; 3050 K STREET, NW; SUITE 400; WASHINGTON; DC; 20007; US Patent Application Number: 20020183631 Date filed: May 8, 2002 Abstract: A method is disclosed which comprises the steps of detecting a pulse wave of a user and measuring pulse wave information for a plurality of beats from the pulse wave; producing a statistical average of the measured pulse wave information; and determining whether the user has arrhythmia or high blood pressure based on the produced statistical average of the pulse wave information. And, an apparatus which comprises a detecting part which detects a pulse wave of a user and measures pulse wave information for a plurality of beats from the pulse wave; a memory device which stores the measured pulse wave information; and a determining part which produces a statistical average of the stored pulse wave information and determines whether the user has arrhythmia or high blood pressure based on the produced statistical average of the pulse wave information. Excerpt(s): This application claims priority on Korean Patent Application No. 10-20010024889, entitled "Method and Apparatus For Detecting Cardiovascular Disease," filed May 8, 2001. The present invention relates to a method and apparatus for detecting cardiovascular disease, more particularly, to a method and apparatus for detecting arrhythmia or high blood pressure using the statistical average of information taken from pulse wave. Generally, those people who have arrhythmia also have high blood pressure, and they usually have both a sphygmomanometer and a device for measuring electrocardiogram. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
Patents 177
·
Method of blood pressure moderation Inventor(s): Swenson, David D.; (Carlsbad, CA), Grey, Thomas L.; (Carlsbad, CA), Gruzdowich, Gregory J.; (Carlsbad, CA) Correspondence: CROCKETT & CROCKETT; 24012 CALLE DE LA PLATA; SUITE 400; LAGUNA HILLS; CA; 92653; US Patent Application Number: 20020133210 Date filed: May 16, 2002 Abstract: A method of controlling the blood pressure in a patient with high blood pressure or low blood pressure utilizing a non-invasive nerve stimulation device applied to the wrist. Excerpt(s): This application is a continuation of U.S. application Ser. No. 09/767,062 filed Jan. 22, 2001, now U.S. Pat. No. 6,393,324, which is a continuation of U.S. application Ser. No. 09/307,272 filed May 7, 1999, now U.S. Pat. No. 6,178,352. This invention relates to moderation of blood pressure. High blood pressure and low blood pressure are usually treated with drugs. Several proposals have been made to treat blood pressure with electrical stimulus applied to the body. For example, Terry, et al, Treating Refractory Hypertension By Nerve Stimulation, U.S. Pat. No. 5,707,400 (Jan. 13, 1998) proposes implantation of an electrical coil around the vagus nerve, which runs superficially through the neck, and stimulation of the vagus nerve to lower high blood pressure. Zhu, Blood Pressure Depressor, U.S. Pat. No. 5,891,181 (Apr. 6, 1999) proposes electrical stimulation of nerves in the ear lobe to lower blood pressure. Pomeranz, et al, Electrotherapy Acupuncture Apparatus and Method, U.S. Pat. No. 4,566,064 (Dec. 3 1985) mentions blood pressure as an indication for electro-acupuncture, but does not mention any point of application. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
Naphthalenyl piperidines as renin inhibitors Inventor(s): Marki, Hans-Peter; (Basle, CH), Breu, Volker; (Schliengen, DE), Vieira, Eric; (Allschwil, CH), Wostl, Wolfgang; (Grenzach-Wyhlen, DE) Correspondence: HOFFMANN-LA ROCHE INC.; PATENT LAW DEPARTMENT; 340 KINGSLAND STREET; NUTLEY; NJ; 07110 Patent Application Number: 20020087002 Date filed: December 18, 2001 Abstract: Piperidine derivatives, their manufacture and use as medicaments is described. The compounds are useful for treating diseases associated with restenosis, glaucoma, cardiac infarct, high blood pressure and end organ damage, e.g. cardiac insufficiency and kidney insufficiency. Excerpt(s): This is a divisional of copending application No. 09/542,303, filed Apr. 4, 2000. The present invention relates to novel piperidine derivatives, their manufacture and use as medicaments. and pharmaceutically acceptable salts thereof. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
178 High Blood Pressure
·
Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome Inventor(s): Marin, Per; (Goteborg, SE) Correspondence: Bradley N. Ruben; Suite 5A; 463 First Street; Hoboken; NJ; 07030; US Patent Application Number: 20030013209 Date filed: June 25, 2002 Abstract: The use of cortisol agonist for preparing a system for diagnosis of the metabolic syndrome and related conditions as belly fatness, insulin resistancy including increased risk of developing senile diabetes, i.e. diabetes type II, high blood fats and high blood pressure, in which system the dose of cortisol agonist is in an interval where a difference is obtained in the inhibitory effect of the autoproduction of cortisol in individuals suffering from the metabolic syndrome, compared to normal values. Excerpt(s): The metabolic syndrome is characterised by an increased amount of adipose tissue inside the abdominal cavity (popularly called belly fatness), insulin resistance with increased risk of developing senile diabetes, i.e. diabetes type II (=NIDDM, noninsulin dependent diabetes mellitus), high levels of blood fats and high blood pressure. Parallel to this is an increased risk of coronary, apoplexy, sudden death and other arteriosclerotic conditions. A hypothetical explanation to the metabolic syndrome could be an overproduction of cortisol, a stress hormone which causes an accumulation of fat inside the abdominal cavity, and insulin resistance. Theoretically this could, through secondary metabolic effects, explain the other disorders related to the metabolic syndrome. In Metabolism, vol. 41, No 8, 1992, pages 882-886, is shown that belly fat women have higher secretion of cortisol than "evenly fat" women. The same work describes the effects of acute mental stress on the production of cortisol. It was shown that belly fat women, at a given stress signal, produced more cortisol than `evenly fat` women. This suggested, but did not prove, that there may be a relationship between stress and belly obesity. A dexamethasone inhibitor test was carried out with 1 mg dexamethasone and subsequent measurement of cortisol content in serum. No difference in inhibitory effect on the production of cortisol could be found between the groups of belly fat women and to evenly fat women and standard values. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html
·
Regulation of human leucine aminopeptidase-like enzyme Inventor(s): Xiao, Yonghong; (Cambridge, MA), Ramakrishnan, Shyam; (Brighton, MA) Correspondence: BANNER & WITCOFF; 1001 G STREET N W; SUITE 1100; WASHINGTON; DC; 20001; US Patent Application Number: 20030049670 Date filed: September 23, 2002 Abstract: Reagents which regulate human leucine aminopeptidase-like enzyme activity and reagents which bind to human leucine aminopeptidase-like enzyme gene products can be used to regulate cellular and extracellular polypeptide degradation. Such regulation is particularly useful for treating cancer, HIV, autoimmune disease, and high blood pressure. Excerpt(s): The invention relates to the area of regulation of cellular and extracellular degradation of polypeptides. More particularly, the invention relates to the regulation of
Patents 179
human leucine aminopeptidase-like enzyme activity to increase or decrease cellular and extracellular polypeptide degradation. Aminopeptidases comprise a family of zinc metalloproteinases that catalyze the removal of N-terminal residues from protein substrates. A leucine aminopeptidase catalyzes the release of an N-terminal amino acid wherein the N-terminal amino acid is preferably Leu, but can be other amino acids such as Pro. A leucine aminopeptidase can also hydrolyze amino acid amides and methyl esters. Elevated levels of leucine aminopeptidase is correlated with various cancers, autoimmune diseases, and HIV. Leucine aminopeptidase has also been shown to decrease high blood pressure. It is an object of the invention to provide reagents and methods of regulating cellular and extracellular degradation of polypeptides. These and other objects of the invention are provided by one or more of the embodiments described below. Web site: http://appft1.uspto.gov/netahtml/PTO/search-bool.html ·
Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators Inventor(s): Strobel, Hartmut; (Liederbach, DE), Schindler, Ursula; (Bad Soden, DE), Schoenafinger, Karl; (Alzenau, DE) Correspondence: FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER; LLP; 1300 I STREET, NW; WASHINGTON; DC; 20005; US Patent Application Number: 20030171352 Date filed: January 24, 2003 Abstract: The present invention relates to compounds of the formula I 1in which A.sup.1, A.sup.2, R.sup.2 and R.sup.3 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds for the therapy and prophylaxis of diseases, for example of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis. The compounds of the formula I have the ability to modulate the endogenous production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the therapy and prophylaxis of disease states which are associated with a disturbed cGMP balance. The invention relates to the use of compounds of the formula I for the therapy and prophylaxis of the designated disease states and for the production of pharmaceuticals therefor, novel compounds of the formula I, pharmaceutical preparations comprising them and processes for their preparation. Excerpt(s): in which A.sup.1, A.sup.2, R.sup.2 and R.sup.3 have the meanings indicated below, which are valuable pharmaceutical active compounds for the therapy and prophylaxis of diseases, for example of cardiovascular disorders such as high blood pressure, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis. The compounds of the formula I have the ability to modulate the endogenous production of cyclic guanosine monophosphate (cGMP) and are generally suitable for the therapy and prophylaxis of disease states which are associated with a disturbed cGMP balance. The invention relates to the use of compounds of the formula I for the therapy and prophylaxis of the designated disease states and for the production of pharmaceuticals therefor, novel compounds of the formula I, pharmaceutical preparations comprising them and processes for their preparation. cGMP is an important intracellular messenger, which elicits a number of pharmacological effects by means of the modulation of cGMPdependent protein kinases, phosphodiesterases and ion channels. Examples are smooth muscle relaxation, the inhibition of platelet activation and the inhibition of smooth muscle cell proliferation and leukocyte adhesion. cGMP is produced by particulate and
180 High Blood Pressure
soluble guanylate cyclases as a response to a number of extracellular and intracellular stimuli. In the case of the particulate guanylate cyclases, the stimulation essentially takes place by means of peptidic messenger substances, such as the atrial natriuretic peptide or the cerebral natriuretic peptide. The soluble guanylate cyclases (sGC), which are cytosolic, heterodimeric heme proteins, however, are essentially regulated by a family of low molecular weight, enzymatically formed factors. The most important stimulant is nitrogen monoxide (NO) or a closely relates species. The importance of other factors such as carbon monoxide or the hydroxyl radical is still largely unclarified. The binding of NO to the heme with formation of a pentacoordinated heme-nitrosyl complex is discussed as an activation mechanism of activation by NO. The release associated therewith of the histidine which is bound to the iron in the basal state converts the enzyme into the activated conformation. Active soluble guanylate cyclases are each composed of one.alpha.- and one.beta.-subunit. Several subtypes of the subunits have been described, which differ from one another with respect to sequence, tissue-specific distribution and expression in various stages of development. The subtypes.alpha.sub.1 and.beta.sub.1 are mainly expressed in the brain and lung, while.beta.sub.2 is especially found in liver and kidney. The subtype.alpha.sub.2 was detected in human fetal brain. The subunits designated as.alpha.sub.3 and.beta.sub.3 were isolated from human b